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SUMMARY
In response to a cytotoxic insult, a cell can die by necrosis or by apoptosis. Therefore, 
the overall objective of this investigation was to identify the mechanisms of drug-induced 
liver cell apoptosis in vitro to help with the discovery of novel markers of apoptosis that 
could be used for predicting hepatocyte apoptosis in vivo. In this investigation, the 
capability of drugs to induce apoptosis in liver cells was investigated using two cellular 
models, namely primary mouse hepatocytes and the hepatoma cell line, HuH7. This 
study was performed using three model compounds, paracetamol, thapsigargin and 
duroquinone.
The hepatotoxin, paracetamol, is a widely used analgesic drug, can induce fatal liver 
injury through a combination of apoptosis and necrosis, when taken in large doses. Our 
work has previously shown that apoptosis plays an essential role in paracetamol-induced 
hepatic injury since inhibiting apoptosis, prevents the development of acute liver failure. 
The endoplasmic reticulum (ER) stress inducer, thapsigargin, acts by selectively 
inhibiting the ER Ca^^-ATPase, which pumps calcium against a concentration gradient 
into the ER. Both paracetamol and thapsigargin caused marked cytotoxicity in HuH7 
cells as evidenced by chromatin condensation and DNA fragmentation. Similarly, the 
redox-cycler, duroquinone, caused cell death in the HuH7 cells and primary hepatocytes 
by both the induction of apoptotic and necrotic cell death.
All three compounds caused the activation of executioner caspases-3 and -7 and also the 
cleavage of caspase-3 cellular substrates including fodrin and cytokeratin 18.
Furthermore, the pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-DL-Asp- 
fluoromethylketone (Z-VAD-fmk) protected from paracetamol and thapsigargin-induced 
cytotoxicity. However, Z-VAD-frnk did not afford protection from duroquinone-induced 
cell death by oxidative stress in the HuH7 cells. Non-caspase proteases including 
calpains, cathepsins, serine proteases and the proteasome were not involved in cell death 
by these compounds.
The manifestation of apoptosis was preceded by a loss of mitochondrial membrane 
potential and the release of cytochrome c and Smac/DIABLO. However, the inhibitors of 
the membrane permeability transition pore (FTP) cyclosporine A and bongkrekic acid 
failed to prevent apoptosis. In contrast, the Bcl-2 pro-apoptotic protein Bax, was found 
to translocate to the mitochondria to allow the release of cytochrome c in the HuH7 cells 
treated with paracetamol, thapsigargin and duroquinone.
It was postulated that as a result of the metabolic activation of paracetamol and the 
concomitant production of reactive oxygen species (ROS), a cellular stress response was 
induced in HuH7 cells. To investigate the role of this stress response in the initiation of 
apoptosis by paracetamol and also thapsigargin and duroquinone, stress-activated protein 
kinases including c-Jun N-terminal kinase (JNK) and p38 and also MEKl/2 and glycogen 
synthase kinase-3 (GSK-3) were investigated. Although JNK was shown to be activated, 
the pharmacological inhibition of JNK, p38 and MEK did not afford protection from cell 
death by these compounds in the HuH7 cells. However, the inhibition of pro-apoptotic 
GSK-3 protected significantly from paracetamol and thapsigargin-induced cell death by 
apoptosis.
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CHAPTER 1
GENERAL INTRODUCTION
- 1  -
1.1. Cell Death by Apoptosis
In the middle of the last century soon after the breakthrough that organisms are made of 
cells, it was discovered that cell death plays a critical role in animal development 
(Glucksmann, 1951; Lockshin and Williams, 1965; Saunders, 1965; Clarke and Clarke, 
1996). Cell death was first observed during amphibian metamorphosis in 1842 and soon 
after was observed to occur in many developing tissues in both invertebrates and 
vertebrates (Kerr et a l, 1974; Kerr et a l, 1987; Arends and Wyllie, 1991). Lockshin and 
Williams used the term “programmed cell death” to refer to the death of given cell types 
during development at predictable places and at predictable times to stress that the deaths 
are somehow programmed into the developmental plan of the organism, following a tight 
sequence of genetically controlled steps towards their own cell destruction (Lockshin and 
Williams, 1965; Jacobson et a l, 1997; Lockshin and Zakeri, 2001). In adult mammals, 
apoptosis is also a continuous important process which occurs in a wide variety of 
proliferating cell populations such as the liver epithelium (Benedetti et a l, 1988), 
prostate (Kerr and Searle, 1973), adrenal cortex (Wyllie et a l, 1973), epithelium lining of 
the intestinal crypts (Potten, 1977), differentiating spermatogonia (Allan et a l, 1987) and 
the reversion of the lactating breast to its resting state after weaning (Walker et a l, 1989).
The developmental biologists and cytologists showed a clear distinction between cell
deaths that occur during animal development and tissue homeostasis from pathological
deaths that occur at the centre of acute lesions such as ischaemia and trauma (a process
called necrosis) (Jacobson et a l, 1997). These dying cells shared many morphological
features distinct from the features observed in necrotic cell death and suggested that these
shared morphological features might be the result of an underlying common, conserved
endogenous cell program. Thus in 1972, Currie and colleagues termed this physiological
-  2  "
form of cell death as apoptosis, from ancient Greek, which means “to fall away from” 
and conjuring notions of the falling of leaves and petals in the autumn (Kerr et a l, 1972). 
As important as cell migration and cell division during embryogenesis, apoptosis allows 
the organism to tightly control cell numbers and natural tissue turn over that control the 
number of cells present in an organ and to protect itself from cells that threaten 
homeostasis (Hengartner, 2000). Since then, the area of apoptosis has expanded greatly 
and has been shown to play a pivotal role in all vertebrate life and has even been found in 
plants and some unicellular organisms (Arends and Wyllie, 1991). Apoptosis is essential 
to ensure health in most organisms. This apoptotic process has also inherent weaknesses 
that when compromised can result in inappropriate cell death and disease pathogenesis 
(Table 1.1). It is currently estimated that over 70% of human disease is caused by a 
malfimction or improper regulation of apoptosis (Krammer, 2000). Apoptosis maintains 
the normal functioning of the immune system, for example, plays the role of killing 
mutated cancerous cells, virally infected cells and autoreactive T-lymphocytes (Knolle 
and Gerken, 2000; Krammer, 2000). When apoptosis malfunctions, it can lead to 
cancers, e.g. lymphoid malignancies (Nagata, 1994; Krammer, 2000), and autoimmune 
diseases, e.g. human systemic lupus erythematosus (Mysler et a l, 1994). However, 
when overstimulated, apoptosis causes stroke damage (Barinaga, 1998), 
neurodegeneration, e.g. Parkinson’s disease and Alzheimer’s disease (Yuan and Yankner,
2000); diabetes (Chervonsky and Wang, 1997) and acquired immunodeficiency 
syndrome (AIDS) (Krammer, 2000).
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1.2. Characteristics of Apoptosis
The term apoptosis, often inappropriately used, as synonymous with programmed cell 
death, defines a type of cell death morphologically, molecularly and biochemically 
distinct from necrotic cell death (Table 1.2). In contrast necrosis is uncontrolled cell 
death occurring as a result of massive tissue injury in which most typically cells lyse 
provoking a substantial inflammatory response (Columbano, 1995; Lockshin and Zakeri,
2001). It is important to recognise that these two terms (apoptosis and necrosis) relate to 
morphological description of cell death only, and it remains possible that the two 
processes might actually be part of a continuum, with necrosis being the ultimate fate for 
cells that undergo apoptotic changes initially (Dong et a l, 1997).
1.2.1. Morphological features
The main morphological characteristics of apoptosis include cellular shrinkage, which is
one of the first observed changes with consequent loss of membrane contact with
neighbouring cells and plasma membrane blebbing (Arends and Wyllie, 1991).
Chromatin condensation is the most commonly described feature of apoptosis in which
the chromatin aggregates peripherally under the nuclear membrane into well-delimited
dense masses of various shapes and sizes together with nuclear shrinkage and migration
of the nucleus at the periphery. Eventually the nuclear envelope breaks up and the
nucleus fragments, and the cell may break into discrete membrane-bound containing
acidophilic globules, called apoptotic bodies (Allen et ah, 1997; Wilson, 1998).
Apoptotic bodies are membrane-bound cell fragments, composed of cytoplasm, tightly
packed organelles and nuclear fragments, which can be clearly seen by electron
microscopy (Fig. 1.1) (Kerr et a l, 1972; Arends and Wyllie, 1991). During apoptosis,
the plasma membrane is kept intact thus preventing cytosolic contents from leaking to the
-4 -
exterior. Therefore apoptosis is not associated with an inflammatory response (Fig. 1.1) 
(Wyllie, 1997).
In some cell types, such as hepatocytes or Jurkat T-lymphocytes, the apoptotic bodies 
remain within the cell structure stabilised by a rigid plasma membrane whereas in most 
other cell types these apoptotic bodies break off from the cell and the surrounding 
phagocytic cells engulf them (Clarke and Clarke, 1996). Apoptotic bodies are rapidly 
degraded within lysosomes, in which time the adjacent cells migrate or proliferate to 
replace the space occupied by the now deleted apoptotic cell (Reed, 2000). Therefore, 
apoptotic cell death is characterised by controlled digestion of the cell by phagocytosis 
without causing an inflammatory response thus directly contradicting necrosis where 
rapid cell swelling and membrane leakage follows the release of the cell contents and 
therefore eliciting an inflammatory response and causing severe tissue damage (Fig. 1.1). 
Thus apoptosis is considered a means of removal of individual cells without producing 
tissue damage (Marshall and Watson, 1997). At least some types of cell death are 
expressed either as apoptosis or necrosis depending on the intensity and duration of the 
stimulus, the rapidity of the death process and the extent of ATP depletion suffered by the 
cell (Columbano, 1995; Kolesnick and Kronke, 1998; Kroemer et a l, 1998).
On the other hand, necrosis is a passive form of cell death that tends to affect contiguous 
cells and characterised by swelling of the cytoplasm and organelles, breakdown of 
plasma membrane, release of lysosomal enzymes, and cell lysis with the release of pro- 
inflammatory intracellular constituents into the extracellular milieu which results in an 
inflammatory response in the surrounding tissue (Fig. 1.1) (Fadeel et a l, 1999).
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Table 1.1. Diseases associated with the malfunctioning of apoptosis.
Diseases associated with increased apoptosis Diseases associated with inhibition of apoptosis
AIDS Cancer
Neurodegenerative disorders Carcinomas with p53 mutations
Alzheimer’s disease Follicular lymphomas
Parkinson’s disease Hormone dependent breast tumours
Retinitis pigmentosa Ovarian cancer
Cerebellar degeneration Prostate cancer
Ischemic injury Breast cancer
Myocardial infarction Autoimmune disorders
Stroke Systemic erythematosus
Reperfusion injury hnmune-mediated glomerulonephritis
Myelodysplastic syndromes Viral infections
Aplastic anaemia Poxvirus
Toxin-induced liver damage Adenovirus
Alcohol Herpesvirus
Table 1.2. Summary of the differentiation between apoptotic and necrotic cell death.
Changes Apoptosis Necrosis
Stimuli Physiological Pathological
Occurrence Single cells Clumps of cells
Cell to cell adhesion Lost in early stages Lost in late stages
Cytoplasmic organelles Late stage swelling Very early stage swelling
Nucleus Karyorrhexis (breakdown) and 
pyknosis
Karyolysis (disappearance)
Nuclear chromatin Compact and in uniformly dense 
masses
Clumping, not sharply defined
Lysosomal enzyme release Absent Present
DNA breakdown Intemucleosomal Randomised
Cell Formation of apoptotic bodies Swelling and disintegration
Phagocytosis by other cells Present Late onset
Exudative inflammation Absent Present
Scar formation Absent Present (dependent on tissue)
NECROSIS
Swelling of cell Q )
Normal cell
Membrane rupture and 
release of cell contents 
causing an inflammatory 
response
APOPTOSIS
Cell shrinkage and 
nuclear chromatin 
.condensation
Nuclear fragmentation 
and formation of 
apoptotic bodies
Phagocytosis without 
eliciting inflammation
Figure 1.1. The apoptotic and necrotic cell death process
Schematic diagram illustrating the basic differences between necrotic (left) and apoptotic 
(right) cell death. Figure adaptedfrom Marshall and Watson, (1997).
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1.2.2. Biochemical features
Apoptotic cells usually exhibit a distinctive range of biochemical modifications. The 
apoptotic process is characterized by a specific pattern of intemucleosomal DNA 
fragmentation (Wyllie, 1980). The degradation of nuclear DNA into nucleosomal units is 
one of the best-characterized biochemical features of apoptotic cell death and it is an 
irreversible event that commits the cell to die (Liu et ah, 1998). First the DNA is cleaved 
into distinct high molecular weight fragments corresponding to >700 kilobase pairs 
(kbp). These fragments are then further degraded to large 50- to 300 kbp and then 
subsequently intemucleosomal cleavage of the DNA into oligonucleosomes into 
multiples of 180 and 200 base pairs. The DNA fragments produce a typical ladder 
formation when resolved by agarose gel electrophoresis, which is very distinctive of 
apoptosis (Columbano, 1995; Marshall and Watson, 1997; Nagata, 2000). The cleavage 
of DNA into high-molecular weight fragments (HMW) has also been observed in some 
forms of necrosis (Columbano, 1995). The mitochondrial DNA remains intact during 
apoptosis (Murgia et a l, 1992).
The formation of HMW DNA fragments is mediated by an Mg^  ^ and Ca^^-dependent
endonuclease which has been shown to be different from the endonuclease that further
degrades the DNA fragments to nucleosomal and oligonucleosomal-sized fragments
(Columbano, 1995). It was shown that the latter digests nuclear DNA as well as naked
DNA and was named caspase-activated DNase (CAD) or DNA fragmentation factor
(DFF40) (Nagata, 2000). CAD is located in the nucleus where it is found bound to a
specific inhibitor, ICAD/DFF45 (inhibitor of caspase-activated DNase), forming an
inactive nuclear complex. During apoptosis, ICAD is proteolytically cleaved by
activated caspase-3 at two positions and thus inactivates its CAD-inhibitory activity, so
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that CAD is freed to cleave the chromosomal DNA (Samejima and Eamshaw, 1998; 
Samejima and Eamshaw, 2000). The CAD/ICAD system indicates that cells have 
developed an elaborate system for this apoptotic process (Nagata, 2000). It is important 
to remember that one of the physiological roles of apoptosis involves the removal of 
harmful cells such as virally infected cells or cancerous cells from the system therefore 
the CAD/ICAD system fragments the chromosomal DNA before it is transferred into the 
phagocytes. Thus the recipient cells may avoid transformation by any activated viral 
genes or oncogenes, or even to reduce the possibility of raising an autoimmune response 
(Knolle and Gerken, 2000; Nagata, 2000). DNA fragmentation is probably the most 
effective way to kill the cells (Nagata, 2000).
Other critical biochemical features that occur during the apoptotic process involve the 
degradation of the cytoskeletal proteins such as fodrin, cytokeratin 18, annexin V, 
gelsolin, laminin, actin and the nuclear lamina which means that the cells are unable to 
maintain their shape and stmcture and subsequently die. Many proteins are cleaved 
during apoptosis including proteins for DNA replication, translation, kinases and 
phosphatases (Nagata, 2000).
Transglutaminase activation during apoptosis causes cross-linking of the cytoplasmic 
proteins that results in membrane stabilisation resulting into covalently linked shrunken 
cells that cut both its cytoplasm and its nucleus into membrane-bound apoptotic bodies 
(Fesus et a l, 1987). Apoptotic cells have been shown to express phosphatidylserine in 
the outer layers of the plasma membrane (this usually resides in the inner membrane 
leaflet) as well as adhesive glycoproteins allowing the early recognition of dead cells by 
integrins and lectins on macrophages and adjacent parenchymal cells for phagocytosis
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without the release of proinflammatory cellular components (Duffield et ah, 2000). Also, 
the extracellular matrix protein vitronectin has been shown to be responsible for binding 
apoptotic cells such as human neutrophils and may serve a fimction in specific cellular 
recognition. Indeed the distinctive recognition pathways used by macrophages for 
binding apoptotic cells may represent a control point in the physiological termination of 
the acute inflammatory reaction (Savill et ah, 1989). In the liver, Kupffer cells and 
endothelial cells are particularly important in the removal of apoptotic lymphocytes 
(Neuman, 2001).
1.3. Intracellular Signalling in Apoptosis
Metazoan cells have a similar enzymatic apparatus that upon activation can initiate 
apoptosis. Over the years, the nematode Caenorhabditis elegcms has been a good model 
organism for investigating the core components of the cell death machinery (Ashkenazi 
and Dixit, 1998). In the development of the organism 1090 cells are generated of which 
131 cells die by apoptosis after a precisely determined series of divisions. Genetic 
studies in the C. elegcms have identified several intracellular mediators of the apoptotic 
pathway. They revealed two loci, ced-3 and ced-4, essential for programmed cell death 
during the worm development and then a third loci, ced-9 that was shown to prevent their 
action. Any mutation in either ced-3 or ced-4 caused the C. elegcms to lose the ability to 
kill the cells by apoptosis. The regulatory genes have shown to have mammalian 
homologues and the mechanism of apoptosis is extremely conserved (Ellis and Horvitz, 
1986; Adams and Cory, 1998; Meier and Finch, 2000).
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1.3.1. Caspases
Most of the morphological changes observed during the apoptotic process (Kerr et a l, 
1972), are caused by a group of intracellular cysteine proteases that are specifically 
activated during the process. The human homologue to ced-3 was first characterised as 
the interleukin-ip converting enzyme (ICE) which is responsible for converting 
proinflammatory cytokine pro-interlukin-1 p in monocytes (Cohen, 1997). However 
when overexpressed, ICE was found to induce apoptosis suggesting that it plays a central 
role in the apoptotic pathway. Further evidence to support the hypothesis of the 
involvement of ICE-like proteases, was the ability of specific natural protease inhibitors, 
such as the cowpox viral serpin, CrmA and baculovirus p35 to inhibit apoptosis (Cohen, 
1997). The name proposed for this family of ICE-like proteases was caspases as the ‘c’ 
refers to the cysteine protease and the ‘aspase’ refers to the preferential cleavage site of 
the enzyme after the aspartate residue (at Asp-Xxxx) and thus their name after Cysteine 
Aspartyl-specific Proteases. The four amino acids (Xxxx) distal the cleavage site 
determine the individual caspase’s distinct substrate specificity (Wolf and Green, 1999). 
Activation of caspases leads to the selective cleavage of a certain set of target proteins, 
usually at one or at most a few aspartate residues in the primary sequence. Caspase 
substrates range from single polypeptide chain enzymes (like PolyADP-ribose 
polymerase) to more complex macromolecules (such as actin, p-catenin, and the nuclear 
lamin network). It is the cutting of these structural macromolecules that leads to the 
disassembly of cell structures that characterises apoptosis (Eamshaw, 1999; Nicholson,
1999).
Individual family members are referred to in order of their publication, so ICE, the first
family member, is caspase-1 (Cohen, 1997). At least 15 different caspases have been
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identified in humans and mice and about two thirds of these have been suggested to 
function in apoptosis. These are highly conserved through evolution and can be found 
fi-om humans all the way down to insects, nematodes and hydra (Adams and Cory, 1998; 
Budihardjo e ta l, 1999; Cikalae/a/., 1999).
Caspases have been subdivided into three subfamilies based on their substrate preference, 
extent of sequence identity and structural similarities. An ICE subfamily, comprising 
caspase-1, -4 and -5; a CED-3/CPP32 (32kDa cysteine putative protease) subfamily 
comprising caspase-3, -6, -7, -8, -9 and -10; and an ICH-1 {ICE and ced-3 homologue) 
subfamily, caspase-2 (Cohen, 1997). Caspases can also be divided in two groups 
according to their fimction, caspase-8, -9, -2 and -10 are also known as upstream initiator 
caspases which posses a proform with large N-temiinal pro-domain which behaves as a 
protein interaction domain to modulate activation of the caspase cascade (Wolf and 
Green, 1999). Whereas caspase-3, 6, and 7 are called downstream effector caspases and 
have short N-terminal prodomains serving no apparent function and their proteolytic 
processing and activation is entirely dependent upon upstream caspases (Salvesen and 
Dixit, 1997; Reed, 2000). As the N-terminal peptide is not required for enzyme activity it 
is usually released after the proteolytic cleavage (Salvesen and Dixit, 1997). Most pro- 
caspases are found in the cytosol except for caspase-2 and caspase-9 which are also found 
in the inter-membrane space of mitochondria, golgi, and nucleus (Fulda et a l, 2001; 
Robertson et al, 2002).
A caspase’s distinct substrate specificity is determined by the four residues amino- 
terminal to the cleavage site in the substrate. These proteases are present as inactive 
prozymogens and generation of an active form requires proteolysis by cleavage in an
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interdomain linker segment at conserved aspartic acid residues to give a heterodimeric 
enzyme with both chains containing essential components of the catalytic machinery. 
The proteolytic cleavage generates large (about 20kd) and small (about lOkd) subunits of 
the active enzymes. The active enzymes consist of heterotetramers composed of two 
large and two small subunits with two active sites per molecule. The primary recognition 
pocket (Si) is well adapted to accept an Asp side chain of the substrate and additional 
pockets ( S 2 - S 4 )  distinguish the caspases from each other (Salvesen and Dixit, 1997; Reed, 
2000). Caspases have varied substrate specificity; a single activated caspase may not 
directly activate all other family members. For example, caspase-9 activates procaspase- 
3 and -7 but can not activate procaspase-6. Propagation of a caspase cascade will thus 
depend on which caspases a cell expresses, the relative concentrations of each caspase, 
and the kinetic efficiency of the individual transactivation reactions (Wolf and Green,
1999).
In a normal surviving cell, aberrant enzymatic activation of caspases is avoided by the 
Inhibitor of Apoptosis (lAP) family of proteins that directly bind and inhibit procaspases 
(Shiozaki et a l, 2003). At least eight members of the mammalian lAPs have been 
identified including XIAP, c-IAPl, C-IAP2 and survivin and they all show anti-caspase 
activity in vitro. Each lAP protein contains one to three copies of the 80 residue zinc 
binding baculoviral lAP repeat (BIR) (Shiozaki et a l, 2003). The different BIR domains 
and segments in the same lAP protein appear to exhibit distinct functions. For example, 
the third BIR domain (BIR3) of XIAP potently inhibits the activity of the processed 
initiator caspase-9 by trapping caspase-9 in an inactive monomeric state and preventing 
any possibility of its homodimerization and subsequent catalytic activity. However, the
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linker region between BIRl and BIR2 selectively targets effector caspases-3 or -7 (Fesik 
and Shi, 2001).
The lAP-mediated inhibition of all caspases is effectively removed by the mitochondrial 
protein Smac (second mitochondria-derived activator of caspases) or DIABLO (with a 
monomeric Mr of 21k) placed in the intermembrane space of mitochondria and released 
into the cytosol during apoptosis. The proapoptotic activity of Smac depends on a 4 
amino acid lAP binding motif located at the N-terminus of the mature protein. Smac 
interacts with multiple lAPs and relieves their inhibitory effect on both initiator and 
effector caspases (Shi, 2001; Shiozaki et a l, 2003; Vaux and Silke, 2003; Orrenius, 
2004). For example, Smac competes with caspase-9 for the same binding site on the 
BIR3 domain of lAP. Smac also binds to the linker peptide between the BIRl and BIR2 
domains, inhibiting caspase-3 and -7 binding (Springs et a l, 2002; Harada and Grant, 
2003). In contrast, procaspase-8 activation is regulated at the CD95 death receptor by 
FLICE (FADD-like interleukin-ip-converting enzyme)-inhibitory proteins (c-FLIP) as 
mentioned in section 1.4.1.1 (Fig. 1.4).
During the apoptotic process, various endogenous key substrates have been identified as 
being proteolytically cleaved by specific effector caspases leading to apoptotic cell death. 
Cleavage takes place in the interdomain regions resulting in the activation of the protein 
or sometimes in inactivation but never in degradation since their substrate specificity 
distinguishes the caspases as among the most restricted of endopeptidases (Hengartner,
2000). Cleavage of nuclear lamina and ICAD is clearly linked to chromatin condensation 
and nuclear shrinkage. For example, caspase-3 cleaves ICAD, prompting release of 
active CAD, which then cleaves DNA and promotes DNA fi^agmentation (section 1.2.2)
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(Woo et a l, 1998; Hengartner, 2000). The nuclear laminas are an important target for 
caspases. Lamins constitute the main structural components of the lamina underlying the 
nuclear membrane. During apoptosis, caspases such as caspase-6, induces the proteolytic 
cleavage of lamins to facilitate the nuclear collapse that is characteristic of apoptosis 
(Caulin e ta l, 1997).
Loss of overall cell shape, cellular shrinkage and membrane blebbing is caused by 
cleavage of cytoskeletal proteins such as fodrin, cytokeratin 18, gelsolin, actin, Gas-2 and 
Rabaptin-5 (Wolf and Green, 1999). ^
Fodrin (non-erythroid spectrin) is a major component of the plasma membrane-associated 
cortical cytoskeleton of most eukaryotic cells. Fodrin is a rod-shaped protein consisting 
of a  and p subunits which form heterodimers aligned in a side-to-side manner. Then the 
fodrin heterodimers further associate to form tetramers which cross-link actin filaments at 
their ends (Martin et a l, 1995). Caspase-3-induced proteolysis of fodrin causes 
membrane blebbing and it may be linked to the extemalization of phosphatidylserine in 
apoptosis. Furthermore, given the fimdamental role of fodrin in maintaining membrane 
organization and integrity, it is thought that cleavage of fodrin in some cells constitutes a 
critical, necessary and sufficient step linking caspase activation to cell death (Martin et 
û r / . ,  1995; Wang era/., 1998).
Cytokeratin 18 is a major component of the intermediate filaments (IFs). IFs are 
composed of members of a family of proteins that organise to form 10-nm filaments and 
share sequence homology and structural features. IF proteins have a large central a 
helical rod domain broken by three short linker regions and are flanked by nonhelical 
NH2 and COOH-terminal domains (Caulin et a l, 1997). Cytokeratin 18 is thought to
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undergo dramatic reorganization which precedes morphological nuclear disruption during 
apoptosis. Keratin 18 undergoes cleavage throughout the cell by caspases-3, -7 and -6 
within the region that links two major a  helical domains. Cleavage of cytokeratin 18 
initiates the orderly processing and dismantling of filament proteins during apoptotic cell 
death (Caulin et a l, 1997).
Caspase-3 also cleaves and activates gelsolin, an important protein that regulates actin 
dynamics and once activated promotes both cytoplasmic and nuclear apoptosis, including 
DNA fragmentation (Wolf and Green, 1999).
Other caspase substrates include DNA repair proteins such as PARP; protein kinases such 
as PAK2, MEKKl, PKCÔ, Akt-1/protein kinase B and Raf-1; other signal transduction 
proteins and inhibitoiy subunits of endonucleases (CIDE family proteins) (Wolf and 
Green, 1999). PARP is possibly the best characterised proteolytic substrate of caspases 
being cleaved in the execution phase of apoptosis by primarily caspase-3 and -7. 
Although the cleavage of PARP is often a valuable indicator of apoptosis, its biological 
relevance is still unclear since PARP-null mice develop normally (Cohen, 1997; Wolf 
and Green, 1999). In addition, hepatocytes do not undergo PARP cleavage during 
apoptosis (section 1.6).
Most caspases are directly involved in cell death; however, a few are not, especially in 
mammals and higher eukaryotes. For example, a subgroup of caspases including 
caspase-1, 4 and 5 in humans are primarily involved in processing pro-inflammatory 
cytokines such as pro-interlukin-18 and pro-interleukin-1 g (pro-IL-1 P) (Reed, 2000). 
Other enzymes are also involved in the intracellular signalling during apoptosis such as 
protein kinases and nucleases however caspases seem to be essential for the accurate and
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limited proteolytic events that characterise this type of programmed cell death (Salvesen 
and Dixit, 1997).
1.3.2. Non-caspase proteases
While the importance of caspases in apoptosis is clearly established, there is substantial 
evidence supporting the role of additional proteases involved in various forms of 
apoptosis (Kidd, 1998; Wang, 2000). The involvement of non-caspase proteases was 
firstly suggested by observations that inhibition of caspases generally causes delays but 
does not fully block cell death resulting fi*om most apoptotic stimuli. Frequently non- 
caspases are activated during apoptosis and their inhibition, as with caspase inhibition, 
can serve to delay apoptosis. In addition there is evidence that non-caspase proteases are 
required for chromatin degradation during apoptosis (Hughes et a l, 1998). The main 
non-caspase proteases that have been mostly linked with apoptosis are calpains, 
cathepsins, granzymes and the proteosome (Kidd, 1998; Johnson, 2000; Wang, 2000; 
Dickinson, 2002; Stenson-Cox et a l, 2003; Liu et a l, 2004). These proteases can act in 
concert with caspases in standard apoptotic processes.
1.3.2.1. Calpains
Calpains comprise a family of cytoplasmic neutral cysteine proteases. The two main 
ubiquitous calpains, calpain I and calpain n, exist as pro-enzyme heterodimers (80kDa- 
29kDa) in resting cells but this is activated by Ca^  ^and autolytic processing (to produce a 
heterodimer 78kDa-18kDa) (Squire and Cohen, 1997; Wang, 2000; Ray e ta l, 2003; Liu 
et a l, 2004). Autolysis cleaves the amino termini of the large and small subunits and 
appears to increase the activity and lower the requirement for Ca^ .^ Although these 
calpains appear to have the same substrate specificity, they are functionally distinguished
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on the basis of their Ca^  ^ sensitivity. Calpains become over-activated under extreme 
conditions that result in sustained elevation of cytosolic calcium levels, which is usually 
associated with necrosis (Johnson, 2000).
Calpain activation in apoptosis has been detected to a variety of apoptotic stimuli in a 
variety of cell types, such as murine thymocytes treated with dexamethasone, 
neuroblastoma cells treated with staurosporine and lymphoma cells treated with radiation 
(Squire and Cohen, 1997; Johnson, 2000; Wang, 2000). In addition, various calpain 
inhibitors were found to protect against apoptosis in some specific systems (Wang, 2000). 
The ability of calpains to promote apoptosis in a variety of systems raises questions 
regarding the molecular mechanisms of calpain action. A large variety of proteins have 
been shown to be calpain substrates, including cytoskeletal proteins (such as fodrin, actin, 
talin, gelsolin), plasma-membrane-associated proteins (such as epidermal growth factor 
receptor, platelet-derived growth factor receptor), and signal transduction (such as c-jun, 
cyclins, p53, Bax, caspase-3 and -9), caspases (such as caspase-12), calmodulin- 
dependent proteins and transcription factors. Furthermore, it is thought that calpains may 
be particularly important in destruction of cellular architecture during apoptosis (Johnson, 
2000; Nakagawa et ah, 2000; Wang, 2000; Rao et ah, 2001; Xie et a l, 2002; Ray et a l, 
2003; Toyota et a l, 2003). However, many of the proteins identified as calpain 
substrates have only been shown to be cleaved by in vitro experiments. Thus it remains 
unclear how many of these proteins are directly cleaved by calpains in vivo (Johnson,
2000). Physiologically, the activity of calpains is regulated by the endogenous protein 
inhibitor, calpastatin, which is commonly expressed and highly specific for calpains. The 
expression and function of calpastatin may be regulated during apoptosis by other
proteases, such as caspases (Wang, 2000; Ray et a l, 2003; Liu et a l, 2004).
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Theoretically if in early apoptosis caspase-3 begins to degrade calpastatin and 
compromise plasma-membrane and cortical cytoskeleton integrity simultaneously, which 
results in the elevation of intracellular calcium levels. Hence, calpain activity would 
increase to further the proteolytic destruction initiated by caspase-3 in apoptosis. 
Caspase-mediated calpastatin cleavage was observed in Jurkat cells following stimulation 
of CD95 or TNF death receptors, or even following treatment with staurosporine 
(Johnson, 2000). In the case of neuronal apoptosis, it has been shown that calpains assist 
in the degradation of key cellular proteins and can be viewed as having an augmentative 
role in the transduction pathway of neuronal apoptosis (Wang, 2000).
1.3.2.2. Cathepsins
Cathepsin proteases consist of at least 12 human family members (Turk et ah, 2000; 
Dickinson, 2002). Cathepsins are proteases that can be subdivided into three distinct 
groups, based on the amino acid that comprises the active site residue: serine proteases, 
cysteine proteases and aspartate proteases (Johnson, 2000). The most extensive evidence 
linking cathepsins with apoptosis has come from studies of the cysteine protease, 
cathepsin B. Cathepsin B is synthesized as a proenzyme and transferred into lysosomes 
where it is activated by proteolytic processing. The compartmentation of cathepsin B 
within acidic vesicles prevents it from inducing cell injury (Guicciardi et a l, 2000; 
Johnson, 2000; Brunke ta l, 2001; Dickinson, 2002).
This lysosomal cysteine protease was viewed initially as a simple housekeeping enzyme 
involved in the terminal degradation of proteins within the lysosomal compartment. 
However cathepsin B can be also secreted into the cytosol where it can degrade collagen, 
fibronectin, laminin and proteoglycans. The degradation of extracellular matrix
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components accounts for the ability of this protease to promote cell migration or 
malignant invasion (Johnson, 2000; Brunk et a l, 2001; Stoka et a l, 2001; Dickinson, 
2002). Reports in different cell types have implicated cathepsin B as participant in cell 
death by apoptosis (Turk et a l, 2000; Stoka et a l, 2001). At first it was shown that 
cathepsin B contributed to bile-salt induced hepatocyte apoptosis by a caspase-8- 
mediated process (Roberts et a l, 1997). In addition, inhibitors of cathepsin B blocked 
hepatocyte apoptosis from the toxic bile salt glycochenodeoxycholate demonstrating the 
involvement of this protease in cell death by apoptosis (Guicciardi et a l, 2000). Reports 
have also shown the involvement of cathepsin B in the upstream death signals of tumour 
necrosis factor (TNF) in hepatocytes (Foghsgaard et a l, 2001; Stoka et a l, 2001). The 
treatment of hepatocytes with actinomycin D and TNF resulted in cathepsin B release 
into the cytosol with increased enzyme activity and linking the death receptor (TNFRl) 
to the mitochondrial enhancement loop of caspase activation. The molecular mechanism 
by which this protease might affect mitochondria to promote cytochrome c release has 
been identified to be a selective proteolysis of the pro-apoptotic Bcl-2 protein. Bid (Stoka 
et a l, 2001; Dickinson, 2002). Furthermore, in some tumour cell lines, cathepsin B has 
shown to be the up- and downstream mediator of caspases in inducing TNF cell death 
and it appears possible that in some cell systems, cathepsin B, might be sufficient for all 
stages of apoptosis without requiring caspases (Foghsgaard et a l, 2001).
Recently the lysosomal aspartyl protease, cathepsin D, has been implicated in apoptosis 
induced by oxidative stress (Foghsgaard et a l, 2001; Stoka et a l, 2001). Whether the 
lysosomal proteases such as cathepsins are released specifically in different cell types by 
specific apoptotic stimuli or there is a generalised release of the proteases into the cytosol
during apoptosis will require further investigation.
- 2 0 -
1.3.2.3. Granzymes
Within the granules of cytotoxic T lymphocytes (CTL), granzymes, a family of serine 
proteases, are key components. The serine esterase, granzyme B, is particularly abundant 
in CTL granules and it shares with caspases the unique characteristic of cleaving 
substrate proteins after aspartate residues (cleaves at Asp-X bonds) (Greenberg, 1996; 
Lieberman, 2003; Stenson-Cox et a l, 2003). CTLs induce apoptosis by releasing 
granzyme B and perforin. Perforin is essential for this process because it binds to 
membrane phosphorylcholine groups in a calcium dependent manner to form pores in the 
membrane of the cell under attack. These pores then allow granzyme B to enter the cell 
and initiate apoptosis. Granzyme B has the ability to impact the caspase pathway of 
apoptosis as it is capable of activating caspase-3, -7 and -9 directly in vitro (Duan et a l, 
1996; Wolf and Green, 1999; Johnson, 2000; Lieberman, 2003). Therefore it seems to 
promote apoptosis by cleaving and activating endogenous caspases in the target cell. It 
remains to be determined which caspases are the preferred in vivo substrates for 
granzyme B (Johnson, 2000; Lieberman, 2003). In cells undergoing granzyme B- 
mediated apoptosis, cleavage of the caspase substrate proteins such as fodrin, PARP, 
lamin B, cytokeratin 18 is also observed. However, these cleavage events leading to cell 
death seem to be due to caspase activation by granzyme B rather than a direct cleavage 
by granzyme B. CTLs derived from granzyme"^" mice (granzyme B gene knockout mice) 
exhibit greatly reduced capability to induce apoptotic DNA fragmentation in target cells 
(Hughes e ta l, 1998; Kidd, 1998; Johnson, 2000; Stenson-Cox e ta l, 2003).
1.3.2.4. The proteosome
The ubiquitin-proteasome system is the major extralysosomal pathway responsible for
intracellular protein degradation in eukaryotes. It is composed of the ubiquitin-
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conjugating system and the 26S proteasome (Merin et a l, 1998), The latter of which 
contains the multicatalytic proteinase complex which has been implicated as playing an 
important role in the cellular process of apoptosis. Although still little is known about the 
role of the proteosome in apoptosis, different studies have shown a contradictory impact 
of proteosome inhibition. Interference with this pathway results in promotion of 
apoptosis in most cell lines but in a few others it protects cells from apoptosis (Orlowski, 
1999).
1.3.3. The Bcl-2 protein family
Bcl-2 was firstly identified as a proto-oncogene in follicular B-cell lymphoma (Kelekar 
and Thompson, 1998; Antonsson and Maritnou, 2000). In these cancerous cells, the Bcl- 
2 gene was found at the breakpoint of the translocation between chromosome 18 and 
chromosome 14 where the gene is under the control of the immunoglobulin heavy chain 
intron enhancer. Expression of the oncogene was shown to enhance the capacity of the 
cells to survive under suboptimal conditions. Subsequently the Bcl-2 protein was 
identified as the mammalian homologue to the apoptosis repressor ced-9 in C  elegcms 
(Antonsson and Maritnou, 2000).
Until now, in humans, many members of the Bcl-2 gene family have been identified and 
all have shown to be highly conserved throughout many vertebrates and invertebrate 
species (Kelekar and Thompson, 1998). The Bcl-2 family of proteins are key regulators 
of apoptosis by targeting mitochondria. Bcl-2 members can be sorted into two groups 
according to their function, the antiapoptotic (promotes survival) members including Bcl- 
2, B cI-xl, Mcl-l, Bcl-w, A-1 and Boo (DIVA) and the proapoptotic (promotes death) 
members including Bax, Bid, Bad, Bak, Mtd, Bcl-xs, Bik, Hrk, Bim, APR (Noxa), p i93,
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Bcl-G, Nip3 and Nix (Table 1.3) (Kelekar and Thompson, 1998; Reed, 2000; Harada and 
Grant, 2003). Also, these proteins have been classified into three fimctional groups 
through sequence comparisons with Bcl-2 (Hengartner, 2000). The sequence homology 
between these family members is confined to four specific regions known as the Bcl-2 
homology (BH) domains (Gross et a l, 1999a; Antonsson and Maritnou, 2000; Tsujimoto, 
2000; Daniel et a l, 2003) (Fig. 1.2). These domains have been shown to mediate protein 
interactions. Members of the first group which all have anti-apoptotic activity, such as 
Bcl-2 and B c1-xl posses all four short BH domains (BH1-BH4) (all four domains are 
essential to ensure anti-apoptotic activity) and also a C-terminal hydrophobic tail which 
localises them as integral membrane proteins in the outer surface of the mitochondria, 
endoplasmic reticulum (ER) (with the bulk of the protein facing the cytosol) and the 
nuclear membrane. Some Bcl-2 family genes produce two or more proteins through 
alternative mRNA splicing, sometimes producing proteins that exert opposing effects on 
cell death regulation, for instance, B c1-xl (anti-apoptotic) versus Bcl-xs (pro-apoptotic) 
(Reed, 2000; Daniel et a l, 2003; Harada and Grant, 2003). Group two members with 
pro-apoptotic activity such as Bax, contain all BH domains except for the N-terminal, 
BH4 domain. Group three members, a large and diverse collection of proteins, also pro­
apoptotic, only have the common feature of the BH3 domain. The BH3 domain is of 
central importance in mediating such as protein-protein interactions and modulating cell 
death. Most members of group two and three are localised in the cytosol or cytoskeleton 
prior to a death signal and then after an apoptotic stimulus induced to target mitochondria 
(Sattler et a l, 1997; Hengartner, 2000; Reed, 2000).
A distinguishing feature of the bcl-2 family is the ability to interact in specific ways to
form homo- and heterocomplexes between anti-apoptotic and pro-apoptotic proteins
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which is considered in some cases to inhibit the biological activity of their partners 
(Knudson and Korsmeyer, 1997). Mutagenesis studies demonstrate that the pro-apoptotic 
activity of the BH3 domain by heterodimerization is mediated by the insertion of the BH3 
region of a pro-apoptotic protein into a hydrophobic cleft composed of BHl, BH2 and 
BH3 from either pro- or anti-apoptotic proteins (Sattler et a l, 1997; Kelekar and 
Thompson, 1998; Antonsson and Maritnou, 2000; Harada and Grant, 2003; Kuwana and 
Newmeyer, 2003; Willis et a l, 2003; Orrenius, 2004). It seems that the ratio between the 
pro- and the anti-apoptotic proteins rules the destiny of the cell. However, observations 
with transgenic and knockout mice have shown that some protein members can also 
regulate apoptosis by independent mechanisms (Tsujimoto, 2000; Harada and Grant, 
2003; Kuwana and Newmeyer, 2003).
The 3-dimensional structure of two proteins of the Bcl-2 family, Bel- xl and Bid have
been solved and it has been shown that the structure in solution of B c1-xl and Bid are
strikingly similar. The main structure of B c1-xl consists of two central hydrophobic
helices (a5 and a6) surrounded by five amphipathic helices as well as a 60-residue
flexible loop. BHl, BH2 and BH3 domains are all located in close proximity on the
surface of the protein and form an elongated hydrophobic cleft binding site that contains
several potential phosphorylation sites located at the N-terminal of the BH3 domain. Bid
shows a very similar overall a-helical content to that of the anti-apoptotic molecule Bcl-
xl (Antonsson and Maritnou, 2000; Harada and Grant, 2003). These proteins show
structural homology to the pore-forming domains of certain bacterial toxins in particular
the closest in structure are diphtheria toxin fragment B, which transports a fragment of
the toxin across the cell membrane, and the bacterial pore-forming colicins A1 and E l,
which kill Escherichia coli by forming non-selective ion channels (Reed, 1997). Thus
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these findings predicted that the Bcl-2 family proteins could function as channels for ions 
and proteins in the mitochondria. Furthermore, in vitro experiments investigating 
mitochondrial targeting by Bcl-2 members showed that some members such as Bcl-2, 
B cI-xl, Bax and Bid, can form ion channels in synthetic lipid membranes. These pores 
can be described as multiconductance (large conductances above InS have been reported 
for both Bax and Bcl-2), pH sensitive and voltage-dependent channels with rather poor 
ion selectivity (Antonsson and Maritnou, 2000; Tsujimoto, 2000). However, until now it 
remains to be determined whether these proteins can form these channels in vivo and 
whether apoptotic regulation actually occurs via the creation of ion channels. Although 
overexpression of Bax in cells or the addition of purified recombinant Bax directly to 
mitochondria triggers the release of cytochrome c, the exact mechanism through which 
Bax triggers the permeability of the outer mitochondrial membrane is unclear 
(Jurgensmeier et a l, 1998; Rosse et a l, 1998).
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Table 1.3. Regulation of apoptosis by the Bcl-2 family proteins:
Bcl-2 family members Effects
1. Bcl-2 subfamily:
Bcl-2 Anti-apoptotic
B c1-xl Anti-apoptotic
Bcl-xs Pro-apoptotic
Bcl-w Anti-apoptotic
2. Bax family:
Bax Pro-apoptotic
Bak Pro-apoptotic
Bok Pro-apoptotic
3. BH3 subfamily:
Bid Pro-apoptotic
Bad Pro-apoptotic
Bik Pro-apoptotic
Elk Pro-apoptotic
Group I
Group n
Ligand
Domain
Pore
Fonnatioo
Dcxnain
Receptor Domain 
(Hydrophobic cleft)
BH3 BH2 BHl
Membrane
Insertion
Domain
1 1
BH4 |bH3 BH2 BHl Bcl-2
Bc1-Xl
Bax
Bak
Group m
BH3 BidBad
BH3 BikBim
Figure 1.2. The Bcl-2 homology domains (BH).
Classification o f the Bcl-2 family o f proteins based on domain organization. The general 
architecture o f the proteins is shown (not in scale). Bcl-2 homology domains (BH) and 
transmembrane domains (TM) are labelled. Figure adapted from Kelekar and 
Thompson, (1998) and Hengartner, (2000).
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Over the years, the pro-apoptotic proteins including Bid, Bax, Bad and Bim have been 
studied to resolve the mechanism by which they target mitochondria to induce apoptosis. 
The protein Bid is an important participant in the pathway that leads to cell death 
mediating mitochondrial dysfunction in response to apoptotic signals, e.g. such as 
activation of a death receptor on the cell surface. Thus, following an apoptotic stimulus, 
caspase-8 cleaves cytosolic p22 Bid removing the N-terminal 52 amino acids, to generate 
a truncated p i5 carboxy-terminal fragment (tBid), exposing both the BH3 dimerization 
domain and the hydrophobic core of the protein (Yin et a l, 1999; Reed, 2000; Zamzami 
et a l, 2000; Harada and Grant, 2003). tBid translocates and inserts into the 
mitochondrial membrane to form ion conductive pores and to induce the release of 
cytochrome c and leading to the activation of caspase-9 followed by caspase-3 and cell 
death by apoptosis (Li et a l, 1998; Luo et a l, 1998; McDonell et a l, 1999; Korsmeyer et 
al, 2000; Wei et a l, 2000). This process also seems to be regulated by B c1-xl (Gross et 
a l, 1999b). Interestingly, recent studies have shown that caspase-8 is not the sole 
caspase capable of activating Bid (Engels et a l, 2000). Bid can also be cleaved by 
caspase-3 in the intrinsic pathway of apoptosis which is independent of death receptors. 
In addition, the noncaspase protease, granzyme B, is the third protease recently shown to 
cleave Bid (Mandic et a l, 2002). Bid knockout mice nearly all survived, some with 
moderate liver damage and over half of the animals showed no liver injury (Antonsson 
and Maritnou, 2000).
Bid also cooperates with Bax to cause mitochondrial dysfunction. Bax is a monomeric
protein found mainly in the cytosol or loosely attached to membranes (Gross et a l,
1999a). The BH3 domain of Bid can bind to the pocket of Bax inducing a
conformational change that enables Bax to target and integrate into the mitochondrial
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membrane where it becomes an integral membrane protein and cross-linkable as 
homodimers and higher order oligomers (Gross et a l, 1999a; Korsmeyer et a l, 2000; 
Harada and Grant, 2003). Thus Bid servers as a chaperone for Bax. Oligomerization of 
Bax leads to its integration into the outer mitochondrial membrane where the protein 
could form a channel however it is still uncertain whether dimerization of Bax normally 
occurs in the cytosol after activation or is coincident with membrane insertion (Gross et 
a l, 1998; Gross et a l, 1999a; Antonsson and Maritnou, 2000). It is possible that 
oligomerization is the result of a change in conformation induced by Bid and possibly 
also by other BH3 domain only proteins (Desagher and Martinou, 2000; Eskes et a l, 
2000; Scorrano and Korsmeyer, 2003). Also, the nature of the signal that controls Bax 
activation remains unclear, though changes in cellular pH, changes in intracellular levels 
of calcium and Bid activation have been suggested to play a role (Reed, 2000). Once Bax 
is inserted in the outer mitochondrial membrane, it is thought that some could be fiirther 
cleaved by the protein calpain (its activity has been targeted to the intermembrane space 
of mitochondria) from frill length p21 Bax to generate a fragment, pi 8 characterised with 
enhanced cytotoxic properties and capable of attacking the inner mitochondrial 
membrane (Von Ahsen et a l, 2000; Wood and Newcomb, 2000; Mandic et a l, 2002). 
Bax knockout in mice gave viable animals with disturbance in the reproductive and 
neuronal tissues. Ovaries from Bax"^  mice failed to undergo normal developmental 
apoptosis resulting in the accumulation of atrophic granulosa cells and primary follicles 
(Antonsson and Maritnou, 2000).
The pro-apoptotic Bcl-2 family member, Bim, is localized to the microtubule-associated
dynein motor complex through association of the LC8 dynein light chain. Following, an
apoptotic stimulus, Bim and the LC8 dissociate from the motor complex and together
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translocate to the mitochondria where Bim associates with Bcl-2 to antagonise its anti- 
apoptotic properties. It remains to be known whether Bim is an active component of the 
dynein motor complex and whether its removal causes damage to the microtubules 
(Gross et a l, 1999a). Interestingly, Bim knockout mice showed specific effects on the 
hematopoietic homeostasis and played an important role in the prevention of 
autoimmunity (Antonsson and Maritnou, 2000).
In healthy cells, the pro-apoptotic protein Bad is phosphorylated by a protein kinase in 
two serine sites (Ser-112 and Ser-136) and sequestered in the cytosol by a 14-3-3 
molecule (Reed, 2000). Following an apoptotic signal. Bad is dephosphorylated and 
translocates to the mitochondria where it associates with Bcl-2 and B c1-xl to cancel their 
anti-apoptotic activity. It seems most likely that Bad phosphorylation regulates the 
exposure of the BH3 domain thus non-phosphorylated Bad is constitutively active due to 
the exposure of the hydrophobic face of the BH3 domain (Gross et a l, 1999a).
Therefore all pro-apoptotic Bcl-2 family proteins are activated after a death stimulus and 
translocated to the mitochondria where all seem to synchronise their action to play a 
major role in transducing signals from the cytosol to the mitochondria where they bind to 
and regulate the activity of other Bcl-2 family members that regulate apoptosis. These 
pro-apoptotic proteins have been reported to control the release of apoptogenic factors 
such as cytochrome c that induces caspase activation; Smac/Diablo, the inhibitor of lAP 
family proteins; and the apoptosis inducing factor (AIF), a flavoprotein implicated in 
nuclear manifestations of apoptosis. AIF is also capable of inducing the mitochondria to 
release cytochrome c, activate caspase-9 and, consequently, activate caspase-3 (Susin et 
al, 1997; Susin a/., 1999b).
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All of these apoptogenic proteins are encoded within the nuclear genome, transported 
into the mitochondria and stored via caspase-independent mechanisms (Budihardjo et a l, 
1999; Scorrano and Korsmeyer, 2003) in the intermembrane space awaiting the release 
into the cytosol upon the breakdown of the outer membrane following a death stimulus. 
Proteins of the Bcl-2 family may also have some extramitochondrial effects in the 
regulation of apoptosis (Reed, 2000).
1.3.4. Pro-apoptotic kinases in apoptosis
The stress-activated kinase, c-Jun N-terminal kinase (INK) is a member of the mitogen-
activated protein (MAP) kinase family which represents a group of signalling cascades
that regulates cellular responses initiated by various forms of stress (Coffey et a l, 2002).
JNK has three isoforms (INKl, 2 and 3) and their splice variants (Hochedlinger et a l,
2002). The INK pathway is activated by such diverse stimuli as inflammatory cytokines
(tumour necrosis factor-a (TNF-a), interleukin-1), environmental stress (UV radiation
and oxidative stress of ischemia/reperfijsion injury), osmotic shock and toxins. A series
of phosphorylation events of specific threonine and tyrosine residues by upstream MAPK
kinases, MKK4 and MKK7 leads to phosphorylation and activation of INK, which in
turn phosphorylates c-jun (Seanor et a l, 2003). c-Iun once phosphorylated, is able to
dimerize and bind to recognition sites in the promoter elements of a broad array of genes
with a variety of cellular effects such as apoptosis. INK-mediated phosphorylation of c-
jun is pro-apoptotic in some cell systems. For example, active c-jun is thought to induce
cytochrome c release from mitochondria to cause apoptosis (Lin and Dibling, 2002;
Marderstein et a l, 2003). In addition to phosphorylation of c-Iun, INK can modulate
gene expression as a consequence of its ability to phosphorylate and activate other
transcription factors. It is thought that the INK pathway plays a role in the signalling
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cascade leading to apoptosis but its role in the liver still remains poorly defined and still 
controversial (Lin and Dibling, 2002). It is clear that the role of the INK pathway in 
apoptosis is both cell type- and stimulus dependent. Furthermore, individual JNK 
isoforms can play different roles in the regulation of the apoptotic process and different 
components of the JNK cascade can have apposing roles in apoptosis, even in the same 
cell type in response to identical death stimuli. The role of JNK in apoptosis is also 
dependent on the activity of other cellular signalling pathways (Hochedlinger et a l, 2002; 
Marderstein et a l, 2003).
The first demonstrated evidence for a proapoptotic fonction of JNK comes fi'om studies 
using mouse embryonic fibroblasts isolated fi-om jnkl"^' and jnk2*^ ‘ mice. These cells 
showed resistance to UV irradiation-induced apoptosis due to failure to activate the 
mitochondrial pathway (Lin and Dibling, 2002). Since then, studies have shown that JNK 
phosphorylates and inactivates the antiapoptotic protein bcl-2, resulting in the 
mitochondrial permeability transition and formation of the apoptosome (Marderstein et 
al, 2003). It is also thought that prolonged JNK activation promotes apoptosis in cells 
where apoptosis has already been initiated by inactivation of suppressors of apoptosis so 
that the apoptotic cells can folfil their death programme. In addition, some groups have 
shown that JNK interacts with lAP (inhibitor of apoptosis by blocking caspase activity, 
section 1.3.1), allowing caspases to promote apoptosis (Lin and Dibling, 2002; 
Marderstein et a l, 2003).
Another important proapoptotic stress-activated kinase is the p38 MAP kinase which is 
activated by chemicals, hydrogen peroxide, radiant and thermal stress and inflammatory 
cytokines (Mitsui et a l, 2001). Furthermore, recent studies have shown that when cells
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receive a genotoxic stress, JNK and p38 MAP kinase, are activated which is thought to 
result in p53-dependent release of cytochrome c from mitochondria and subsequent 
activation of caspase-9 (Mitsui et ah, 2001).
Recently, glycogen synthase kinase-3 (GSK-3) has also shown to play a role in apoptosis 
(Crowder and Freeman, 2000; Cross et a l, 2001). This kinase is a ubiquitously 
expressed serine/threonine protein kinase so called because it was one of originally five 
kinases known to phosphorylate glycogen synthase, the rate limiting enzyme in glycogen 
synthesis (Smith et a l, 2001). However it is now apparent that GSK-3 phosphorylates 
and modulates the activity of a number of key regulatory proteins in the cell including: 
microtubule associated proteins (Tau, MAP-IB) (Lucas et a l, 1998; Elyaman et a l, 
2002b); transcription factors (B-catenin, c-jun, NFAT) (Nikolakaki et a l, 1993; Beals et 
al, 1997; Hart et a l, 1998); a translation initiation factor (eIF2B) (Welsh et a l, 1998) 
and insulin receptor substrate-1 (IRS-1) (Eldar-Finkelman and Krebs, 1997). Therefore 
GSK-3 activity has the potential to regulate a broad range of cellular processes including 
microtubule stability, gene transcription, protein translation and glycogen metabolism 
(Coghlan et a l, 2000).
GSK-3 exists as two isoforms (a and P) with molecular weights of 51 and 46kDa, 
respectively. The catalytic domains are 95% identical at the amino acid level, whereas 
the amino- and carboxy-termini are less conserved. GSK-3 a has an additional -60 amino 
acid residues N-terminal to the kinase domain which is glycine rich (Smith et a l, 2001). 
Differences in function between the isoforms have yet to be established. GSK-3 which 
plays a key role in a number of diverse cellular processes, is pro-apoptotic (Cross et a l,
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2001; Elyaman et a l, 2002b). GSK-3 is one of several known substrates of protein 
kinase B (PKB)/Akt, a downstream target of PI 3-kinase (phosphatidylinositol 3-kinase) 
with a crucial role in preventing apoptosis. PKB phosphorylates GSK-3 at phospho-Ser- 
9 in response to insulin and growth factors, which inhibits GSK-3 activity. Furthermore, 
studies have demonstrated that the PI 3-kinase/PKB pathways are anti-apoptotic required 
for cell survival and PKB is thought also to negatively regulate other proapoptotic 
proteins such as Bad and caspase-9 (Crowder and Freeman, 2000; Cross et a l, 2001).
Clear pharmacological and biochemical evidence has shown that selective inhibition of 
the endogenous pool of GSK-3 activity in primary neurons is sufficient to prevent 
apoptotic death and thus implicating GSK-3 as a physiologically relevant and principal 
regulatory target of the PI 3-kinase/PKB pathway (Cross et a l, 2001; Song et a l, 2002). 
In fact, overexpression of GSK-3 p in neuroblastoma cells was shown to be sufficient to 
induce apoptosis (Song et a l, 2002). Similarly, the inhibition of the PI 3-kinase/PKB 
pathway that normally maintains GSK-3 in an inhibited state also demonstrated that 
GSK-3 promotes the subsequent apoptotic process. GSK-3P has been shown to be a key 
intermediate in several apoptotic signalling pathways, such as ER stress. It seems that 
ER stress promotes dephosphorylation and activation of GSK-3 p leading to activation of 
caspase-3 and cell death (Crowder and Freeman, 2000; Elyaman et a l, 2002b; Song et 
a l, 2002).
1.4. The Pathways of Apoptosis
Currently, two major pathways are known to activate the apoptotic machinery. One
involves the activation of specific death receptors, receptor pathway (“intrinsic
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pathway”), and the other one involves mitochondrial dysfunction, mitochondrial pathway 
(“extrinsic pathway”), both resulting in cleavage and activation of effector caspases that 
dismantle the cell to cause death (Zimmermann et a l, 2001).
1.4.1. Receptor-mediated pathway
Death receptors belong to the tumour necrosis factor (TNF) gene superfamily (Nagata, 
1994; Bodmer et a l, 2002). Members of this family are characterised by two to five 
copies of cysteine-rich extracellular domains and also contain a homologous cytoplasmic 
sequence known as the death domain. The death domain is essential for signal 
transduction of the apoptotic signal although sometimes they mediate fonctions that are 
distinct from or even counteract apoptosis. Molecules that transmit apoptotic signals 
from the death receptor into the cell also contain specific death domains (Ashkenazi and 
Dixit, 1998). The best-characterised death receptors so far, includes CD95 (also called 
Fas, Apol), TNFRl (also called p55), death receptor 3 (DR3), DR4 and DR5 (also called 
TRAJL-R) (Ashkenazi and Dixit, 1998; Budihardjo et a l, 1999). However, among all 
death receptors CD95 is by far the best characterised (Engels et a l, 2000).
1.4.1.1. The CD95 receptor and ligand interaction
CD95 receptor is a widely expressed glycosylated cell surface protein of 45kDa 
belonging to the TNF receptor family comprising 335 amino acids. CD95 receptor is a 
type I transmembrane protein and can be produced also in several soluble forms (Nagata, 
1994; Walczak and Krammer, 2000).
Under physiological conditions, the natural ligand of the receptor, CD95L triggers CD95-
mediated apoptosis. This receptor ligand is mainly expressed by CD8^ cytotoxic T-
lymphocytes and natural killer cells and acts as a major effector of their cytotoxic effects.
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Furthermore, CD95 ligand is not normally expressed in hepatocytes, although FasL- 
mRNA may be expressed in culture after exposure to dexamethasone and during several 
conditions of oxidative stress (Galle et ah, 1995; Strand et a l, 1998).
CD95L is a 40kDa type H membrane glycoprotein. When CD95 receptor binds its 
ligand, the recognition event is translated into intracellular signals that then lead to 
caspase activation. There are three main steps: ligand-induced receptor trimerization, the 
recruitment of intracellular receptor proteins, and initiation of caspase cascade activation. 
Binding of the trimeric CD95 ligand causes trimerization and activation of the receptor 
(Ashkenazi and Dixit, 1998) (Fig. 1.3). The trimerized cytoplasmic region recruits an 
adapter protein known as Fas-associated death domain (FADD or Mort-1) and through 
homotypic interaction binds through its own death domain to the clustered death domain 
of CD95 receptor. FADD also contains a death effector domain (DED) that servers as an 
adaptor molecule to recruit and bind to the analogous domain repeated in tandem within 
procaspases-8 or -10 in which the prodomain contains two death effector domains and 
both bind FADD, to form a death inducing signalling complex (DISC) (Fulda et a l, 
2001; Micheau et a l, 2002). FADD knockout mice studies have shown that FADD is 
essential for apoptosis induction by CD95. In fact FADD gene deletion causes 
embryonic lethality in mice which also showed that FADD has other critical signalling 
functions besides coupling CD95 to procaspase-8 (Ashkenazi and Dixit, 1998). Upon 
recruitment to the DISC, caspase-8 oligomerization drives its activation through a series 
of self-proteolytic cleavage steps. The activated caspase-8 is released in the cytosol to 
then activate downstream effector caspases including caspase-3 and caspase-7 as well as 
pro-apoptotic Bcl-2 proteins such as Bid which in turn targets mitochondria, activating
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caspase-9 and committing the cell to apoptosis (Yin et a l, 1999; Fulda et a l, 2001) (Fig. 
1.4).
The death receptor TNFRl has a similar death domain-containing protein partner called 
TRADD (TNFRl-associated death domain-containing protein) (Hsu et a l, 1995). 
TRADD binds to FADD via interactions between their death domains which suggest that 
CD95 and TNFRl share a common signalling pathway downstream of FADD. However, 
it has been shown that TNFRl has another signalling pathway via REP (receptor 
interacting protein) which binds to TRADD via the death domain. The death domain of 
RIP is responsible for the signal transduction to apoptosis (Hsu et a l, 1995).
The regulation of caspase-8 activation is mediated by the cellular FLICE-inhibitory 
proteins (c-FLIP) which are also recruited to the DISC. c-FLIP is a potent inhibitor, 
blocking the receptor-mediated signalling pathway upstream before caspase-8 activation 
and release (Micheau et a l, 2002; Harada and Grant, 2003). Two forms, c-FLIPl (long 
form) and c-FLIPs (short form) have been characterised so far, which correspond to c- 
FLIP splice variants at the mRNA level (Krueger et a l, 2001).
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Figure 1.3. Apoptosis signalling by the CD95 death receptor.
Abbreviations: CD95L, CD95 receptor ligand; FADD, Fas-associated death domain; 
DD, death domain; DED, death effector domain, DISC, death-inducing signalling 
complex and FLIP, FLICE-inhibitory protein. Refer to text for description. Adapted 
from Ashkenazi and Dixit, (1998).
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C-FLIPs consists of two DEDs whereas c-FL IPl has an additional c-terminal caspase-like 
domain and resembles caspase-8 in its overall structural organisation. In the protease­
like domain of c-FLIPl, the catalytically active cysteine is replaced by a tyrosine 
rendering the molecule proteolytically inactive. Both c-FL IPl and caspase-8 at the DISC 
are partially processed and the cleaved intermediates remain bound to the DISC and can 
no longer be replaced by procaspase-8. This prevents activation of the cytoplasmic 
procaspase-8 pool and renders the cell resistant to CD95-induced apoptosis (Micheau et 
al, 2002). In the caspase-8-FLIP heterodimer, through the association of the protease 
domains, c-FL IPl activates procaspase-8 differently compared with activation in a 
homodimer resulting in a partially active protease as it allows the first cleavage step of 
procaspase-8. Partially active caspase-8 is not released into the cytoplasm because 
cleavage between the DEDs and the caspase-unit within caspase-8 and c-F L IP l does not 
occur. As a result, the activity of the heterodimer remains membrane-restricted and does 
not result in apoptosis. In contrast, c-FLIPs completely blocks cleavage and activation of 
pro-caspase-8 and therefore its full length pro-caspase-8-c-FLIPs heterodimer can be 
detected at the DISC (Krueger et a l, 2001; Micheau et a l, 2002). Upon stimulation of 
CD95 death receptor, c-FL IPl seems the prime substrate of the caspase-8-FLIP 
heterodimer. c-FL IPl is rapidly cleaved which causes a conformational change in the 
protein that results in a weakening of the interaction between both proteins, possibly 
resulting in their dissociation (Micheau et a l, 2002).
Recently, two different apoptosis signalling cell types have been identified in CD95-
mediated apoptosis induced by drug treatment (Fulda et a l, 2001). In type I cells, such
as peripheral T cells and thymocytes, caspase-8 is activated at the DISC in large
quantities resulting in direct processing of caspase-3 and the general caspase cascade
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independently of mitochondrial activation. Interestingly, apoptosis was not blocked by 
overexpression of Bcl-2. In type II cells, such as hepatocytes, seems that the amount of 
caspase-8 generated at the DISC is limited which means that apoptosis occurs through 
mitochondrial perturbations and generation of active caspase-3 and caspase-9 
downstream of mitochondria. Overexpression of Bcl-2, completely blocked caspase-3 
and -8 activation (Scaffidi et a l, 1998; Fulda et a l, 2001). Studies using Bid-deficient 
cultured cells demonstrated that effector caspase activity was reduced, the cleavage of 
apoptotic substrates was altered, cytochrome c was not released and mitochondrial 
dysfunction was delayed. These findings strongly indicated that Bid is a critical substrate 
in vitro and in vivo for apoptotic signalling by the death receptor pathway and mediates a 
mitochondrial amplification loop (linking both pathways) that is essential for apoptosis in 
some cell types such as hepatocytes (Yin et a l, 1999).
The CD95 signalling system plays an important role in the liver. The CD95 receptor is 
expressed in both developing and mature liver cells and it is believed that the 
physiological role of CD95 is to maintain liver homeostasis since mice deficient in CD95 
receptor develop liver hyperplasia (Adachi et a l, 1995; Walczak and Krammer, 2000). 
This was also observed in humans showing mutations in the CD95 gene (Adachi et a l, 
1995). Over the years, the CD95 apoptosis signalling pathway has been thoroughly 
investigated and clearly defined. Nowadays this system is commonly used as a positive 
control model for apoptosis both for in vitro and in vivo studies.
From all the TNF family members, the CD95 ligand shares highest sequence homology 
with TRAIL also capable of inducing apoptosis. The signal transduction pathways for 
the two pro-apoptotic TRAIL receptors (DR4 & DR5) seems to use both FADD and
-39-
caspase-8 which then activates downstream caspases or cleaves REP directly (executes 
apoptosis independently of the pro-apoptotic machinery of mitochondria) (Sprick et a l, 
2000; Walczak and Krammer, 2000; Kim and Seol, 2003). Pre-clinical studies in mice 
and non-human primates have previously shown that administration of recombinant 
human TRAIL (rh-TRAIL) can induce apoptosis in human tumours but yet does not 
induce apoptosis in normal cells. This would make TRAIL of great potential to use in the 
treatment of human cancers (Walczack et a l, 1999; Walczak and Krammer, 2000).
1.4.2. Mitochondrial pathway
Mitochondria are dynamic organelles that are essential for the life of eukaryotic cells. 
These organelles have two membranes: an outer membrane surrounding the 
intermembranous space and an inner membrane limiting the matrix. Mitochondria 
produce the majority of the cellular energy store in the form of ATP by oxidative 
phosphorylation and thus are often referred to as the powerhouse of the cell as well as 
participating in the calcium, redox and pH homeostasis. Accumulating evidence has 
shown that mitochondria play also an essential role in cell death by apoptosis (Desagher 
and Martinou, 2000; Loefter and Kroemer, 2000; Waterhouse et a l, 2001). This role is 
increasingly recognised as an active process mediated by regulated effector mechanisms 
(Bemardi et a l, 1999). The most frequent apoptotic abnormalities are a reduction in 
mitochondria size and the matrix becomes hyperdense in apoptosis. This is often known 
as mitochondrial pyknosis (Zhuang et a l, 1998; Martinou et a l, 1999; Martinou and 
Green, 2001).
Once a death stimulus is triggered, mitochondria are known to coordinate caspase 
activation through the release of cytochrome c to cause apoptosis (Fig. 1.4) (Antonsson
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and Maritnou, 2000; Desagher and Martinou, 2000; Hengartner, 2000; Harada and Grant, 
2003; Kuwana and Newmeyer, 2003; Orrenius, 2004). Cytochrome c is located in the 
intermembrane space of mitochondria and it plays a major role in respiration, 
transporting electrons from complex HI to complex IV of the electron transport chain. As 
electrons are transported along, protons are pumped out of the matrix creating a negative 
potential called the mitochondrial transmembrane potential (A'Pm)- This potential is used 
by ATP synthase to form ATP from ADP and free phosphate. The ATP is then 
exchanged with ADP from the cytoplasm via the adenine nucleotide transporter (ANT) in 
the inner membrane and the voltage-dependent anion channel (VDAC) in the outer 
membrane (Waterhouse et a l, 2002).
The current apoptotic mechanism in mammalian cells is that once released into the 
cytosol, cytochrome c binds to Apaf-1 (apoptotic protease-activating factor 1), 
presumably changing its conformation from an inhibitory to an active form. The binary 
complex of cytochrome c and Apaf-1 then binds its critical cofactor ATP or dATP. This 
complex recruits and activates procaspase-9 to form a complex known as the apoptosome 
(Martinou and Green, 2001; Shi, 2001; Zimmermann et a l, 2001). Once caspase-9 is 
activated it stays within the apoptosome as a holoenzyme to maintain its catalytic activity 
(the apoptosome acts as an allosteric regulator for the enzymatic activity of caspase-9) 
that in turn activates other effector caspases that orchestrate the biochemical execution of 
cells (Adrain and Martin, 2001) (Fig. 1.4). Apoptosis therefore is dependent on ATP. 
Furthermore if mitochondrial damage occurs and it fails to produce ATP early during 
apoptosis, the apoptosome is unable to form, caspase-9 is not activated and therefore cells 
die by necrosis (Adrain and Martin, 2001; Martinou and Green, 2001).
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In vitro data has shown that once the mitochondrial pathway is stimulated, caspase-8 can 
also be activated downstream of caspase-9, most likely by caspase-3 or other effector 
caspases. Thus, initiator and effector caspases seem to activate each other giving rise to 
extensive crosstalk with several positive feedback loops. Caspase-8 is therefore located 
in the execution phase of apoptosis which may either cleave other caspases or activate 
Bid resulting in enhanced cytochrome c release and speeding up of the death process 
(Fig. 1.4) (Engels et a l, 2000).
It is still not known precisely how cytochrome c and other proteins are released from the 
mitochondrial intermembrane space. In addition to the release of cytochrome c, many 
other proteins normally confined to the intermembrane space of mitochondria such as 
several pro-caspases (mainly pro-caspase-2, -3, and -9), Smac/DIABLO, AIF (57kDa), 
EndoG, Htra2/0mi, HSP60, HSPIO, sulfite oxidase (104kDa), DNase G and adenylate 
kinase (isoenzyme 2) (25kDa) are also released into the cytosol (Susin et a l, 1996; Susin 
et a l, 1997; Susin et a l, 1999a; Loeffer and Kroemer, 2000; Martinou and Green, 2001; 
Amoult et a l, 2003; Kuwana and Newmeyer, 2003; Lorenzo and Susin, 2004). 
However, one key question is: do cytochrome c, Smac and other mitochondrial proteins 
exit the mitochondria on the same time scale and via the same pathway? Although the 
answer to this question is still contradictory, recent studies in HeLa cells have shown that 
the release of cytochrome c is a rapid process and complete (Springs et a l, 2002) and 
occurs in parallel with the release of Smac and HtrA2/0mi, which is caspase- 
independent. Interestingly, the release of pro-apoptotic EndoG and AIF were however 
dependent on caspase activation (Arnoult et a l, 2003). However these observations may 
be dependent on the cell type and the apoptotic stimuli.
-42-
So far research has shown two main prevailing models for cytochrome c release in 
apoptosis: the non-specific rupture of the outer mitochondrial membrane by swelling of 
the matrix and expansion of the inner membrane, and the formation of autonomous 
channels by Bcl-2 family members, such as Bax (Martinou and Green, 2001; Amoult et 
a l, 2003).
1.4.2.1. The permeability transition pore
Two main models can account for matrix swelling. The first model involves the 
hyperpolarization of the inner membrane that has shown to precede cytochrome c release. 
This hyperpolarization could be due to the inability to exchange mitochondrial ATP for 
cytosolic ADP during apoptosis (Green and Reed, 1998; Crompton, 1999; Desagher and 
Martinou, 2000). This antiport is normally mediated by VDAC (or mitochondrial porin) 
located in the outer membrane where it forms a large HiO-filled pore, allowing low Mr 
solutes to permeate freely and to gain access to the solute-specific transport systems of 
the inner membrane, and the ANT which is placed in the inner membrane where it 
mediates ADP-ATP exchange, essential for the bioenergetic function of the mitochondria 
(Crompton, 2000). VDAC closure causes an impairment of ATP-ADP exchange that 
inhibits FiFo-ATPase activity resulting in the inhibition of HT re-entry to the matrix, 
causing hyperpolarization of the inner membrane and thus causing an increase of the 
mitochondrial transmembrane potential (AT^ m) An increase in A'Pm is predicted to 
promote an osmotic matrix swelling leading to outer membrane rupture (Desagher and 
Martinou, 2000; Zamzami et a l, 2000).
Another possible mechanism implicates a mitochondrial megachannel known as the 
permeability transition pore (PTP) (Fig. 1.5). In vitro, the PTP opens under conditions of
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oxidative stress, high levels of Ca^  ^ or low ATP concentrations and possibly by Bax 
(Desagher and Martinou, 2000). The structure and composition of the PTP remains only 
partially defined, its constituents include VDAC, ANT and cyclophilin D (a water soluble 
matrix protein).
This channel operates in concert at the inner and outer contact sites thus causing 
mitochondrial permeability transition which is a sudden increase of the membrane 
permeability to solutes with molecular mass below approximately l.SkDa (Bemardi et 
a l, 1999). The PTP seems to operate in three distinct stages: a closed state with intact 
a low conductance state where the pore is permeable to molecules 300Da and ATm 
decreases reversibly and finally the high conductance state characterised for an 
irreversible collapse of the A'Pm due to membrane mpture (Gmbb et a l, 2001).
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Figure 1.4. Signalling pathways for apoptosis.
Two major pathways activate the effector caspases, leading to apoptotic cell death. In 
the first, death receptor activation by death ligands results in the activation o f caspase-8 
illustrating the action o f both pro- and anti-apoptotic proteins Bax and BcI-Xl 
respectively. The second pathway shows the effect o f cellular damage (DNA damage) 
leading to mitochondrial dysfunction and cytochrome c release into the cytoplasm. The 
subsequent binding o f cytochrome c to Apaf-I leads to the activation o f the caspase 
cascade through the activation o f capsase-9. Bid activated by caspase-8 acts as an 
important link between both pathways also inducing the release o f cytochrome c into the 
cytoplasm (Antonsson and Maritnou, 2000). Caspase activation is regulated by 
inhibitors, c-FLIP and lAP. Abbreviations: lAP, inhibitor o f apoptosis; c-FLIP, FLICE 
(FADD-like interleukin-Ip-converting enzyme)-inhibitory protein; Apaf-I, apoptotic 
protease-activating factor-I; AIF, apoptosis-inducing factor; FADD, Fas-associated 
protein with death domain; CD95L, CD95 receptor ligand. Adopted from Hengartner, 
(2000).
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Opening of this nonselective, voltage-dependent channel in the inner membrane allows 
for an equilibration of ions within the matrix and the inter membrane space thus 
dissipating the gradient across the inner membrane and uncoupling the respiratory 
chain. Most importantly pore opening results in a volume dysregulation of mitochondria 
due to the hyperosmolality of the matrix which causes the matrix space to expand. This 
matrix volume expansion can eventually cause outer membrane rupture thereby releasing 
all contents of the intermembrane space. The inner membrane has numerous folded 
christae and therefore does not burst as it has a considerably larger surface area than the 
outer membrane which means that expansion of the inner membrane upon matrix 
swelling can subsequently rupture the outer membrane (Green and Reed, 1998; Desagher 
and Martinou, 2000). However, in some circumstances, cytochrome c release and 
caspase activation can occur before any detectable loss of AWm suggesting that opening 
of the PTP may occur downstream of the apoptosome-mediated caspase activation. 
Furthermore caspases have been shown to induce opening of the PTP (Desagher and 
Martinou, 2000). Caspase-dependent opening of the PTP could form a feedforward 
amplification loop through which the initial cytochrome c release would induce matrix 
swelling, rupture of the outer membrane and loss of the remaining cytochrome c and 
other intermembrane proteins. Another alternative could be that caspases target proteins 
involved in the control of mitochondrial homeostasis such as Bcl-2, thus contributing to 
the late mitochondrial dysfunction that often follows apoptosis in vitro. This physical 
membrane breakage seems more likely to be a consequence than a cause of cytochrome c 
release. Indeed, once the outer membrane is permeabilized, eventually the mitochondria 
will stop working because cytochrome c depletion impairs electron transport and ATP 
production (Martinou and Green, 2001). The main criticism of the PTP model is that it
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does not seem to be compatible with the ability of mitochondria to remain functional long 
enough to allow caspase activation (as ATP is necessary) and apoptosis. Therefore, it 
seems likely that other mechanisms exist responsible for the initial cytochrome c leakage 
(Desagher and Martinou, 2000).
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Figure 1.5. The mitochondrial permeability transition pore (PTP).
This diagram shows the possible components o f the mitochondrial PTP. When the 
channel opens water and solutes can enter the matrix causing matrix swelling and 
rupture o f the outer mitochondrial membrane. Abbreviations: ANT, adenine nucleotide 
translocator; BPR, benzodiazepine peripheral receptor; CK, creatine kinase; HK, 
hexokinase; VDAC, voltage-dependent anion channel; Cph. D, cyclophilin D. Taken 
from Desagher, (2000).
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1.4.2.2. Cytochrome c-conducting channels
The second theory for the permeabilization of the outer mitochondrial membrane is 
suggested by the presence of Bcl-2 family proteins in mitochondrial membranes. In vitro 
research has shown that some pro-apoptotic Bcl-2 members, such as Bax, and anti- 
apoptotic members, such as Bcl-2, can form channels in synthetic membranes. For 
example, Bax has shown the ability to produce pores as discrete leakage sites in pure 
phospholipids membranes in the absence of other proteins (Epand et a l, 2002). 
However, it is of concern how a 20kDa protein (Bax) could form a channel that allows 
large proteins to pass through. It is known that Bax monomers must form oligomers to 
be functional which suggests that probably Bax and Bax-like proteins could form 
multimeric megachannels in the outer membrane to allow an initial release of cytochrome 
c however, there is no in vivo evidence of such channels as yet (Martinou and Green, 
2001; Epand et a l, 2002). Also it has been found that Bax and the truncated form of Bid 
(tBid) can decrease the stability of planar phospholipid bilayers suggesting that pro­
apoptotic proteins might act directly by destabilizing the outer mitochondrial membrane. 
Both proteins could promote the formation of a lipidic pore or protein-lipid complex 
large enough to allow proteins to difihise into the cytosol (Desagher and Martinou, 2000; 
Kuwana et a l, 2002). Alternatively, it is possible that Bax cooperates with VDAC to 
form a large pore which has shown in vitro conductance levels tenfold greater than those 
of the VDAC and Bax channels respectively (Desagher and Martinou, 2000; Zamzami 
and Kroemer, 2001).
Recently, some research work using patch clamping techniques allowed the first direct
biophysical evidence for the existence of a novel ion channel in the outer membrane of
mitochondria (Pavlov et a l, 2001). This specific channel termed mitochondria apoptosis-
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induced channel (MAC) showed that it is voltage-independent and displayed multiple 
conductance levels corresponding to a pore size that would allow cytochrome c and 
larger proteins to diffuse across the outer michondrial membrane. The study 
demonstrated that Bax played an essential role in MAC activation either by forming the 
channel by itself or in association with other membrane proteins. However, contrary to 
other reports VDAC was not involved (Degterev et a l, 2001; Pavlov et a l, 2001).
The channel theory offers the advantage of maintaining functional mitochondria during 
the time necessary for the activation of caspases because the latter process requires ATP. 
However, there is still no proven evidence that the Bcl-2 proteins do form mitochondrial 
channels in vivo. Furthermore, whether the lumen of these pores is sufficiently large to 
allow cytochrome c and other proteins through the membrane is even less certain. It 
could be that both models are not exclusive and could occur sequentially or concurrently 
in certain apoptotic pathways (Zamzami and Kroemer, 2001).
1.5 Liver Apoptosis and Disease
The liver is a large organ composed of a single cell type, the hepatocyte (Hinton and 
Grasso, 2000). These cells are assembled into sheets, each a single cell thick, which 
bifurcate and fuse to give a very complex network arranged around a central hepatic vein 
with portal tracts located at its periphery. Through this network, run the liver capillaries, 
known as sinusoids and lined by sinusoidal endothelial cells (SECs). Within the 
sinusoids lie Kupffer cells which are fixed macrophages which form attachments both to 
the walls of SECs and by means of processes pushed through the fenestrations, to the 
hepatocytes (Hinton and Grasso, 2000).
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Pathological apoptosis is potentially an important mechanism of acute liver injury. In the 
liver, apoptosis also occurs as a normal stage of development and then in the adult liver, 
both for organogenesis, renewal of cells and for the elimination of hepatocytes whose 
DNA has been damaged or which harbour viral proteins (Columbano and Shinozuka, 
1996; Jones and Gores, 1997). Often, liver disease is either associated with the 
disruption of apoptosis such as in hepatocellular carcinoma or with enhanced hepatocyte 
apoptosis as observed in viral and autoimmune hepatitis, metabolic disorders and 
cholestatic disease (Neuman, 2001).
Apoptosis of the endothelial cells causes injury of the bile duct that impairs bile flow, a 
common feature of several chronic human liver diseases. This pathological feature leads 
to cholestatic diseases including primary biliary cirrhosis, primary sclerosis cholangitis, 
biliary atresia and drug related liver diseases (Sokol et a l, 1995). Cholestatic liver 
diseases results from the destruction of bile duct epithelial cells (cholangiocytes) which 
results in cholangiocyte apoptosis mediated by cytotoxic T-lymphocytes. Cholangiocyte 
apoptosis results in the retention and accumulation of toxic bile salts within the 
hepatocytes, which in turn results in bile salt-mediated apoptosis of hepatocytes by direct 
activation of the CD95 death receptor pathway. Therefore, apoptosis of both cell types 
(cholangiocytes and hepatocytes) contributes to liver dysfunction (Faubion et a l, 1999; 
Miyoshi e^ûr/., 1999).
In alcoholic liver disease, there is evidence that chronic alcohol consumption enhances 
hepatocyte apoptosis before the onset of necrosis through oxidative stress and the 
stimulation of the CD95 death receptors (Higuchi et a l, 1996; Cui et a l, 1997).
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Normally, virally infected cells are eliminated by apoptosis and it is generally considered 
a mechanism of host defence. Several viruses such as herpes virus, adenovirus and 
vaccinia virus synthesise viral proteins that specifically inhibit apoptosis mediated by 
various mechanisms. Alternatively, many viruses may induce apoptosis by enhancing the 
various apoptotic mechanisms of the hosts. Several studies have shown a significant 
increase in apoptotic bodies in patients with chronic hepatitis B and C. Apoptosis is an 
important component in acute viral hepatitis and it is enhanced by the activation of death 
receptors (Crispe et a l, 2000; Knolle and Gerken, 2000). For instance, CD95 protein 
expression was found to be enhanced in some patients with fiilminant hepatitis B and C 
virus infection (Rivero et a l, 1998; Kaplowitz, 2000).
Hepatocytes are known to express high levels of CD95 receptor which has been shown in 
vivo by intraperitoneal injection of anti-CD95 antibody in mice to result in the death of 
the animals through fulminant hepatitis like massive liver damage (Ogasawara et a l, 
1993). Humans showing mutations in the CD95 gene showed substantial liver 
hyperplasia (Adachi et a l, 1995).
In the development of hepatocellular carcinoma, there is strong evidence which 
demonstrates the disruption of apoptosis at several steps of the process. The analysis of 
22 patients with hepatocellular carcinoma revealed a partial or complete loss of CD95 
receptor which is normally expressed constitutively in hepatocytes. It is thought that loss 
of CD95 receptor expression is one means through which malignant cells can escape the 
CD95-mediated killing of cytotoxic T-lymohocytes (Higaki et a l, 1996). Also, like in 
many other tumour cells, the human hepatoblastomas co-express both CD95 receptor and 
its ligand on their surface. However, these tumour cells have developed mechanisms
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such as the expression of Bcl-2 and Fas-associated phosphatase-1, and the expression of 
soluble CD95 so that these tumour cells do not destroy themselves and avoid apoptosis 
and they can therefore proliferate (Lee et a l, 1999).
1.6 Drug-induced Liver injury
The liver is the site of xenobiotic metabolism and thus it is a frequent target of drug 
toxicity, as well as glycogen storage and has 75% of its blood flow derived from the 
digestive organs (Kaplowitz, 2000; Kaplowitz, 2002). Owing to the potentially damaging 
metabolites that are generated during drug metabolism, damage to the liver can occur 
(Kaplowitz, 2000). Therefore, liver failure could induce severe consequences for 
metabolism, immune response, antimicrobial defences and detoxification. Xenobiotics 
reach the liver via the systemic circulation and are transformed by the cytochrome P450 
enzymatic system into reactive metabolites. The endothelial cells of the hepatocytes 
sinusoids that possess fenestrae allow different proteins to come into direct contact with 
hepatocytes enabling the liver to eliminate the toxic metabolites and/or further modify 
them.
Liver toxicity is the principal cause of drug withdrawal for safety reasons during clinical 
trials. Despite important progress in the understanding of the mechanisms of liver 
toxicity, “non-hepatotoxic” molecules have not been able to be designed rationally. 
Furthermore, there is no ‘universal’ in vitro primary screening approach for early 
identification of hepatotoxic molecules. In most cases, hepatotoxicity is detected at later 
stages of drug development in animal studies or clinical trials (Ballet, 1997).
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Although cell death induced by cytotoxic drugs has been reported to involve in vitro and 
in vivo activation of death receptor systems such as the CD95 system, several recent 
reports have also demonstrated that drug-induced apoptosis could not be blocked by 
putative antagonistic anti-CD95-antibodies. Thus in most cases drug-induced apoptosis 
is found to involve perturbations of mitochondrial function (Fulda et a l, 2001). 
Activation of death receptors, mitochondrial damage and oxidative stress of the 
endoplasmic reticulum are the most important apoptotic pathways that induce liver injury 
(Xie et a l, 2002). Although these findings have emphasized the importance of apoptosis 
as a ubiquitous pathway for cell death, many cytotoxic drugs have also been described as 
inducers of necrosis (Kass and Orrenius, 1999; Robertson and Orrenius, 2000).
Several hepatotoxins including paracetamol (Ray et a l, 1993), carbon tetrachloride 
(LeSage et a l, 1999a; LeSage et a l, 1999b), cocaine (Casacales et a l, 1994), alcohol 
(Goldin et a l, 1993; Patel and Gores, 1995) or dimethylnitrosamine (Ray et a l, 1992) 
have been shown to induce DNA fragmentation in vitro and the formation of apoptotic 
bodies has been observed after treatment of animals with thioacetamide, lead, cocaine, D- 
galactosamine (Feldmann, 1997).
1.6.1 Hepatotoxicity by paracetamol
Paracetamol (acetaminophen) is one of the most frequently used analgesic/antipyretic 
drugs and is generally considered safe in normal therapeutic doses. However, when 
paracetamol is consumed in large doses, it is known to damage various cells or tissues 
such as hepatic, renal, cardiac and central nervous system (Bae et a l, 2001).
The nature of the hepatotoxicity initiated by paracetamol has been the subject of much
debate over the years. Hepatic necrosis resulting from massive overdosage from
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paracetamol was first reported in rats by Boyd and Bereczky in 1966 (Boyd and 
Bereczky, 1966), and a report of this complication in man soon followed (Davidson and 
Eastham, 1966; Prescott et a l, 1971; Moore et a l, 1985).
Paracetamol-induced hepatotoxicity in mice is characterised by hepatomegaly and 
massive centrilobular congestion which precedes the appearance of cell death. Plasma 
accumulation due to endocytic vacuolation of hepatocytes in the centrilobular regions 
accounts for the initial increase in liver size. There are two major consequences of 
paracetamol-induced hepatotoxic congestion. First, blood and plasma volumes fall 
significantly, and it has been suggested that hypovolaemic shock contributes to the early 
mortality. Secondly, the impaired circulation within the congested liver probably 
aggravates the initial injury (Walker et a l, 1985).
Centrilobular hepatic necrosis is a characteristic feature observed in paracetamol 
overdose (Dixon et a l, 1975). However, recent reports have presented evidence for the 
occurrence of apoptosis in paracetamol-induced liver damage both in vivo and in vitro 
(Adams et a l, 2001; Gujral et a l, 2002). Ray et al. (1996) has even concluded that, in 
paracetamol-induced liver cell injury, the majority of the hepatocytes predominantly 
choose to die via the apoptotic programmed cell death pathway rather than facing the 
unprogrammed consequences of necrosis (Ray et a l, 1996). It was hypothesized that 
40% or more of the hepatocytes die by apoptosis (Ray and Jena, 2000).
Despite numerous investigations, the mechanism of paracetamol-induced liver cell death 
is still very controversial. However, it has been considered to be entirely the 
consequence of its metabolism by the cytochrome P-450 (CYP-450) system within the 
hepatocytes (Nelson, 1990).
-54-
Paracetamol is metabolised by sulfation and glucuronidation but as the dose is increased, 
these pathways become saturated and a greater proportion of the drug is available for 
oxidation by the mixed-function oxidases, including microsomal cytochromes P-450 2E1, 
1A2, and 3 A in humans and experimental animals (Bae et a l, 2001). It is a product of 
this pathway, N-acetyl-p-benzoquinone imine (NAPQI), which is known to be 
responsible for the hepatic damage (Bessems and Vermeulen, 2001). In the liver, NAPQI 
is mainly detoxified by reduction to the parent compound (paracetamol) or by 
conjugation at the /w^/a-position with glutathione (GSH), both reactions which consume 
GSH (Mitchell et a l, 1985). Thus as GSH becomes depleted, a greater proportion of 
NAPQI is fi"ee to cause cell damage by interaction with cellular macromolecules resulting 
in oxidation and arylation of cellular proteins primarily via cysteinyl residues and 
initiates cellular death. There also seems to be a significant role for activation of 
oxidative pathways that lead to liver damage and subsequently induce significant 
inflammation (Hardwick et a l, 1992).
NAPQI as a highly reactive metabolite can also covalently bind and interact with critical 
thiol groups fi’om intracellular target enzymes that help maintain the large calcium 
concentration gradient across the cell membrane thus causing an uncontrolled increase in 
intracellular calcium concentration that may lead to deleterious cellular effects such as 
activation of calcium-dependent degradative enzymes (proteases, endonucleases and 
phospholipases) and changes to the cytoskeleton (Hardwick et a l, 1992; Ishida et a l, 
2002). Therefore the toxicity of NAPQI metabolite depends on several factors, including 
the ability to clear the toxic metabolite by GSH trapping and the level of specific 
cytochrome P450 enzymes that are expressed by the hepatocyte for more rapid
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conversion of paracetamol to NAPQI (Moore et a l, 1985; Harman et a l, 1991; Bessems 
and Vermeulen, 2001).
In addition, the release of soluble pro-inflammatory and pro-apoptotic molecules from 
parenchymal and non-parenchymal liver cells such as TNF, CD95L, interleukin (IL)-lp 
and nitric oxide are believed to contribute to paracetamol-induced toxicity (Blazka et a l, 
1995; Laskin et a l, 1995; Blazka et a l, 1996; Gadner et a l, 1998; Zhang et a l, 2000; 
Fiorucci et a l, 2002; Ishida et a l, 2002).
The critical role of apoptosis in eliciting paracetamol-induced liver injury was 
demonstrated by a report from our laboratory showing that caspase inhibitors provided 
protection from paracetamol-induced hepatotoxicity in mice. These findings highlighted 
the importance of apoptosis in the initial events that lead to paracetamol-induced hepatic 
injury and ultimately necrosis in vivo (El-Hassan et a l, 2003).
1.7 Project Objective
The main objective of this study was to identify the mechanisms of drug-induced liver 
cell apoptosis in vitro. This investigation could help in the discovery of novel markers 
of apoptosis that could be used for predicting hepatocyte apoptosis in vivo.
This study was performed using three model compounds, paracetamol, thapsigargin and
duroquinone. Whereas paracetamol is a well established hepatotoxin, the other two
compounds were chosen to represent two major mechanisms of drug-induced cellular
injury, such as ER stress and oxidative stress, respectively. The ability of these drugs to
trigger apoptosis in liver cells was investigated using two cellular models, including (a)
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primary mouse hepatocytes and (b) the hepatoma cell line, HuH7. The HuH7 cell line 
was established from a hepatoma tissue removed at surgical operation from a 57-year old 
Japanese male with well differentiated hepatocellular carcinoma and the enzyme pattern 
in HuH7 cells was shown to resemble that of the original hepatoma tissue (Nakabayashi 
et a l, 1982; Rang et a l, 1999).
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CHAPTER 2
MATERIALS AND METHODS
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2.1 Materials
Reagents used in this study are listed below according to suppliers;
Affinity Research Products Ltd, UK
Mouse monoclonal antibody to a-fodrin (non-erythroid oll-spectrin)
Alexis Corporation Ltd., UK
Puromycin dihydrochloride, staurosporine (antibiotic AM-2282)
Amer sham Pharmacia Biotech Ltd, UK
Hybond enhanced chemiluminescence (ECL) nitrocellulose membrane 
Bachem, Switzerland
Z-Val-Ala-DL-Asp-fluoro-methylketone (Z-VAD-fink) and N-acetyl-Asp-Glu-Val-Asp- 
aldehyde (Ac-DEVD-CHO).
Bio-Rad Laboratories Ltd, UK
Kaleidoscope prestained molecular weight protein standards (high range), protein assay 
dye reagent, Whatmann 3 mm filter paper, N, N, N, N-tetramethylethylenediamine 
(TEMED) and 0-globulin protein standards.
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British Drug House (BDH)/AnalaR Ltd, UK
Glycine, polyoxyethelenesorbitan (Tween-20), magnesium chloride (MgCli), potassium 
chloride (KCl), sodium chloride (NaCl), P-mercaptoethanol, glycine, sodium dodecyl 
sulphate (SDS) and sucrose.
BD PharMingen, USA
Phycoerythrin (PE)-conjugated monoclonal active caspase-3 antibody apoptosis kit, 
purified mouse anti-cytochrome c antibodies (clones; 7H8.2C12 and 6H2.B4) and 
purified hamster anti-mouse anti-CD95 monoclonal antibody (Jo2).
Calbiochem-Novabiochem Ltd, UK
Human anti-caspase-3 polyclonal antibody (rabbit), carbobenzoxy-L-leucyl-L-leucyl-L- 
leucinal (MG-132, proteasome inhibitor), thapsigargin, N-acetyl-leu-leu-norleucinal 
(ALLN in solution, calpain inhibitor I) and 1,9-pyrazoloanthrone (JNK inhibitor H), 
bongkrekic acid, p38 MAP kinase inhibitor (SB 203580) and MAP kinase kinase (MEK) 
inhibitor (PD 98059).
Cell Signalling Technology Inc, USA
Phospho-SAPK/JNK (Thrl83/Tyrl85) polyclonal antibody (rabbit) and SAPK/JNK 
control cell extracts.
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DakoLtd, UK
Peroxidase-conjugated goat anti-mouse immunoglobulins, peroxidase-conjugated goat 
anti-rabbit immunoglobulins and fluorescein isothiocyanate (FITC)-conjugated rabbit 
anti-mouse immunoglobulins.
Enzyme Systems Products, Livermore, CA, USA 
Z-Phe-Ala-FMK (Z-FA-fmk)
Fischer Scientific International Co., UK
Methanol, ethanol, sodium hydroxide (NaOH), hydrochloric acid (HCl), acetic acid 
(glacial) and formaldehyde and paraformaldehyde.
Invitrogen, UK
Foetal bovine serum (FBS), insulin, trypsin-EDTA solution, L-glutamine (200mM), non- 
essential amino acids (100 x stock), William’s E media with Glutamax and Dulbecco’s 
Modified Essential Medium (DMEM) without Glutamax and high in glucose.
Kamiya Biomedical Company, USA
Human anti-CD95 monoclonal antibody (CH-11).
Molecular Probes, USA
Hoechst 33258 (bis-benzimide) dye, tetramethylrhodamine ethyl ester (TMRE) and anti­
cytochrome c oxidase (COX) (subunit IV) mouse monoclonal antibody (clone 20E8- 
C12).
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Oxoid, UK
Phosphate buffered saline (PBS) tablets
PIERCE, USA
SuperSignal West Pico chemiluminescent substrate 
Roche Diagnostics, Germany
Collagenase H, bovine serum albumin (BSA) fraction V, alanine aminotranferase, lactate 
dehydrogenase (LDH) cytotoxicity detection kit, M30 CytoDEATH, phenyl-methyl- 
sulfonyl-fluoride (PMSF), aprotinin, pepstatin, leupeptin, cyclosporin A.
Santa Cruz Biotechnology Inc, USA 
Mouse anti-Bax monoclonal antibody (B-9)
Sigma-Aldrich Chemical Co. Ltd, UK
Ammonium persulphate, cycloheximide, glycerol, poly-L-lysine hydrobromide (MW 
70,000-150,000), trypan blue 0.4%, 3-amino-7-dimethylamino-2-methyl phenazine 
hydrochloride (MTT dye), isopropanol, dimethyl sulphoxide (DMSO), 
ethylendiaminetetraacetic acid (EDTA), Nonidet P-40 (NP-40), N-tosyl-L-phenylalanine 
chloromethyl ketone (TPCK), acrylamide/bis-acrylamide solution (40% w/v), HEPES, 
[ethylenebis(oxyethylenitrilo)]-tetraacetic acid (EGTA), saponin, duroquinone, ponceau 
S, sodium vanadate (NaV0 4 ), glycerol, paracetamol (acetaminophen, 99% pure), 3-(2,4- 
dichlorophenyl)-4-( 1 -methyl-lH-indol-3-yl)-lH-pyrrole-2,5-dione (SB-216763) and 3- 
[(3 -chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)- lH-pyrrole-2,5-dione
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(SB415286), mannitol, sucrose, calcium chloride (CaCy, Tris, bromophenol blue and 
propidium iodide (PI).
Stressgen Biotechnology, USA 
Rabbit anti-Hsc70 polyclonal antibody
Upstate Biotechnology, USA 
Anti-SAPKlb/JNK3 rabbit polyclonal IgG
Vector Laboratories Inc, USA
VECTASHIELD® mounting medium without propidium iodide (PI)
Anti-caspase-7 mouse polyclonal antibody and anti-Smac/DIABLO rabbit polyclonal 
antibody were a gift from Prof Gerald M. Cohen (MRC Toxicology Unit, Leicester, UK).
2.2 Solutions and Buffers
2.2.1 General
Phosphate Buffered Saline (PBS)
Dissolved one tablet of PBS in 100ml of milHQ water. The solution was mixed 
thoroughly and sterilised prior use.
-63-
Poly-L-lysine (for coating culture flasks)
A working solution of lOgg/ml was prepared in sterile milliQ water. One ml of this 
solution was used to coat each well of 6-well and 24-well plates (Falcon) at 37°C for 1 
hour. The solution was then aspirated and each well rinsed with sterile milliQ water and 
dried in an oven overnight or for a minimum of 3 hours.
2.2.2 Primary hepatocyte isolation
Hanks-buffered salt solution (lOx stock)
This buffer was prepared by dissolving 8g NaCl (1.4M), 0.4g KCl (54mM), 0.23g 
MgS0 4  (19mM), 60mg Na2HP0 4  (4.2mM) and 60mg KH2PO4 (4.4mM) in 100ml milliQ 
water and stored at 4°C.
1 X Hanks Buffer
This buffer was freshly prepared by dissolving 745mg Hepes (12mM) and 525mg 
NaHCOs (25mM) in 225ml milliQ water and mixed with 25ml 10 x Hanks stock 
solution.
Pre-collagenase perfusion buffer
This solution was freshly prepared by dissolving BSA (0.75% w/v) and EDTA (0.02% 
w/v) in 150ml 1 x Hanks buffer, the pH adjusted to 7.45 with IM NaOH and the solution 
filter sterilised. The solution was gassed with carbogen before use.
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Collagenase perfusion buffer
This solution was freshly prepared by dissolving 200mg BSA (0.2% w/v), 50mg 
collagenase H (0.05% w/v) and 30mg CaCh (2.7mM) in 100ml 1 x Hanks buffer, the pH 
adjusted to 7.45 with IM NaOH and the solution filter sterilised. The solution was 
gassed with carbogen before use.
2.2.3 SDS-PAGE and Western blotting
Homogenisation buffer (MSH-EDTA)
This buffer was prepared by adding the following: 210mM mannitol, 70mM sucrose, 
3mM Hepes, ImM EDTA, ImM pefabloc block, Ipg/ml pepstatin, Ipg/ml leupeptin and 
Ipg/ml aprotinin. The buffer was prepared in milliQ water and pH adjusted to 7.1 with 
KOH.
Cell lysis buffer
10ml lysis buffer stock (50mM Tris-Cl and 150mMNaCl, pH7.5) supplemented with 1% 
(v/v) NP-40, 0.2% (v/v) SDS, ImM pefabloc, 2pg/ml aprotinin, 2pg/ml leupeptin and 
ImM NaV0 4  . This buffer was freshly prepared and kept in ice.
Intracellular medium, buffer A
Intracellular medium buffer (10ml) supplemented with IpM cyclosporin A. The 
intracellular medium buffer was prepared by dissolving 20mM NaCl, lOOmM KCl, 2mM 
MgCli, ImM EGTA, 23mM Hepes in 200ml milliQ water and the pH adjusted to 7.1 
with KOH. The volume was made up to 250ml with milliQ water and the solution stored 
at4"C.
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Intracellular medium buffer, B
Buffer A supplemented with 1 mg/ml saponin.
Ammonium persulphate stock solution (10% w/v)
Ammonium persulphate (O.lg) was added to 1ml milliQ water and mixed thoroughly. 
This solution was made fresh for casting SDS-PAGE gel.
Coomassie stain
This was prepared by mixing 25ml coomassie brilliant blue (1% w/v stock), to a mixture 
of 45ml methanol, 10ml glacial acetic acid and 20ml milliQ water.
Destaining buffer
Made by mixing 45ml methanol and 10ml glacial acetic acid in 45ml of milliQ water 
Ponceau S  (membrane staining dye)
This working solution was prepared by mixing 0.1 mg Ponceau S, 5ml glacial acetic acid 
and made up to 100ml with milliQ water. Stored at room temperature.
Loading buffer fo r SDS-PAGE (2 x stock)
Prepared by mixing 5ml stacking gel buffer, 2ml SDS (20% w/v stock), 4g glycerol, 
0.5ml p-mercaptoethanol, 0.1ml bromophenol blue (1% w/v stock) and made up volume 
to 10ml with milliQ water. The buffer was stored in the dark for a maximum of 2 weeks.
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Resolving gel buffer
Tris base (45.3g) was dissolved in 400ml milliQ water and the pH adjusted to 8.8 with 
HCl. The volume was made up to 500ml and the solution stored at 4°C.
Resolving gel (15%) (enough fo r two gels)
These reagents were added in the following order: 1ml milliQ water; 5ml resolving gel 
buffer; 3.8ml acrylamide/bis-acrylamide solution (40% w/v); lOOpl SDS (20% w/v 
stock); 150pl ammonium persulphate stock solution (10% w/v) and 3 pi TEMED. The 
solution was mixed well, poured and allowed to set at room temperature.
Resolving gel (7.5%)
These reagents were added in the following order: 1.9ml milliQ water; 5ml resolving gel 
buffer; 1.9ml acrylamide/bis-acrylamide solution (40% w/v); 1ml SDS (20% w/v stock); 
150pl ammonium persulphate (10% w/v) and 3 pi TEMED. The solution was mixed 
well, poured and allowed to set at room temperature.
Stacking gel buffer
Prepared by dissolving 15.12g Tris base in 400ml milliQ water. The pH was adjusted to 
6.8 with HCl and the volume made up to 500ml. The solution was stored at 4°C.
Stacking gel (4%) (enough fo r two gels)
These reagents were added in the following order: 1.9ml milliQ water, 2.5ml stacking gel 
buffer, 0.5ml acrylamide/bisacrylamide solution (40% w/v), 50pl SDS (20% w/v stock).
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50pl ammonium persulphate (10% w/v) and 15pl TEMED. The solution was mixed 
well, poured and allowed to set at room temperature.
Running buffer, pH  8.3
Prepared by dissolving 3.02g Tris base, 14.44g glycine, 5ml SDS (20% w/v stock) in 
900ml milliQ water and the volume made up to 1 litre.
Tranffer buffer, pH  8.3
Prepared by dissolving 3.02g Tris base, 14.44g glycine in 800ml milliQ water and 200ml 
methanol was added to make a 1 litre solution.
JO X Tris buffered saline (TBS)-Tween buffer (TBS-T), pH  7.6
Prepared by dissolving 48.4g Tris base, 160g NaCl in 1.8ml milliQ water and the pH 
adjusted to 7.6 with HCl. Then added 20ml Tween-20 and the final volume made up to 2 
litres using milliQ water. The buffer was stored at 4°C and diluted Ix prior use.
Milk blocking solution
Prepared by adding 5g of fat-free milk powder to 100ml of 1 x TBS-T buffer. The 
solution was mixed thoroughly prior use.
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2.2.4 Immunocytochemistry
4Yo Paraformaldehyde fixing buffer
Prepared by dissolving 2g of paraformaldehyde (4% w/v) in 25ml of 2 x PBS and a few 
drops of IM NaOH, The solution was heated to 65°C until thoroughly dissolved and then 
adjusted pH to 7.2 with NaOH. Then, made up volume to 50ml with milliQ water.
Blocking buffer
This buffer was prepared by dissolving 3g BSA (3% w/v), 50mg saponin (0.05% w/v) in 
100ml PBS and the pH adjusted to 7.2.
2.3 Animals
Male Balb/C mice were purchased from Bantin & Kingman (UK) at a weight of about 
25g and 6-8 weeks old. The animals were housed in a room at 24 ± 2°C and a 12:12-h 
light/dark cycle for at least one week prior to all experiments. Animals were fed 
commercial laboratory chow pellets and water ad libitum.
2.4 In Vivo Experiments
Paracetamol, dissolved in PBS, was injected intraperitoneally at a dose of 500mg/Kg. 
Anti-CD95 antibody, dissolved in PBS, was also injected intraperitoneally at a dose of 
30pg/animal. Control animals always received an equivalent volume of PBS via the 
intraperitoneal route.
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After 6 hours, the mice were sacrificed by an intraperitoneal injection of a lethal dose of 
sodium pentobarbital (0.2ml/animal) (Phone Merieux Limited). The livers were carefiilly 
removed and chopped in small pieces. The pieces of liver tissue were snap frozen by 
immersion into a bath of hexane cooled by a mixture of ethanol and dry ice and then 
stored in glass tubes at -80°C for further biochemical analysis.
2.5 Preparation of Liver Homogenates
Total liver homogenates were prepared in ice-cold MSH-EDTA buffer by homogenising 
frozen liver sections using a glass-Teflon homogeniser to yield an overall 25% (w/v) liver 
homogenate.
2.5.1 Subcell ular fractionation
This method was performed according to (El-Hassan et a l, 2003). Liver homogenates 
were placed into 1.5ml Eppendorf tubes and centrifuged at 500 x g for 10 minutes at 4°C. 
The pellet was discarded and the supernatant was collected and re-centrifuged further at 
14,000 X g for 10 minutes at 4°C. The supernatant (postmitochondrial cytosol) was 
removed and the pellet (mitochondria) was washed by re-suspending in MSH-EDTA 
buffer and gently homogenised on ice by hand using a glass-Teflon homogeniser. The 
pellet was centrifuged again at 14,000 x g for 10 minutes at 4°C. The final mitochondrial 
pellet was gently re-suspended in 600pl MSH-EDTA buffer. Both cytosolic and 
mitochondrial fractions were divided into aliquots and frozen at -80°C for further 
analysis. The postmitochondrial cytosol fraction was completely devoid of mitochondria 
as evidence by the absence of cytochrome c oxidase activity.
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2.6 Cell Culture
2.6.1 Isolation of mouse hepatocytes
Mouse hepatocytes were isolated by a retrograde, non-recirculating in situ collagenase 
perfusion of the livers from male Balb/C mice (25g, 6-8 weeks old) by a modified 
procedure from Moldeus et a l, (1978) and Seglen, (1972). This method involves the 
caimulation and perfusion in situ via the abdominal section of the inferior vena cava, with 
perfusate efflux through the hepatic portal vein.
The animal was anaesthetised by an intraperitoneal injection of 120mg/Kg body weight
of sodium pentobarbitone, and then the animal was secured on a grid platform above a
large plastic container. The skin of all the abdominal area was swabbed with 70%
ethanol. The abdominal cavity was then opened and carefully the viscera were deflected
to the right. A loose ligature was placed around the exposed upper inferior vena cava.
The vessel was then cannulated and ligated, using a 22-gauge Teflon caimula
(Venisystems) towards the liver entering the vena cava above the renal vein branches.
Any air bubbles present in the perfusate were dispelled prior to cannulations. Then the
cannula was rapidly connected to the perfusion silicon tubing primed with pre-
collagenase buffer flowing at 3ml/min via a peristaltic pump. As soon as the liver
swelled briefly, the portal vein was cut to allow perfusate to flow out. The pre-
collagenase buffer was allowed to perfiise for 5 minutes and meanwhile the thoracic
cavity was opened and the thoracic aorta and vena cava clamped shut to ensure maximum
perfusion delivery to the liver. After 5 minutes, the peristaltic pump was temporarily
switched off while the perfusate reservoir was emptied and changed to the collagenase
buffer, ensuring there was no mixing of solutions. The pump was then switched on again
and the collagenase buffer also flowing at 3ml/min was allowed to perfuse for 8-10
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minutes to allow digestion of the liver, during which time the gall bladder was carefully 
dissected out. The liver was judged to be frilly digested when carefully applied pressure 
on the liver with the use of blunt forceps resulted in a depression that remained for 
several seconds instead of recovering immediately.
The liver was transferred into a sterile glass petri-dish containing pre-warmed PBS at 
37°C supplemented with 1% (w/v) BSA. The liver was held with blunt sterile forceps 
and the Glisson’s capsule was gently removed and the hepatocytes were dispersed by 
gentle agitation. The resultant suspension was filtered through sterilised 64pm gauze and 
made up to 50ml with PBS in a sterile Falcon tube. The cells were allowed to settle for 
10 minutes at room temperature.
2.6.2 Preparation and treatment of primary hepatocyte cultures
After approximately 10 minutes, the supernatant was aspirated and the soft hepatocyte 
pellet was gently re-suspended in 10ml pre-warmed (37°C) William’s E media with 
Glutamax supplemented with 10% (v/v) FBS, 50IU/ml penicillin/50pg/ml streptomycin 
solution and lOpg/ml insulin (growth medium) and centrifuged at 33 x g for 2 minutes. 
This step was repeated twice to wash the cell pellet. Finally, the hepatocytes were re­
suspended in 10ml growth medium.
Viability of isolated hepatocytes was assessed using the vital stain trypan blue. Trypan 
blue is only taken up by cells with damaged plasma membranes, which indicates that 
cells are non-viable. Therefore counting cells and comparing between white and blue 
stained hepatocytes following trypan blue treatment shows the percentage viability and 
the yield of the isolated hepatocytes. A 200pl aliquot of the cell suspension was added to
-72-
200pl of trypan blue solution (0.4%). The Eppendorf tube was gently mixed and an 
aliquot of 20pl was placed into each chamber of an ‘Improved Neubauer’ 
haemocytometer (BDH). The haemocytometer uses a five by five grid, and all of these 
squares were counted in both chambers for both total number of cells and number of blue 
cells. Hepatocyte preparations with viability >60% were used for experiments. Cells 
were seeded into culture plates according to the experiment and cultured in a humidified 
carbon dioxide (CO2) incubator (5% CO2  ; 95% air) at 37°C for a maximum of four days 
and cells were allowed to recover for 24 hours prior to treatment. Treatments were 
always prepared in William’s E medium supplemented with 2% (v/v) FBS, 50IU/ml 
penicillin/50pg/ml streptomycin solution and lOpg/ml insulin (assay medium).
2.6.3 Maintenance and treatment of HuH7 cells
HuH7 cells were a kind gift from Prof R. Bartenschlager from the University of Mainz, 
Germany. The HuH7 cells were routinely cultured as monolayers in DMEM without 
Glutamax, supplemented with 10% (v/v) FBS, lOOIU/ml penicillin and lOOpg/ml 
streptomycin solution, 1 x non-essential amino acids and 2mM L-glutamine (growth 
medium) in a humidified CO2  incubator (5% CO2  : 95% air) at 37°C. Cells were 
subcultured every 5 days at 1x10  ^cells per 75cm^ culture flask (NUNC).
Cells were washed with PBS to remove dead cells and debris from the flasks. Cells were 
harvested by addition of 2ml 0.05% trypsin/0.02% EDTA solution. After incubation at 
37°C for 3 minutes to allow cells to detach, the cell suspension was centrifuged at 100 x g 
for 5 minutes. The supernatant was discarded and the cell pellet was re-suspended in 
10ml pre-warmed (37°C) growth medium. A single cell suspension was obtained by 
gently aspirating the solution with a 10ml pipette for several times. The cells were
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counted using the haemocytometer and seeded into culture plates according to the 
experiment. Cells were incubated at 37°C and allowed a minimum period of 24 hours 
prior to treatment to allow cells to recover. The morphology was noted daily and 
treatment was always performed at near confluence (80-90%) in DMEM supplemented 
with 2% FBS, 50Units/ml penicillin/50pg/ml streptomycin, Ix non-essential amino acids 
and 2mM L-glutamine (assay medium).
2.6.4 Culture of HeLa cells
The human cervical carcinoma cell line (HeLa) was originally obtained from the 
European Collection of Animal Cell Cultures (ECACC). HeLa cells were routinely 
cultured in growth medium as mentioned in section 2.6.3 in a humidified CO2 incubator 
(5% CO2 : 95% air) at 37°C. This cell line was used as a positive control for caspase 
processing in Western blotting analysis. HeLa cells were treated in 75cm^ culture flasks 
at near confluence (80-90%) with 150ng/ml anti-CD95 human antibody (CH-11), 
supplemented with Ipg/ml cycloheximide (protein synthesis inhibitor), in assay media 
for 7 hours. Then, cell lysates were prepared according to section 2.10.2 for Western 
blotting.
2.7 Compound Preparation
The compounds used in this study for the in vitro treatment of HuH7 cells or primary 
mouse hepatocytes are paracetamol (lOmM), thapsigargin (IpM) and duroquinone 
(0.5mM). In addition, these cells were treated with the apoptotic inducers, staurosporine 
(IpM) and puromycin (20pM) as positive controls for caspase-3 activation. All drugs
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were dissolved in DMSO and stocks stored at -20°C. On the day of treatment, the 
compounds were diluted accordingly in assay medium so that the final concentration of 
DMSO in the cell incubation mixture never exceeded 0.1% (v/v) and no induction or 
suppression of apoptosis was observed. In all experiments DMSO controls were run in 
parallel. Cultures were examined for alterations in morphology during treatment using 
phase contrast microscopy (Zeiss Telaval inverted light microscope).
2.8 Cytotoxicity Assays
2.8.1 MTT reduction assay
HuH7 cells and primary mouse hepatocytes were seeded at 6000cells/well into 96-well 
culture plates and allowed to recover for 24 hours. Cells were treated with paracetamol, 
thapsigargin or duroquinone accordingly for the initial dose-ranging studies. At the end 
of every treatment period, the cytotoxicity marker MTT was used to assess the level of 
cell viability. The MTT assay for mitochondrial integrity is based on the reduction of the 
soluble yellow MTT tétrazolium salt to a purple insoluble formazan product by cellular 
dehydrogenases (Supino, 1995).
20pl of MTT stock (5mg/ml) in PBS kept at 4°C was added to each well of 96-well plates 
2 hours before sampling, during which time, the plates were incubated at 37°C as normal. 
Then, the medium was removed and 200pl of isopropanol was added to each well. The 
plates were placed on an orbital shaker at room temperature for 20-30 minutes, until a 
homogenous colour was obtained in each well. The isopropanol was then transferred to a 
clean 96-well plate (200pl/well) and the absorbance of the product was measured at 
540nm using a MCN212 microplate reader. The absorbance is proportional to the 
number of viable cells.
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2.8.2 Lactate dehydrogenase (LDH) assay
HuH7 cells were seeded at 60,000cells/well into poly-L-lysine coated 24-well culture 
plates and allowed to grow for 24 hours. Cells were treated with paracetamol (lOmM) or 
thapsigargin (IpM) for 24, 30, 48 and 54 hours or duroquinone (0.5mM) for 8, 24 and 30 
hours. In some studies, the HuH7 cells were pre-treated with protease inhibitors, enzyme 
kinase inhibitors or mitochondrial FTP inhibitors for 30 minutes to 1 hour incubation 
before normal treatment with the compounds. The assessment of cell viability was 
performed using the LDH cytotoxicity detection kit according to the manufacturer’s 
instructions. This colorimetric assay is widely used for the quantification of cell death 
and cell lysis based on the measurement of LDH activity released from the cytosol of 
damaged cells into the supernatant. The LDH activity is determined in an enzymatic test: 
first NAD^ is reduced to NADH/H^ by the LDH-catalyzed conversion of lactate to 
pyruvate. Then a catalyst (diaphorase) transfers H/H^ from NADH/H^ to the tétrazolium 
salt INT which is reduced to formazan (red).
At every specific time-point, an aliquot of 120pl of assay medium was carefully removed 
from each well and placed into sterile 1.5ml Eppendorf tubes. Samples were stored at 
4°C until all time-points were collected. Then, each well was incubated with 0.1% (v/v) 
Triton X-100 at 37°C for 5 minutes (to obtain the total levels of LDH) and aliquots of 
120pl from each well were transferred into 1.5ml Eppendorf tubes. Samples were 
centrifuged at 2300 x g for 3 minutes and lOOpl of each aliquot was transferred into 
corresponding wells of an optical clear 96-well plate. To determine the LDH activity, 
lOOpl of reaction mixture was added to each well and incubated for up to 30 minutes at 
20°C (protected from light). The absorbance of the samples was measured at 492nm 
using a MCN212 microplate reader.
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2.9 Morphological Analysis by Fluorescence Microscopy
2.9.1 Nuclear staining
Both primary hepatocyte cultures and the HuH7 cells were stained with Hoechst 33258 
dye for the analysis of changes in nuclear morphology as a direct marker for apoptosis 
(Jones et a l, 1998). Cells seeded at 250,OOOcells/well were grown in 6-well plates on 
sterile square coverslips (BDH) for treatment. Plates with coverslips were previously 
coated with poly-L-lysine to allow cell attachment.
After treatment, the media was removed and the cells were fixed in 4% (v/v) 
formaldehyde prepared in PBS (2ml/well) at 4°C overnight. The next day, the 
formaldehyde was aspirated and 1 ml/well PBS was added to wash the cells. Then, 
2ml/well PBS containing 2pg/ml Hoechst dye was added to each well and plates 
incubated for 5 minutes at room temperature (protected from light). The solution was 
removed and cells washed again in PBS. The glass cover slips were carefully removed 
and fixed on to microscope slides (BDH) and visualization of the staining was performed 
using a Zeiss Axiovert 135 fluorescence microscope (excitation wavelength >360nm; 
emission wavelength >420nm). The nuclei were scored as either normal in which the 
chromatin was uncondensed or apoptotic in which the chromatin was highly condensed 
(yielding a high blue fluorescence) or fragmented into discrete apoptotic bodies. A total 
o f200 cells per sample were counted.
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2.9.2 Detection of cytochrome c by Immunostaining
HuH7 cells seeded at 60,000cells/well were grown in 24-well plates on sterile poly-L- 
lysine coated round glass coverslips for treatment. At the end of every treatment, the 
media was removed and the cultures washed with PBS (pre-warmed at 37°C) and then 
fixed with 4% paraformaldehyde buffer (1 ml/well) for 30 minutes at room temperature. 
The cells were then washed 6 x with blocking buffer (1 ml/well) and then lOOpl of 
blocking buffer supplemented with cytochrome c antibody (6H2.B4) (1:100) was added 
to each well and incubated overnight at 4°C.
The next day, cells were washed 6 x in blocking buffer and then lOOpl of blocking buffer 
supplemented with FITC-linked secondary antibody (1:100) was added to each well and 
incubated for 1 hour at room temperature (protected fi’om light). Cultures were washed 
again 8 x in blocking buffer and then incubated in 1ml blocking buffer supplemented 
with 2pg/ml Hoechst dye for 5 minutes at room temperature. Cells were washed 1 x in 
blocking buffer and then the coverslips were carefully removed and fixed on to 
microscope slides containing 2pl per cover slip of VECTASHIELD mounting medium. 
Visualization of the staining was performed using a Zeiss Axiovert 135 fluorescence 
microscope (excitation wavelength >520; emission wavelength, >480).
2.9.3 Detection of mitochondrial membrane potential with TMRE
HuH7 cells seeded at 250,000cells/well were grown in 6-well plates on sterile poly-L- 
lysine coated round glass coverslips for treatment. After treatment, the cultures were 
washed with pre-warmed PBS and then incubated at 37®C for 15 minutes with 2ml/well 
assay medium supplemented with 0.5pM TMRE and 2pg/ml Hoechst (protected from 
light). Cultures were then transferred to a Zeiss POC chamber (containing 0.5ml PBS)
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mounted on a Zeiss Axiovert 135 fluorescence microscope for visualization of the 
staining (excitation wavelength >560nm; emission wavelenght >520nm).
2.10 Preparation of Cell Extracts
2.10.1 Total cell lysates
HuH7 cells grown in 75 cm  ^ culture flaks were treated with compounds at near 
confluence. Once treatment was concluded, cells were disrupted from the culture flasks 
using disposable cell scrapers (Costar) and the cultures were transferred to Falcon tubes 
(kept in ice). Samples were centrifuged at 100 x g for 3 minutes. The supernatant was 
discarded and the pellet washed in 1ml ice-cold PBS and transferred into sterile 1.5ml 
Eppendorf tubes. Then samples were microcentrifuged at 2300 x g for 5 minutes. The 
pellets were re-suspended in lOOpl cell lysis buffer and incubated in ice for 15 minutes. 
Samples were vortex-mixed 30 seconds each and microcentrifuged at 15700 x g for 15 
minutes at 4°C. Samples were then stored at -80°C for Western blotting analysis.
2.10.2 Separation of cytosolic proteins from membrane (mltochondrla)- 
associated proteins
Cultures were detached with trypsin/EDTA solution, collected in Falcon tubes and
centrifiiged at 80 x g for 5 minutes at room temperature. The supernatant was discarded
and the pellet re-suspended in 1ml intracellular medium, buffer A. The pellets were
transferred to 1.5ml Eppendorf tubes and microcentrifiiged at 2300 x g for 5 minutes.
The cells were washed again in buffer A, re-suspended in 50pl intracellular medium,
buffer B and incubated on ice for 10 minutes during which time the tubes were inverted a
few times. Then, a 5pi aliquot from each sample was mixed with 5 pi trypan blue and
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placed in the haemocytometer to confirm that cell permeabilization was >95%. Samples 
were centrifuged at 2300 x g for 5 minutes. The supernatants (cytosolic proteins) were 
carefully removed and placed into 1.5ml Eppendorf tubes and kept in ice. The pellets 
(mitochondrial proteins) were re-suspended in lOOpl cell lysis buffer and incubated in ice 
for 15 minutes. Then, samples were vortex-mixed for 30 seconds each and centrifiiged at 
15700 X g for 15 minutes at 4°C. Samples were stored at -80°C for Western blotting 
analysis.
2.11 Protein Quantification
Protein concentration in the cell samples was assessed using the BioRad protein assay 
(BioRad Laboratories). The test is a dye-binding assay based on the differential colour 
change of the dye in response to different protein concentrations.
Samples were diluted 1:10 in Milli-Q water (lOOpl total volume) and mixed. The 
concentrated dye reagent was also diluted 1:5 in Milli-Q water and 5ml of diluted dye 
was added per sample and mixed thoroughly. After 10 minutes, the optical density was 
measured at 595nm using a Kpntron 932 spectrophotometer. A blank sample (1:10 lysis 
buffer) was run to normalise readings. Several dilutions of protein standards, bovine 5- 
globulin (0.2-1.4mg/ml), were also run in parallel. Then, the OD5 9 5  values were plotted 
versus the concentrations of the standards and the unknown protein concentrations were 
read from the standard curve.
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2.12 Western Blotting
2.12.1 Sample preparation
Protein samples were mixed in 2 x loading buffer (20pl total volume), boiled for 5 
minutes, centrifuged at 15700 x g for 1 minute at 4°C and samples loaded onto 
polyacrylamide gels. A total protein concentration of 50-80pg was loaded per lane.
2.12.2 Polyacrylamide gel electrophoresis (PAGE)
SDS-PAGE gels were prepared using the mini-PROTEAN electrophoresis gel system 
(BioRad). Samples were resolved by SDS-PAGE on 15% or 7.5% gels which offered 
optimum range of protein separation. A 4% stacking gel was always used. The gels were 
prepared using the recipe described in section 2.2.3. Samples were run in parallel to 5pi 
Kaleidoscope pre-stained protein standards. Electrophoresis was carried out in running 
buffer at room temperature for 2 hours at lOOV until the loading dye was within 2mm of 
the bottom of the gel.
2.12.3 Western transfer of proteins
The proteins from the polyacrylamide gel were electrotransferred into a Hybond-C
nitrocellulose membrane using a mini-trans-blot module from BioRad (Towbin, 1979);
(Egger and Bienz, 1994). Whatmann 3mm paper, nitrocellulose membrane and sponges
were soaked in transfer buffer for 5 minutes. Transfer of proteins was prepared by
layering a piece of filter paper, followed by the gel, the nitrocellulose membrane and then
another filter paper. This was then sandwiched with the sponges and then placed in the
transfer module and the tank was filled with chilled transfer buffer. A block of ice was
also inserted in the tank to keep the buffer cool during the process. The transfer was
performed at room temperature at lOOV for 2 hours.
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Following transfer, the efficiency of the transfer process was checked by staining the gel 
in Coomassie blue stain for 1 hour on a shaker and then destained overnight. Also, the 
protein profile was checked by staining the nitrocellulose membrane with Ponceau S stain 
for 3 minutes followed by a quick destain in Milli-Q water.
2.12.4 Immunoblotting
The membrane was incubated in 15ml milk blocking solution for 1 hour. Then, the 
membrane was probed with primary antibody. The primary antibodies used, caspase-3 
(1:1000), caspase-7 (1:2000), Bax (1:500), cytochrome c oxidase (1:1000), cytochrome c 
(7H8.2C12) (1:500), fodrin (1:2000), Smac/DIABLO (1:1000), Hsc70 (1:1000), 
phospho-SAPK/JNK (1:1000) and SAPKlb/JNK3 (1:1000) were diluted accordingly in 
10ml milk blocking solution. Incubation with primary antibodies was carried out 
overnight at 4°C in an orbital roller. The next day, the membrane was washed 2 x for 10 
minutes each in Ix TBS-T buffer on a shaker at room temperature. After washing, the 
membrane was incubated with peroxidase-conjugated secondary antibody (1:1000) 
prepared in milk blocking (10ml) solution for 1 hour at room temperature in a roller. 
Finally, the blot was washed again 2 x for 10 minutes each in Ix TBS-T buffer on a 
shaker. The blot was visualized using the enhanced chemiluminescent detection system 
(ECL) from Pierce (Crisp and Dunn, 1994). The membrane was incubated in substrate 
reagent for 5 minutes, then the reagent was drained off and the blot was wrapped in Saran 
wrap and exposed to X-ray film (Fuji) for a variable period of time ranging from 5 to 30 
minutes.
After visualization, the membrane was carefully removed from the Saran wrap and 
incubated in 15ml PBS supplemented with ImM sodium azide for 2 hours. Then, the
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membrane was rinsed in 1 x TBS-T buffer for 5 minutes and the membrane was re­
probed with primary antibody again. This method for the reutilization of immunoblots 
was followed from (Kaufmann, 2001).
2.13 Flow Cytometry Studies
For these studies, HuH7 cells were grown in 25cm^ tissue culture flaks and treated with 
the compounds at near confluence.
2.13.1 Analysis of DNA content
This flow cytometry study was performed by a modified procedure from (Nicoletti et a l, 
1991). The media was removed from the flasks and placed into 10ml centrifuge tubes 
and cultures detached with 1ml trypsin/EDTA solution. Samples were centrifuged at 100 
X g for 5 minutes. The supernatant was then discarded and the pellets were fixed in an 
ice-cold solution of 70% (v/v) ethanol: 30% PBS overnight at 4°C, by gradual addition 
whilst vortex mixing. This technique rendered all samples suitable for analysis as heavily 
clumped specimens were readily broken up by the processing. The samples were 
centrifuged at 100 x g for 3 minutes and pellets incubated in 1ml PBS supplemented with 
lOpg/ml propidium iodide and 1 mg/ml RNase for 30 minutes at 37°C (protected from 
light). Analysis was carried out using a Beckman Coulter Epics XL flow cytometer 
(argon laser, excitation wavelength 488nm). A minimum o f20,000 events were acquired 
in list mode while gating the forward and side scatters to exclude propidium iodide- 
positive cell debris and analysed in FL-3 (PI detector, 620nm) for the appearance of the 
sub-Gi peak.
-83-
2.13.2 Detection of caspase-3 activation
This study was carried out using the PE-conjugated monoclonal active caspase-3 
antibody apoptosis kit, according to the manufacturer’s instructions. The media was 
removed from each flask and placed into 10ml centrifuge tubes and the cultures were 
detached with 1ml trypsin/EDTA solution. Then, samples were centrifiiged at 100 x g for 
3 minutes and cell pellets were washed twice with 1ml cold PBS. The pellets were re­
suspended and incubated in 0.5ml Cytofix/Cytoperm solution for 20 minutes on ice. 
Following incubation, cultures were centrifuged at 100 x g for 3 minutes, the supernatant 
discarded and the cell pellets washed twice in 0.5ml Perm/Wash buffer at room 
temperature. After centrifugation again at 100 x g for 3 minutes, the cell pellets were re­
suspended in lOOpl Perm/Wash buffer supplemented with 20pl PE-conjugated caspase-3 
antibody and incubated for 30 minutes at room temperature (protected from light). 
Samples were centrifuged at 100 x g for 3 minutes and washed in 1ml Perm/Wash buffer 
once and then cell pellets were re-suspended in 0.5ml Perm/Wash buffer for analysis. 
Samples were analysed using a Beckman Coulter Epics XL flow cytometer (argon laser, 
excitation wavelength 488nm). A minimum of 10,000 events were recorded and 
analysed in FL-2 (PE detector, 575nm) for the appearance of the corresponding neo­
epitopes.
2.13.3 Detection of cytokeratin 18 cleavage
At the end of treatments, the media was removed from each flask and placed into 10ml
centrifuge tubes and the cultures were detached with 1ml trypsin/EDTA solution.
Samples were centrifuged at 100 x g for 3 minutes and cell pellets were washed twice
with 1ml cold PBS. The cell pellets were then re-suspended and fixed in 1ml ice-cold
pure methanol at -20°C for 30 minutes. After incubation, samples were centrifuged at
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100 X g for 3 minutes and cells were washed twice in 0.5ml washing buffer (PBS 
containing 0.1% Tween-20). Next, the samples were incubated in lOOpl incubation 
buffer (PBS containing 1% (w/v) BSA and 0.1% Tween-20) supplemented with 2pl M30 
CytoDEATH antibody (mouse monoclonal antibody against the caspase-3-cleaved 
fragment of cytokeratin 18) (1:50) at room temperature for 60 minutes. Following 
incubation, samples were centrifuged at 100 x g from 3 minutes and pellets were washed 
twice in 1ml washing buffer. Cell pellets were then incubated in 100 pi incubation buffer 
containing Ipl FITC-linked secondary antibody (1:100) at room temperature for 30 
minutes (protected from light). Samples were centrifuged at 2,000 for 3 minutes and cell 
pellets were washed twice in 1ml washing buffer. Finally the pellets were re-suspended 
in 0.5ml washing buffer and analysed using a Beckman Coulter Epics XL flow cytometer 
(argon laser, excitation wavelength 488nm). A minimum of 10,000 events were recorded 
and analysed in FL-1 (FITC detector, 525nm) for the appearance of the corresponding 
neo-epitopes.
2.14 Statistical Analyses
The Bonferroni or LSD (all means) one-way ANOVA post-hoc test were carried out 
using the SPSS software package.
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CHAPTER 3
PARACETAMOL-INDUCED INJURY CAUSES
APOPTOSIS IN LIVER CELLS
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3.1 Introduction
Liver damage can be induced by infectious, pharmacological, environmental, or 
inflammatory/immune responses (Robertson and Orrenius, 2000). Possibly one of the 
most common insults to the liver is by accidental or purposeful paracetamol poisoning, 
which shows a direct toxicity to the hepatocytes and is the leading cause of hospital 
admission in USA (Zhang et a l, 2002; Dargan and Jones, 2003; McGregor et a l, 2003).
The hepatotoxin, paracetamol, is a widely used analgesic drug and safe when 
administered at normal therapeutic doses (Bae et a l, 2001; Pierce et a l, 2002). 
However, an overdose of paracetamol can induce severe hepatic injury which can be 
fatal. For example, ingestion of amounts of paracetamol only two or three times the 
maximum daily recommended dose can cause critical hepatotoxicity and higher doses 
have shown to induce severe centrilobular necrosis that is potentially fatal in both 
experimental animals and in man (Davidson and Eastham, 1966; Mitchell et a l, 1973; 
Dixon et a l, 1975; Whitcomb, 1994; Makin and Williams, 1997; Gujral et a l, 2002; 
McGregor et a l, 2003). As a result, an overdose from paracetamol constitutes a public 
health problem despite its relative safety when administered properly.
Paracetamol is metabolised by sulfation and glucuronidation but as the dose is increased, 
these pathways become saturated and a greater proportion of the drug is available for 
oxidation by the mixed-function oxidases, including microsomal cytochromes P-450 2E1, 
1A2, and 3A in humans and experimental animals. It is a product of this pathway, N- 
acetyl-p-benzoquinone imine (NAPQI), which is known to be responsible for the hepatic 
damage (Bessems and Vermeulen, 2001; Jaeschke et a l, 2003). In the liver, NAPQI is 
mainly detoxified by reduction to the parent compound (paracetamol) or by conjugation
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at the Twe/a-position with glutathione (GSH), both reactions which consume GSH 
(Mitchell et a l, 1985). Thus as GSH becomes depleted, a greater proportion of NAPQI 
is free to cause cell damage by interaction with cellular macromolecules resulting in 
oxidation and arylation of cellular proteins primarily via cysteinyl residues and initiates 
cellular death. There also seems to be a significant role for activation of oxidative 
pathways that lead to liver damage and subsequently induce significant inflammation 
(Hardwick et a l, 1992). Also, GSH has shown to be essential for the maintenance of 
intracellular calcium homeostasis. Furthermore, elevation of intracellular calcium levels 
appears to represent a common trigger for apoptosis in cells of many diverse tissue 
origins (Moore e ta l, 1985; Harman et a l, 1991; Hardwick et a l, 1992).
NAPQI as a highly reactive metabolite can also covalently bind and interact with critical 
thiol groups from intracellular target enzymes that help maintain the large calcium 
concentration gradient across the cell membrane thus causing an uncontrolled increase in 
intracellular calcium concentration that may lead to deleterious cellular effects such as 
activation of calcium-dependent degradative enzymes (proteases, endonucleases and 
phospholipases) and changes to the cytoskeleton (Hardwick et a l, 1992; Ishida et a l, 
2002). Therefore the toxicity of NAPQI metabolite depends on several factors, including 
the ability to clear the toxic metabolite by GSH trapping and the level of specific 
cytochrome P450 enzymes that are expressed by the hepatocyte for more rapid 
conversion of paracetamol to NAPQI (Moore et a l, 1985; Harman et a l, 1991; Bessems 
and Vermeulen, 2001).
Paracetamol-induced toxicity leads to a variety of severe cellular dysfunctions, including 
mitochondrial damage, disruption of calcium homeostasis, ATP depletion, lipid
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peroxidation and mitochondrial oxidant production (Bae et a l, 2001; Gujral et a l, 2002; 
Jaeschke et a l, 2003) which inevitably leads to parenchymal cell death.
The nature of the hepatotoxicity initiated by paracetamol has been the subject of much 
debate over the years and the role and mechanism of paracetamol-induced liver cell death 
is still controversial. In recent years, research has demonstrated that paracetamol causes 
liver damage through a combination of apoptosis and necrosis (Lawson et a l, 1999; 
Adams and Cory, 2001; Gujral et a l, 2002; Pierce et a l, 2002; El-Hassan et a l, 2003). 
In vivo studies using rats and mice have presented evidence for the contribution of 
apoptotic cell death in paracetamol-induced hepatic damage (Ray et a l, 1996; Gujral et 
a l, 2002; El-Hassan et a l, 2003). In addition, recent in vivo and in vitro reports have 
demonstrated the involvement of the mitochondrial pathway of apoptosis and of 
important pro-apoptotic proteins by paracetamol intoxication (Adams and Cory, 2001; 
Gujral et a l, 2002; El-Hassan et a l, 2003).
The main concern about paracetamol-induced liver apoptosis is that there is little or no 
activity detected from the execution caspases-3 and -7 which are essential for the 
development of the apoptotic process (Lawson et a l, 1999; Pierce et a l, 2002; El-Hassan 
et a l, 2003). Therefore, from these observations it is thought that the initial damage by 
paracetamol-induced liver toxicity develops through apoptosis even though it fails to go 
to completion and instead switches to secondary necrosis (Adams and Cory, 2001; Pierce 
et a l, 2002; El-Hassan et a l, 2003). However, apoptosis must play a critical role in 
paracetamol-induced in vivo hepatic injury since inhibiting apoptosis by caspase 
inhibition prevents the development of acute liver failure (El-Hassan et a l, 2003).
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Despite numerous investigations, the mechanism of paracetamol-induced liver cell death 
is still very controversial.
Until now, the in vitro methodologies that adequately model the molecular and cellular 
characteristics of paracetamol-induced hepatocyte death by apoptosis have been elusive. 
Furthermore, primary cultures of rat hepatocytes respond to cytotoxic doses of 
paracetamol primarily by necrosis (Nagai et a l, 2002), whereas a transgenic hepatocyte 
cell line (TAMH cells) display only incomplete biochemical evidence for apoptosis 
(Pierce et a l, 2002). Consequently, there is an important need for the development of an 
appropriate in vitro model for the study of paracetamol-mediated liver cell apoptosis. 
Using the human hepatoma cell line, HuH7, this chapter will investigate the role and 
mechanism of apoptosis by paracetamol-induced toxicity in these liver cells.
3.2 Paracetamol-induced toxicity in HuH7 cells
Preliminary dose ranging studies were performed to assess the cytotoxicity of 
paracetamol in HuH7 cells. HuH7 cells were treated with various concentrations of 
paracetamol including, 1, 5 and lOmM and the cell viability was assessed at 24 and 48 
hours and compared with the control cultures. Cell viability was measured by the MTT 
reduction assay.
The treatment of HuH7 cells with paracetamol showed a clear dose-dependent decrease 
in cell viability with evident cytotoxicity at 48 hours at the lOmM dose (32% of control 
MTT reduction). However, little toxicity was observed at the 24 hour time point of 
paracetamol treatment (lOmM) (72% of control MTT reduction) (Fig. 3.1).
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The cultures were also viewed by phase contrast microscopy and photographs 
representing morphological changes seen at 48 hours are shown in Figure 3.2. At 48 
hours, the morphology of HuH7 control cells appeared healthy and cells were confluent 
(Fig. 3.2a) whereas HuH7 cells exposed to lOmM paracetamol appeared unhealthy, most 
cells were floating or detaching from the culture flask and showed condensed 
morphology (typical feature of dead cells) (Fig. 3.2b).
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Figure 3.1. Dose ranging studies of paracetamol-induced toxicity in HuH7 cells.
HuH7 cells were incubated in the presence o f 1, 5 and lOmMparacetamol. Cell viability 
was measured at 24 (blue) and 48 hours (red) by the MTT reduction assay as described 
under Materials and Methods. MTT results are expressed as % cell viability o f control. 
Each point is the mean o f two independent experiments.
Figure 3.2. Morphological changes of HuH7 cells at 48 hours post-treatment.
HuH7 cells were incubated in the absence (DMSO only) (a) or presence o f paracetamol 
(lOmM) (b) for 48 hours. The cell morphology was analysed by light microscopy as 
described under Materials and Methods, (a) control cells appeared healthy and 
confluent whereas (b) treated cells were unhealthy and most cells were detached and 
showed condensed morphology. Mag. X200.
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3.3 induction of Apoptosis by Paracetamoi in HuH7 Ceiis
Cytotoxicity and the loss of cell viability can be caused by apoptosis or necrosis (Kass 
and Orrenius, 1999; Robertson and Orrenius, 2000). It was therefore vital to establish 
whether paracetamol-induced cytotoxicity (lOmM) at 24 and 48 hours, caused death by 
apoptosis or necrosis in HuH7 cells. To perform this investigation, the nuclear 
morphology of HuH7 cells was analysed by staining with the Hoechst 33258 nuclear dye 
as a direct marker for apoptosis and samples were viewed by fluorescence microscopy 
(Fig. 3.3).
The nuclear staining of control cultures (DMSO only) showed homogenous blue stained 
nuclei of a healthy confluent monolayer (Fig. 3.3a). However in both 24 and 48 hours 
time points of paracetamol treatment, the cells showed apoptotic nuclei (as shown by 
arrows) which stained bright and small compared to normal cells due to chromatin 
condensation and nuclear shrinkage during apoptosis. Furthermore, also apparent was 
the fragmentation of the nuclei to form apoptotic bodies which is a very typical apoptotic 
feature (Fig. 3.3b and c). There was a visible increase in the amount of apoptotic cells at 
the 48 hour treatment compared with the 24 hour time point (Fig. 3.3b and c).
The nuclear staining investigation verified that paracetamol-mediated toxicity causes cell 
death by apoptosis in HuH7 cells. To quantify the amount of apoptotic cells in 
paracetamol treated cultures, the HuH7 cells were fixed and stained with the nuclear dye, 
propidium iodide, and samples were analysed for DNA content by flow cytometry. As 
soon as the cells are fixed in ethanol and subsequently rehydrated, some of the lower 
molecular weight DNA, cleaved by endonuclease attack during apoptosis, leaches out, 
lowering the DNA content of apoptotic cells. Analysis of the DNA histograms showed
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that the apoptotic cells can be observed in a sub-Gl position (Ap) adjacent to the G1 peak 
of the cell cycle. The histograms showed that in paracetamol treatment for 48hr, there 
was a clear increase in the number of apoptotic cells as compared to controls (Fig. 3.4a 
and b). Examination of the time course of the induction of apoptosis showed a time- 
dependent increase in the amount of apoptosis in paracetamol-treated cultures, reaching 
53% apoptosis by 48 hours (Fig. 3.4c). Therefore, this study confirmed that paracetamol- 
induced toxicity in HuH7 cells causes the activation of the apoptotic pathway to induce 
cell death.
3.4 The Role of Caspases In Paracetamol-induced Apoptosis
3.4.1 Effect of caspase inhibitors
Proteases and in particular caspases have shown to be the essential executioners of 
apoptotic cell death (Cohen, 1997; Salvesen and Dixit, 1997; Thomberry and Lazebnik, 
1998; Wang, 2000; Shiozaki et a l, 2003). Therefore, the role of caspases in 
paracetamol-induced apoptosis was investigated. In the first approach, the involvement 
of caspases was examined using specific peptide inhibitors that are directed against the 
substrate cleavage site. HuH7 cells were pre-treated with two different general caspase 
inhibitors, Z-VAD-fmk and Ac-DEVD-cho (for 30 minutes) prior to addition of 
paracetamol (lOmM) for 24, 30, 48 and 54 hours. The level of cytotoxicity was 
measured at the specific time points by the LDH toxicity assay. The most striking 
protection from cytotoxicity was with Z-VAD-fmk, which produced almost complete 
inhibition of paracetamol-induced cytotoxicity and apoptosis at lOOpM (Fig. 3.5). 
Whereas, the caspase-3/7 specific inhibitor, Ac-DEVD-cho, decreased paracetamol-
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induced cell death although the protection was not statistically significant (Fig. 3.6). 
None of the caspase inhibitors used were toxic to the HuH7 cells as assessed by the LDH 
cytotoxicity assay (Fig. 3.5 and 3.6).
3.4.2 Effect of non-caspase protease inhibitors
Non-caspase proteases have also been implicated in apoptosis in a wide variety of cell 
types (Bruno et a l, 1992; Kaufmann et a l, 1993; Chow et a l, 1995; Feamhead et a l, 
1995; Squire and Cohen, 1997)including in primary hepatocytes (Cain et a l, 1995; Kwo 
et a l, 1995; Gressner et a l, 1997; Roberts et a l, 1997; Jones et a l, 1998) and hepatoma 
cell lines (Adjei et a l, 1996; Pierce et a l, 2002). Here, the possibility that non-caspase 
proteases may also contribute to HuH7 cell apoptosis following paracetamol treatment 
was investigated. The cells were pre-treated with the calpain inhibitor, ALLN (IpM); 
proteasome inhibitor, MG-132 (0.5pM); serine protease inhibitor, TPCK (lOpM) and 
cathepsin inhibitor, Z-FA-fink (50pM) for 30 minutes prior to the addition of 
paracetamol (lOmM). The investigation into Z-FA-fink was important to rule out any 
non-specific effect of the reactive fmk moiety of the caspase inhibitor, Z-VAD-fmk 
toward cathepsins or the bioactivation pathway for paracetamol. Cytotoxicity was 
assessed by the LDH toxicity assay. Analysis of the data showed that calpain and 
cathepsin inhibition by ALLN and Z-FA-fink respectively, caused no protection fi*om 
paracetamol-induced cell death at both 24 and 48 hours Fig. 3.7 and 3.10). Similarly, the 
inhibition of serine proteases by TPCK afforded no prevention of cell death by 
paracetamol at 48 hours of treatment (Fig. 3.9). Furthermore, the proteosome inhibitor 
proved to be very toxic to the HuH7 cells (Fig. 3.8). Taken together, these results 
demonstrated that caspases and not other proteases contribute to HuH7 cell apoptosis 
upon paracetamol treatment.
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Figure 3.3. Analysis of nuclear morphology changes of HuH7 cells induced by 
paracetamol.
HuH7 cells were incubated in the absence (DMSO only) (a) or presence o f paracetamol 
(lOmM) for 24 (b) and 48 hours (c). Cells were fixed and stained with the Hoechst 33258 
dye before visualization by fluorescence microscopy as described under Materials and 
Methods. Arrows show apoptotic cells that appear small and bright compared to control 
cells (a) due to nuclear shrinkage and chromatin condensation during apoptosis. Mag. 
X400.
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Figure 3.4. Induction of apoptosis by paracetamol-mediated cytotoxicity.
At specific time points ofparacetamol (lOmM) treatment, cell samples were fixed, stained 
with PI and analysed for DNA content by flow cytometry as described under Materials 
and Methods. Panels (a & b) represent the DNA histograms. Cells were incubated in the 
absence (DMSO only) (a) or presence o f paracetamol (lOmM) (b) fo r 48 hours. Red 
fluorescence (PI/DNA) was recorded after gating to exclude any clumped cells. The 
positions o f the apoptotic cells (Ap) and the different cell cycle phases (Gl, S, G2/M) are 
marked, (c) Summary o f flow cytometry data. HuH7 cells were incubated in the absence 
(black) or presence o f paracetamol (lOmM) (red) for specific times points as shown in 
the graph. Each time point is the mean ±SEM o f at least three independent experiments. 
Statistical analyses were performed using Bonferroni (all means) one-way ANOVA post 
hoc test. * * "^Significantly different from control, P< 0.001.
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Figure 3.5. Effect of Z-VAD-fmk on paracetamol-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) (light blue), Z-VAD-fmk 
(lOOpM) (green) or presence o f paracetamol (lOmM) (blue) after pre-treatment with Z- 
VAD-fmk (100pM) (red). Cytotoxicity was assessed by the LDH toxicity assay as 
described under Materials and Methods. Each time point is the mean ±SEM o f three 
independent experiments. Statistical analyses were performed using Bonferroni (all 
means) one-way ANOVA post hoc test. Significantly different from paracetamol 
treatment (blue), P< 0.01. ***Significantly different from paracetamol treatment, P< 
0. 001.
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Figure 3.6. Effect of Ac-DEVD-cho on paracetamol-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO) (light blue), Ac-DEVD-cho (lOOpM) 
(orange) or presence o f paracetamol (lOmM) (blue) cfter pre-treatment with Ac-DEVD- 
cho (lOOpM) (grey). Cytotoxicity was assessed by the LDH toxicity assay as described 
under Materials and Methods. Each time point is the mean ±SEM o f three independent 
experiments.
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Figure 3.7. Effect of calpain inhibition on paracetamol-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) (light blue), calpain inhibitor 
(ALLN) (IpM) (green) or presence o f paracetamol (lOmM) (blue) after pre-treatment 
with calpain inhibitor (ALLN) (IpM) (pink). Cytotoxicity was assessed by the LDH 
toxicity assay as described under Materials and Methods. Each time point is the mean 
±SEM o f at least three independent experiments.
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Figure 3.8. Effect of proteasome inhibition on paracetamol-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) (light blue), proteasome 
inhibitor (IpM) (cream) or presence o f paracetamol (lOmM) (blue) after pre-treatment 
with proteasome inhibitor (IpM) (purple). Cytotoxicity was assessed by the LDH toxicity 
assay as described under Materials and Methods. Elach time point is the mean ±SEM o f 
at least three independent experiments.
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Figure 3.9. Effect of TPCK on paracetamol-induced apoptosis in HuH7 cells.
HuH7 cells were incubated in the absence (DMSO only) (light blue), TPCK (lOpM) 
(green) or presence o f paracetamol (lOmM) (blue) after pre-treatment with TPCK 
(lOpM) (red). Cytotoxicity was assessed by the LDH toxicity assay as described under 
Materials and Methods. Each time point is the mean ±SEM o f at least three independent 
experiments.
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Figure 3.10. Effect of Z-FA-fmk on paracetamol-induced apoptosis in HuH7 cells.
HuH7 cells were incubated in the absence (DMSO) (light blue), Z-FA-fmk (IpM) (green) 
or presence o f paracetamol (lOmM) (blue) after pre-treatment with Z-FA-fmk (IpM) 
(grey). Cytotoxicity was assessed by the LDH toxicity assay as described under 
Materials and Methods. Each time point is the mean ±SEM o f at least three independent 
experiments.
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3.4.3 Detection of caspase-3 and -7 activation
Most of the morphological changes observed during the apoptotic process are known to 
be caused by caspases (Cohen, 1997; Salvesen and Dixit, 1997). The previous results 
obtained with the general caspase inhibitor, Z-VAD-fink, have provided evidence for the 
involvement of members of this family in the apoptotic cell death process triggered by 
paracetamol. Unfortunately, the low degree of specificity of the inhibitors towards 
individual members of the caspase family and the high concentrations required to 
overcome their poor membrane permeability (Margolin et a l, 1997) restricts the ability to 
identify the individual members that participate in the death execution phase. In order to 
further identify the caspases involved in paracetamol-mediated apoptosis in HuH7 cells, 
the activation of the effector caspases, caspase-3 and -7, as important members of the 
execution phase was investigated. Their activation was examined by Western blotting.
During apoptosis pro-caspase-3 (p32) is cleaved to produce two small catalytically active 
fragments, p i7 and p20. Examination of the Western blot showed the detection of the 
pl7 active fragment of caspase-3 in paracetamol treated samples both at 24 and 48 hours 
(Fig. 3.11a). In addition, the p i7 fragment of caspase-3 was also observed for 
staurospoiine and puromycin cell treatments for 24 hours both of which are well known 
inducers of apoptosis. However, the p i7 band was not observed in the control sample 
(DMSO-treated only) (Fig. 3.11a). Unexpectedly, analysis of the pattern of caspase-3 
degradation reveals that the p29 fragment (caspase-3 without pro-domain) was 
constitutively present in these cells. Also a third immunoreactive (p20) was present in all 
the samples.
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Similarly, pro-caspase-7 during apoptosis is cleaved to produce a small catalytically 
active fragment, pl9 (the smaller fragment is not detected by the antibody). This active 
fragment was detected by Western blot analysis in HuH7 cells treated with various 
concentrations of paracetamol, including 0.5, 5, and lOmM, for 48 hours. Again, the 
active fragment of caspase-7 was not detected in the control cultures (Fig. 3.11b). In 
summary, the Western blot results demonstrated the activation of effector caspases-3 and 
-7 in paracetamol-induced apoptosis.
To further confirm that caspase-3 is active in paracetamol-induced apoptosis in HuH7 
cells as shown earlier by Western blotting, cell samples under treatment with paracetamol 
for 24, 30 and 48 hours were fixed and immunostained with a PE-conjugated active- 
caspase-3 antibody and analysed by flow cytometry. Initial analysis of the histograms of 
control cultures showed a standard peak of fluorescence (Fig 3.12a). However, the 
histogram corresponding to paracetamol treatment for 48 hours showed a shift of 
fluorescence of the main peak with the appearance of an adjacent peak with increased 
fluorescence that represented apoptotic cells with active caspase-3 (Fig. 3.12a). The pre­
treatment of cells with Z-VAD-fmk presented a histogram with a standard peak of 
fluorescence like control and therefore showing an evident inhibition of caspase-3 
activation (Fig. 3.12a). The time-course study of caspase-3 activation showed a time- 
dependent increase in the cleavage and activation of caspase-3 during paracetamol 
treatment. At the 48 hour time point of paracetamol treatment, there was a significant 
caspase-3 activation compared to control (Fig. 3.12b). Interestingly, again at the 48 hour 
time point of paracetamol treatment in which cells were pre-treated with Z-VAD-fmk, 
there was an evident inhibition of caspase-3 activation which was found significant
compared to the paracetamol treatment alone (Fig.3.12b). The flow cytometry
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investigation confirmed that caspase-3 is involved in the apoptotic pathway induced by 
paracetamol. Furthermore, the lack of immunoreactivity in control cells (Fig. 3.12b) 
demonstrates that the 20kDa band (Fig. 3.11a) detected by Western blot is unrelated to 
the p20 large subunit of caspase-3.
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Figure 3.11. Activation of caspase-3 and -7 in paracetamol-induced apoptosis.
HuH7 cells were incubated (a) in the absence (DMSO only) or presence o f paracetamol 
(lOmM) for 24 and 48 hours and (b) in the absence (DMSO only) or presence o f 
paracetamol (10, 5, O.SmM) for 48 hours. Cell samples were subjected to SDS-PAGE 
followed by immunoblotting with an antibody directed against caspase-3 (a) or caspase-7 
(b) as directed under Materials and Methods. Fifty pg o f protein were loaded in each 
lane. The blots (a) and (b) are representative o f at least three independent experiments. 
Abbreviations (a): stauro, staurosporine (IpM) and puro, puromycin (20pM) which are 
known inducers o f apoptosis.
1 0 3 -
Control cells Paracetamol 48hr Paracetamol and Z-VAD
9
44% ±1.62% ± 1.1c0)
£i
Caspase-3 cleavage
l ^ i ' T T'm n — "I ■r r n i i i i
Ap 
8% ± 3.1
5 0
0  Paracetamol (10mM)
Q  Paracetamol + Z-VAD (lOOpM) 
n  Control
3 0
20 ###
CO 1 0
g. 0 
g 5 020 3 0 4 0
Time (hr)
Figure 3.12. Cleavage of casapase-3 by paracetamol-induced apoptosis.
At specific time points o f paracetamol (lOmM) treatment, HuH7 cell samples were 
immunostained with a PE-conjugated active caspase-S antibody and samples were 
analysed by flow cytometry as described under Materials and Methods, (a) Represent 
histograms o f caspase-3 cleavage o f three different samples. The positions o f the 
apoptotic cells (Ap) are marked, (b) Summary o f flow cytometry data. HuH7 cells were 
incubated in the absence (DMSO only) (grey) or presence o f lOmM paracetamol (blue) 
after pre-treatment with lOOpM Z-VAD-fmk (red) fo r specific times points as shown in 
the graph. Each time point is the mean ±SEM o f at least three independent experiments. 
Statistical analyses were performed using Bonferroni (all means) one-way ANOVA post
hoc test. Significantly different from control, P< 0.001. 
from paracetamol treatment (blue), P< 0.001.
Significantly different
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3.4.4 Cleavage of caspase-3 cellular substrates
During the apoptotic process, the activation of caspase-3 is known to induce cleavage and 
processing of various important endogenous cellular substrates which lead to cell death 
by apoptosis (Martin et ah, 1995; Caulin et al., 1997; Wang et a l, 1998; Wolf and Green, 
1999). In this section, the cleavage of two important cytoskeletal proteins, a-fodrin and 
cytokeratin 18, by caspase-3 during paracetamol-induced apoptosis was investigated.
Fodrin cleavage during apoptosis was investigated by Western blotting using an anti- 
fodrin polyclonal antibody. Caspase-3 cleaves a-fodrin to produce a pl20 fragment of 
the cytoskeletal protein (Martin et a l, 1995) (Fig. 3.13). Analysis of the Western blot 
showed the detection of the p i20 band in the 48 hour paracetamol (lOmM) treated 
sample, however, no pl20 fragment was observed in the control sample. This band was 
also observed after treatment of HuH7 cells with staurosporine (IpM) or puromycin 
(20pM) for 24 hours (well known inducers of apoptosis) (Fig. 3.11). The analysis of the 
pattern of a-fodrin degradation reveals that the calpain cleaved fragment of a-fodrin 
(pi45) was constitutively present in these cells (Fig. 3.13).
Processing of the intermediate filament, cytokeratin 18, in paracetamol-treated HuH7 
cells was examined by flow cytometry. These studies were performed by 
immunostaining the cells with a monoclonal antibody against the caspase-3 cleaved 
fragment of cytokeratin 18. Analysis of the flow cytometry data showed a time- 
dependent increase in cytokeratin 18 cleavage in paracetamol-treated samples. In 
addition, at 48 hours of paracetamol treatment, the amount of cytokeratin 18 cleavage 
was significant compared to control cultures (Fig. 3.14). Interestingly, the pre-treatment 
of HuH7 cells with Z-VAD-fink showed at 48 hours of treatment a near complete
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inhibition of cytokeratin 18 cleavage as compared to samples treated with paracetamol 
alone, due to inhibition of caspase-3 activation (Fig. 3,14).
Both sets of data clearly demonstrated that caspase-3 plays an important role in the 
apoptotic cell death pathway of paracetamol-treated HuH7 cells in which cellular 
substrates are cleaved to dismantle the cell and cause death by apoptosis.
3.4.5 Activation of caspases-3 and -7 in paracetamol-treated animals
The role of the executioner caspases-3 and -7 was fiirther investigated in in vivo 
paracetamol-mediated parenchymal cell apoptosis given their importance in liver 
apoptosis (Jones et a l, 1998; Woo et a l, 1999; Zheng et a l, 2000). Liver homogenates 
from mice dosed intraperitoneally for 6 hours with paracetamol (500mg/kg) or mouse 
anti-CD95 antibody (30pg/ml) were prepared and the cytosolic fractions were analysed 
by Western blotting for caspases-3 and -7 activation.
Liver cytosolic fractions from anti-CD95 treated mice showed partial disappearance of a 
band corresponding to the size of pro-caspase-3 (Fig. 3.15a). This was also observed 
after paracetamol dosing, suggesting caspase-3 processing and activation. However, the 
small fragments of the enzyme, p20 and p i7, were not detected in either treatment case. 
The appearance of the catalytically active fragment (p i7) was clearly observed in HeLa 
cells treated with human anti-CD95 antibody as a positive control (Fig. 3.15a).
The anti-CD95 antibody treated fractions showed evident caspase-7 processing and 
activation as the analysis of the Western blot showed a clear loss of the p29 form of pro- 
caspase-7 with the appearance of the small catalytically active fragment (pi9), whereas 
paracetamol-exposed mice showed no caspase-7 activation (Fig 3.13b). In the
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paracetamol-treated samples, the pro-caspase-7 band and the p29 protein fragment were 
detected and there was no observed band for the active fragment (p i9) (the smaller 
fragment is not recognised by the antibody). Interestingly, as mentioned in section 3.4.3, 
HuH7 cell treatment with paracetamol caused clear caspase-3 and -7 activation, however, 
in vivo paracetamol-treated liver samples have shown no evidence for this enzyme 
activation to occur.
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Figure 3.13. Analysis of Fodrin cleavage following paracetamol-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) or presence o f paracetamol 
(lOmM) for 48 hours. Cells were lysed and subjected to SDS-PAGE followed by 
immunoblotting with anti-fodrin (all-spectrin) monoclonal antibody as described under 
Materials and Methods. The blot showed a-fodrin cleavage by caspase-3 with the 
appearance o f the I20kDa band and it is representative o f three independent 
experiments. Fifty pg o f protein was loaded in each lane. Abbreviations: stauro, 
staurosporine (IpM) and Puro, puromycin (20pM) treatments for 24 hours as positive 
controls.
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Figure 3.14. Cytokeratin 18 cleavage following paracetamol-induced apoptosis.
Cells were incubated in the absence (DMSO only) (orange) or presence o f paracetamol 
(lOmM) (blue) after pre-treatment with Z-VAD-fmk (lOOpM) (green) for the times 
indicated. Samples were fixed and immunostained with an antibody directed against the 
caspase-3 cleaved fragment o f cytokeratin 18 and then analysed by flow cytometry as 
described under Materials and Methods. Each time point is the mean ±SEM o f at least 
three independent experiments. Statistical analyses were performed using Bonferroni 
(all means) one-way ANOVA post hoc test. ^'^'^Significantly different from control, P< 
0.001; Significantly different from paracetamol treatment (blue), P<0.001.
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Figure 3.15. Processing of caspase-3 and -7 in paracetamol-treated mouse liver 
homogenates.
Mice were dosed intraperitoneally with paracetamol (500mg/kg) or mouse anti-CD95 
antibody (SOpg/ml), and after 6 hours the animals were euthanized and the livers 
removed for homogenisation and isolation o f cytosolic fractions as described in the 
Materials and Methods. The proteins were separated by SDS-PAGE and immunoblotted 
for caspases-3 (a) and -7 (b) as described in the Methods section. Each lane represents a 
separate animal. In the blot for caspase-3 a positive control fo r the detection o f p  17 
(HeLa cells exposed to human anti-CD95 antibody (150ng/ml) fo r 7 hours) was included. 
Fifty pg o f protein were loaded in each lane. The blots (a) and (b) are representative o f 
at least three independent experiments. This work was carried out jointly with Dr. Hasan 
El-Hassan (El-Hassan, 2004).
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3.5 Activation of the Mitochondriai Pathway in Apoptosis
3.5.1 Loss of mitochondrial cytochrome c during apoptosis
Apoptosis through the activation of the mitochondrial pathway is known to induce the 
release of cytochrome c from the intermembrane space of mitochondria to the cytosol 
where it activates the caspase cascade to cause cell death by apoptosis (Bemardi et a l, 
1999; Desagher and Martinou, 2000; Martinou and Green, 2001; Waterhouse et a l, 
2001). The translocation of cytochrome c from the mitochondria to the cytosol in 
paracetamol-induced apoptosis in HuH7 cells was examined by immunocytochemistry 
and Western blotting.
The HuH7 cells incubated with paracetamol for 24 hours were immunostained with a 
monoclonal cytochrome c antibody and counterstained with the Hoechst 33258 nuclear 
dye before the results were analysed by fluorescence microscopy. Healthy cells showed a 
distinctive punctuate green staining of cytochrome c in the mitochondria surrounding the 
nucleus of cells as shown by the group of cells pointed by the red arrow (Fig. 3.16a). In 
addition, the nuclear counterstain of these cells showed homogenous blue stained nuclei 
typical of healthy cells (red arrow). However, apoptotic cells appeared with a 
homogenous green staining due to the release of cytochrome c from the mitochondria 
spreading throughout the cytosol and nucleus and showed typical apoptotic blebbing. An 
example is shown in Figure 3 .16a.
Analysis of the Western blot showed that cytochrome c in the control cultures is found in 
the pellet fraction (which contains mitochondrial proteins). A weak band of cytochrome 
c was also observed in the supernatant fraction accounting for some cell death in the 
control cultures (Fig. 3.16b). Paracetamol-treated samples for 24 hours showed a
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cytochrome c band in the pellet fraction, however, there was also an evident band 
detected in the supernatant fraction (cytosolic proteins) (Fig. 3.16b). Thus, the data 
demonstrated that at the early time point of 24 hour paracetamol treatment, where 
cytotoxicity becomes detectable, cytochrome c was released from mitochondria to induce 
apoptotic cell death. The detection of the protein, Hsc70, was used as a loading control 
for the Western blot.
3.5.2 Release of Smac/DIABLO from the mitochondria to allow caspase 
activation
The mitochondrial protein Smac is released into the cytosol during apoptosis where it is 
known to bind to multiple inhibitors of apoptosis such as the lAP-mediated inhibition of 
caspases. These caspase inhibitors are effectively removed by Smac to allow caspase 
activation (Springs et ah, 2002; Shiozaki et a l, 2003). Smac translocation into the 
cytosol like with cytochrome c was analysed in paracetamol-treated (lOmM) HuH7 cells 
for 24 hours by Western blotting.
Analysis of the blot showed as expected for the control samples a strong band for Smac 
in the pellet fraction (mitochondrial proteins) and no band was observed in the 
supernatant fraction (cytosolic proteins) (Fig. 3.17). Paracetamol-treated samples showed 
a strong band in the pellet fraction corresponding to Smac but also a band (Smac) was 
detected in the supernatant fraction, thus Smac translocates into the cytosol at the early 
time point of 24 hour paracetamol treatment (Fig.3.17).
Anti-Hsc70 and COX antibodies were used as loading controls for the Western blots. 
The detection of COX in the pellet fraction ensured no contamination between fractions 
with mitochondrial proteins.
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In summary, the data showed that the pro-apoptotic protein Smac was released from the 
mitochondria to the cytosol, together with cytochrome c, to induce caspase activation and 
apoptosis in paracetamol-treated HuH7 cells.
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Figure 3.16. Translocation of cytochrome c from mitochondria to the cytosol.
HuH7 cells were incubated in the absence (DMSO only) or presence o f paracetamol 
(lOmM) for 24 hours, (a) Cells were fixed, stained with a monoclonal cytochrome c 
antibody and counterstained with Hoechst nuclear dye and analysed by fluorescence 
microscopy as described under Materials and Methods. Apoptotic cells are shown by 
white arrows. Mag. X400. (b) Cell samples were subjected to SDS-PAGE followed by 
immunoblotting with a monoclonal antibody against cytochrome c as mentioned in the 
Methods section. Fifty pg o f protein were loaded in each lane. Blot (b) is representative 
o f three independent experiments. Super, supernatant fraction which contained cytosolic 
proteins; and pellet, pellet fraction which contained membrane-bound proteins. Anti- 
Hsc70 was used as a loading control.
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Figure 3.17. Translocation of Smac/DIABLO from the mitochondria to the cytosol.
HuH7 cells were incubated in the absence (DMSO only) or presence o f paracetamol 
(lOmM) for 24 hours. Cell samples were subjected to SDS-PAGE followed by 
immunoblotting with a monoclonal antibody against Smac as described under Materials 
and Methods. The blot is representative o f three independent experiments. Fifty pg o f 
protein were loaded in each lane. Super, supernatant fraction which contained cytosolic 
proteins and pellet, pellet fraction which contained membrane-bound proteins. The 
membrane was re-probed with anti-Hsc70 and COX as loading controls.
3.5.3 Loss of mitochondrial membrane potential in apoptosis
The previous data have demonstrated that the pro-apoptotic proteins, cytochrome c and
Smac are released from the mitochondria to the cytosol to induce caspase activation and
apoptosis in HuH7 cells undergoing apoptosis triggered by paracetamol. In addition, a
study was performed to investigate whether there is a loss of mitochondrial membrane
potential and therefore mitochondrial damage in apoptotic HuH7 cells. Cells treated with
paracetamol (lOmM) for 24 hours were stained alive with the mitochondrial dye TMRE
and counterstained with Hoechst. Samples were viewed by fluorescence microscopy.
The Hoechst counterstain of healthy cells showed homogenous blue stained nuclei of
normal healthy cells, however, there was also some clear apoptotic cells which appeared
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small and bright due to nuclear shrinkage and chromatin condensation as shown by the 
white arrows (Fig. 3.18b). Healthy cells showed red TMRE staining locating the 
mitochondria all around the nuclei of cells. However, the apoptotic cells (as shown by 
white arrows) showed no red staining by TMRE (Fig. 3.18a). The TMRE dye is 
^equestered-intO-the_jnitochondrial matrix by the mitochondrial membrane potential.
therefore only healthy cells with functional mitochondria are stained. Consequently, the 
TMRE staining showed that there is a loss of mitochondrial membrane potential and thus 
mitochondrial damage occurs early in apoptotic HuH7 cells under paracetamol treatment.
3.5.4 Inhibition of the mitochondrial permeability transition pore in 
paracetamol-induced apoptosis
A possible mechanism for the release of cytochrome c during apoptosis is the opening of 
the mitochondrial permeability transition pore (FTP) which in vitro research has shown 
that it operates in concert at the inner and outer contact sites to cause mitochondrial 
permeability transition which allows the leakage of cytochrome c (Desagher and 
Martinou, 2000; Grubb et a l, 2001). Although the structure and composition of the 
channel is still partially defined, there are two components, cyclophilin D and the adenine 
nucleotide translocator (ANT) (Fig. 1.6) which are known to be inhibited by cyclosporin 
A and bongkrekic acid respectively, so that the function of the FTP is inhibited (Bemardi 
e ta l, 1999).
The role of mitochondrial FTP was examined in paracetamol-treated HuH7 cells with 
both inhibitors. Cells were pre-treated with cyclosporin A (IpM) or bonkrekic acid 
(50pM) for 1 hour prior to the addition of paracetamol (lOmM). Cytotoxicity was 
measured by the release of LDH. The assay showed that paracetamol-induced toxicity
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and induction of apoptosis was not inhibited by cyclosporin A or bonkrekic acid 
suggesting that mitochondrial FTP was not causal to apoptosis (Fig. 3.19). Therefore, the 
inhibition of the FTP had no effect on paracetamol-induced apoptosis and cytochrome c 
release which must occur through an alternative route.
Figure 3.18. Analysis of mitochondrial membrane potential.
HuH7 cells were treated with paracetamol (lOmM) for 24 hours. Cells were stained with 
the TMRE mitochondrial dye (a) and counter stained with Hoechst nuclear dye (b) and 
samples were viewed by fluorescence microscopy as described under Materials and 
Methods. White arrows indicate apoptotic cells on right and left panels. Apoptotic cells 
showed no TMRE staining on left panel. Magnification, 400X.
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Figure 3.19. Inhibition of the mitochondrial FTP.
HuH7 cells were treated with paracetamol (lOmM) in the absence (blue) or presence o f 
(a) cyclosporine A (IpM) (CSP) (yellow) or (b) bongkrekic acid (50pM) (orange). 
Cytotoxicity was assessed by the LDH toxicity assay as described under Materials and 
Methods. Each time point is the mean ±SEM o f three independent experiments.
3.6 Translocation of Bax to the Mitochondria in Paracetamol- 
induced Apoptosis
The pro-apoptotic Bcl-2 protein, Bax, is known to translocate from the cytosol to the 
mitochondria to cause mitochondrial dysfunction and apoptosis. It is thought that Bax 
can target and integrate into the outer mitochondrial membrane by oligomerization with 
other Bax molecules so that a mitochondrial channel is formed to allow cytochrome c 
release to the cytosol (Epand et a l, 2002; Scorrano and Korsmeyer, 2003).
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Bax translocation from the cytosol to the mitochondria in apoptosis was investigated in 
HuH7 cells treated with paracetamol (lOmM) for 24 hours by Western blotting using a 
monoclonal antibody directed against Bax.
The control samples showed a strong band for Bax in the supernatant fraction (cytosolic 
proteins) whereas only a weak band was detected in the pellet fraction. On the contrary, 
paracetamol-treated samples for 24 hours, showed a strong band for Bax in the pellet 
fraction compared to the band detected in the supernatant (Fig. 3.20). These results 
demonstrated that Bax translocates to the mitochondria to induce apoptosis in the HuH7 
cells treated with paracetamol for 24 hours and this precedes major onset of cell death by 
apoptosis. Bax can provide the mechanism by which cytochrome c is released from the 
mitochondria to induce apoptosis in paracetamol-treated HuH7 cells. Hsc70 and COX 
were used as loading controls. The detection of COX in the pellet fraction ensured no 
contamination of the supernatant fraction with mitochondrial proteins.
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Figure 3.20. Bax translocation from the cytosol to the mitochondria.
HuH7 cells were incubated in the absence (DMSO control) or presence o f paracetamol 
(lOmM) for 24 hours. Cell samples were subjected to SDS-PAGE followed by 
immunoblotting with a monoclonal antibody against Bax as described under Materials 
and Methods. The blot is representative o f three independent experiments. Fifty pg o f 
protein were loaded in each lane. Super, supernatant fraction which contained cytosolic 
proteins and pellet, pellet fraction which contained membrane-bound proteins. The 
membrane was re-probed with anti-Hsc70 and COX as loading controls.
3.7 Signalling of Protein Kinases in Paracetamoi-induced 
Apoptosis
3.7.1 The Effect of JNK, p38 kinase and MEK inhibition
There are several MAP kinases (mitogen-activated protein kinases) including, c-Jun N- 
terminal kinase (JNK), p38 kinase and extracellular-regulated protein kinase (ERK) 
which can directly regulate the activity of transcription factors controlling gene 
expression (Kyriakis and Avruch, 2001). JNK and p38 kinase are well known stress- 
activated MAP kinases which belong to a group of signalling cascades that regulate
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cellular responses initiated by various forms of stress (Kyriakis and Avruch, 2001; 
Hochedlinger et a l, 2002). There is evidence that JNK and p38 kinase could play an 
important role in the initial signalling cascade leading to the activation of apoptotic cell 
death in some cells (Bae et a l, 2001; Hochedlinger et a l, 2002). On the other hand, the 
signal transduction pathway formed by MEK (Map kinase/ERK kinase) which in turn 
activates ERK modulates cell cycle progression and cell survival. Thus MEK is mostly 
thought to be associated with protection of cells from apoptosis (Hagemann and Blank, 
2001).
The role of JNK signalling in paracetamol-induced apoptosis was first investigated by 
Western blotting using a JNK and a phospho-JNK monoclonal antibodies. The phospho- 
JNK antibody only detects JNK when activated by phosphorylation at Thrl83/Tyrl85. 
Analysis of the blot showed that JNK was constitutively expressed in HuH7 cells. Active 
phosphorylated JNK was detected in paracetamol-treated (lOmM) cells for 48 hours 
whereas no phospho-JNK was observed in the control (Fig. 3.21). The results were 
confirmed by the positive control sample, containing 293 cell extracts treated with UV 
(40J/m^), purchased from Cell Signalling Technology (Fig. 3.21). Thus, the Western blot 
showed that in paracetamol-treated HuH7 cells, JNK was phosphorylated and therefore 
activated.
The role of JNK and also p38 kinase and MEK in paracetamol-induced toxicity was 
examined using specific selective inhibitors. HuH7 cells were pre-treated with the JNK 
inhibitor (30pM) or p38 kinase inhibitor (SB 203580) (lOpM) or MEK inhibitor (PD 
98059) (50pM) for 1 hour before normal treatment with paracetamol (lOmM) for several 
time points. Cell viability was measured by assaying for LDH activity.
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The JNK data clearly show that there was no inhibition of cytotoxicity and apoptosis by 
the pre-treatment of HuH7 cells with the JNK inhibitor (Fig.3.22). On the contrary, JNK 
inhibition caused a significant increase in cytotoxicty by paracetamol at the 54 hour time 
point. This result demonstrated that although phosphorylation and activation of JNK 
occurred in HuH7 cells under paracetamol treatment (Fig. 3.22), it is apparent that JNK is 
not involved in the signalling pathway to cause apoptotic cell death.
Similarly, the inhibition of p38 kinase showed no protection from paracetamol-induced 
toxicity and apoptosis (Fig. 3.23). MEK inhibition caused no significant increase in 
paracetamol-induced cytoxicity and also no protection from toxicity and apoptosis (Fig. 
3.23). This set of experiments demonstrated that both p38 kinase and MEK were not 
involved in the apoptotic process of cell death mediated by paracetamol in HuH7 cells.
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Figure 3.21. Phosphorylation of JNK in paracetamol-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO control) or presence o f paracetamol 
(lOmM) (Para) for 48 hours. Cell samples were subjected to SDS-PAGE followed by 
immunoblotting with a monoclonal antibody against JNK and phospho-JNK as described 
under Materials and Methods. The blot is representative o f three independent 
experiments. Eighty pg o f protein was loaded in each lane. Positive control is 293 cell 
extracts treated with UV (40J/m^) purchased from Cell Signalling Technology.
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Figure 3.22. Effect of JNK inhibition in apoptosis induced by paracetamol.
HuH7 cells were incubated in the absence (DMSO control) (light blue), JNK inhibitor 
(30pM) (yellow) or presence o f paracetamol (lOmM) (blue) after pre-treatment with 
JNK inhibitor (30pM) (pink). Cytotoxicity was assessed by the LDH toxicity assay as 
described under Materials and Methods. Each time point is the mean ±SEM o f three 
independent experiments. . Statistical analyses were performed using Bonferroni (all 
means) one-way ANOVA post hoc test and asterisks indicate significant difference from  
the paracetamol treatment (blue) *P<0.05.
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Figure 3.23. Effect of p38 kinase and MEK inhibition.
HuH7 cells were incubated in the absence (DMSO control) (light blue) or presence o f 
paracetamol (lOmM) (blue) after pre-treatment with p38 Map kinase inhibitor (10pM) 
(SB 203580) (grey) or MEK inhibitor (50pM) (PD 98059) (pink). Cytotoxicity was 
assessed by the LDH toxicity assay as described under Materials and Methods. Each 
time point is the mean ±SEM o f three independent experiments.
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3.7.2 Pro-apoptotic signalling of GSK-3 in HuH7 cells
The enzyme, glycogen synthase kinase-3 (GSK-3), has shown in recent years the 
potential to regulate a broad range of cellular processes including apoptosis (Cross et a l, 
2001; Smith et a l, 2001; Elyaman et a l, 2002b). The pro-apoptotic effects of this 
enzyme were investigated in HuH7 cells treated with paracetamol by the use of three 
inhibitors including, lithium chloride (LiCl) (20mM), SB216763 (25pM) and SB415286 
(3pM). HuH7 cells were pre-treated with these inhibitors for 1 hour prior normal 
treatment with paracetamol (lOmM). Cell death was determined using the LDH 
cytotoxicity assay.
First of all, the pre-treatment of HuH7 cells with LiCl clearly showed an inhibition of 
cytotoxicity compared to the paracetamol treatment with no inhibitor. In addition, this 
inhibition of cell death was found significant at both 48 and 54 hours of paracetamol 
treatment (Fig. 3.24). Furthermore, the use of both SB inhibitors of GSK-3 activity 
showed also a significant inhibition of cell toxicity by paracetamol at the 54 hour time 
point and this protection was found significant in both cases (Fig. 3.25). Analysis of 
caspase-3 activation by flow cytometry with cell samples pre-treated with the SB415286 
inhibitor showed at 48 hours a significant inhibition of caspase-3 cleavage compared to 
paracetamol treated cells with no GSK-3 inhibitor (Fig. 3.26). Therefore, these results 
confirmed that the protection effect observed by LiCl and the SB inhibitors was due to 
the inhibition of the apoptotic pathway.
The data demonstrated that in HuH7 cells treated with paracetamol, GSK-3 may provide 
an important mechanistic link between paracetamol-induced toxicity and the activation of 
the mitochondrial pathway of apoptosis.
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Figure 3.24. Inhibition of GSK-3 by lithium chloride (LiCl) .
HuH7 cells were incubated in the absence (DMSO control) (yellow), LiCl (20mM) 
(green) or presence o f paracetamol (lOmM) (blue) after pre-treatment with LiCl (20mM) 
(red). Cytotoxicity was assessed by the LDH toxicity assay as described under Materials 
and Methods. Each time point is the mean ±SEM o f three independent experiments. 
Statistical analyses were performed using Bonferroni (all means) one-way ANOVA post 
hoc test and asterisks indicate significant difference from the corresponding control 
group (blue) (ANOVA Bonferroni procedure, *P<0.05 and **P<0.01).
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Figure 3.25. Inhibition of GSK-3 by SB216763 and SB415286.
HuH7 cells were incubated in the absence (DMSO control) (light blue) or presence o f 
paracetamol (lOmM) (blue) after pre-treatment with SB216763 (25pM) (grey) or 
SB415286 (3pM) (yellow). Cytotoxicity was assessed by the LDH toxicity assay as 
described under Materials and Methods. Each time point is the mean ±SE7M o f three 
independent experiments. Statistical analyses were performed using Bonferroni (all 
means) one-way ANOVA post hoc test. * Significantly different from paracetamol 
treatment (blue), P< 0.05.
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Figure 3.26. Inhibition of caspase-3 cleavage by SB415286.
HuH7 cells were incubated in the absence (a) or presence o f paracetamol (lOmM) (b) 
after pre-treatment with GSK-3 inhibitor (SpM) (SB415286) (c) fo r 48 hours. Cell 
samples were fixed and immunostained with a PE-conjugated active caspase-3 antibody 
and samples were analysed by flow cytometry as described under Materials and 
Methods, (a, b, c) Represent histograms o f caspase-3 cleavage o f three different 
samples. The position o f the apoptotic cells (Ap) are marked. Each value is the mean 
±SEM o f at least three independent experiments. Statistical analyses were performed 
using Bonferroni (all means) one-way ANOVA post hoc test. * Significantly different 
from paracetamol treatment (b), P< 0.05.
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3.9 Discussion
The main objective of this investigation focused to evaluate the mode of cell death in the 
human hepatoma cell line, HuH7 during toxic treatment with paracetamol. Although the 
ultimate mechanism of liver cell death by paracetamol overdose is generally accepted to 
occur by necrosis (Lawson et a l, 1999; Gujral et a l, 2002; Pierce et a l, 2002), recent 
research has also shown that apoptosis plays a causal role in the initial events that lead to 
liver injury, since inhibiting apoptosis prevents the development of acute liver failure (El- 
Hassan et a l, 2003). Therefore, the precise signalling mechanism through which 
paracetamol-induces cell death is still a matter of debate and in order to continue to 
further understand the importance and the role of apoptosis in liver damage, there is a 
need to find an in vitro model that may adequately represent the molecular and cellular 
characteristics of paracetamol-induced hepatocyte death in vivo.
In this chapter, the data have shown that the HuH7 cells exposed to lOmM paracetamol 
undergo apoptotic cell death as shown by standard morphological criteria of apoptosis 
including, nuclear shrinkage, chromatin condensation and margination, DNA 
fragmentation and apoptotic body formation (Kerr et a l, 1972). Apoptotic cell death 
triggered by paracetamol was shown to occur by the activation of the mitochondrial 
pathway which is in agreement with other reports (Adams et a l, 2001; Boulares et a l, 
2002; El-Hassan et a l, 2003). Disruption of mitochondrial integrity has been reported to 
occur after paracetamol administration in liver and isolated hepatocytes. In addition, 
structural alterations in mitochondria are considered to be the first morphological changes 
observed in the cell after a hepatotoxic dose of paracetamol (Placke et a l, 1987; Losser 
and Payen, 1996).
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Activation of the mitochondrial pathway of apoptosis in the HuH7 cells was 
characterized by the release of important pro-apoptotic factors including, cytochrome c 
and Smac/DIABLO with a loss of mitochondrial membrane potential. The results 
showed that the release of these pro-apoptotic factors occurred in parallel which is also 
supported by other studies (Amoult et a l, 2003). The release of cytochrome c is 
recognized to be an early apoptotic event which is essential for the activation of the 
mitochondrial pathway by the interaction of cytochrome c with Apaf-1, dATP and the 
recruitment of caspase-9 which leads to activation of the caspase cascade. The formation 
of this complex stimulates the activation of caspase-9 which in turn activates the 
executioners caspase-3 and -7 to cause apoptotic cell death (Fulda el a l, 1998; Parone et 
a l, 2002; Waterhouse et a l, 2002). The translocation of cytochrome c to the cytosol by 
paracetamol has been observed both in vivo (Adams et a l, 2001; El-Hassan et a l, 2003) 
and in vitro (Boulares et a l, 2002).
The induction of necrosis by paracetamol in in vitro hepatocytes cultures does not induce
leakage of cytochrome c from mitochondria which has shown to require a specific
apoptotic co-stimulus (Nagai et a l, 2002). The release of cytochrome c into the cytosol
is known to be a multistep process involving an increase in outer membrane permeability,
the diffusion of a free pool of cytochrome c and the dissociation of the main bulk of
cytochrome c from cardiolipin followed by its translocation into the cytosol. This
process is rapid and complete in most cells (Ott et a l, 2002; Amoult et a l, 2003). The
precise mechanism by which cytochrome c and other mitochondrial proteins are released
into the cytosol during apoptosis is still controversial. One of the favoured mechanisms
for the release of cytochrome c involves the opening of the mitochondrial megachanel,
known as the mitochondrial permeability transition pore (PTP). This pore is composed
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primarily of a protein complex including cyclophilin D, the adenine nucleotide 
translocator (ANT) and the voltage-dependent anion channel (VDAC) (or mitochondrial 
porin) (Crompton, 2000; Desagher and Martinou, 2000). In isolated rat hepatocytes and 
isolated mitochondria, the reactive metabolite of paracetamol, NAPQI, has shown to 
induce damage to mitochondria and to induce opening of the PTP through its pro-oxidant 
activity and calcium mobilization (Kass et a l, 1992; Weis et a l, 1992). Interestingly, the 
inhibition of the mitochondrial PTP opening by specific protein inhibitors such as 
cyclosporine A (blocks the ANT) and bongkrekic acid (blocks VDAC) have shown to 
protect fi*om drug-induced and receptor-mediated apoptosis in liver cells in vitro and in 
vivo (Kass et a l, 1992; Marchetti et a l, 1996; Zamzami et a l, 1996; Pastorino and Hoek, 
2000; Yerushalmi et a l, 2001; Haouzi et a l, 2002; Zhao et a l, 2003). The results fi'om 
this chapter clearly showed that neither of these PTP inhibitors prevented fi’om the 
development of apoptotic cell death by paracetamol in the HuH7 cells and therefore the 
activation of the mitochondrial pathway did not involve opening of the mitochondrial 
PTP to cause apoptosis.
Another prevailing model for the release of cytochrome c in apoptosis involves the 
formation of membrane channels by the pro-apoptotic Bcl-2 family member, Bax (Epand 
et a l, 2002). In the HuH7 cells, pro-apoptotic Bax was found to translocate fi’om the 
cytosol to the mitochodria at the early stage of apoptotic death by paracetamol. Bax has 
shown to form channels in synthetic membranes and various reports have suggested that 
once Bax is attached to the outer mitochondrial membrane, it oligomerizes to form 
multimeric membrane megachannels that can allow cytochrome c leakage (Martinou and 
Green, 2001; Epand et a l, 2002; Scorrano and Korsmeyer, 2003). However, there is still 
no evidence for these channels in vivo.
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The translocation of Bax to the mitochondria has shown to be stimulated by the pro- 
apoptotic Bcl-2 family member. Bid. During apoptosis, the cleavage of Bid to a p i5 
truncated form, tBid, can bind Bax causing a conformational change in Bax that allows 
its migration and insertion to the mitochondria outer membrane. Thus, Bid serves as a 
chaperone for Bax redistribution to the mitochodnria to cause cytochrome c release and 
apoptosis (Kuwana et a l, 2002; Roucou et a l, 2002; Scorrano and Korsmeyer, 2003). 
Although Bid cleavage and translocation to the mitochondria was not investigated in the 
HuH7 cells, it has shown to play an important role in paracetamol-induced apoptosis in 
vivo (El-Hassan et a l, 2003). There are however other factors that could induce Bax 
translocation to the mitochondrdia including, depletion of ATP levels (Mikhailov et a l,
2001), perturbation of intracellular calcium homeostasis (Pan et a l, 2001), a loss of 
mitochondrial membrane potential (Smaili et a l, 2001) and changes in intracellular pH 
(Tafani et a l, 2002). All of these factors have been shown to contribute in paracetamol- 
induced hepatic damage (Moore et a l, 1985; Kass et a l, 1992; Weis et a l, 1992). 
Following the activation of the mitochondrial pathway, paracetamol-induced apoptosis in 
the HuH7 cells lead to the activation of the executioner caspases-3 and -7 which are 
known to play a central role in the execution of the apoptotic program (Cohen, 1997). 
The executioner caspase-3 is known to cleave a wide variety of cellular substrates and 
promote DNA fragmentation, both of which lead to cell death (Cohen, 1997). In HuH7 
cells, the cleavage of two important cellular substrates including a-fodrin (Martin et a l, 
1995; Wang et a l, 1998) and cytokeratin 18 (Caulin et a l, 1997) as important 
components of the cytoskeleton were shown to be cleaved by caspase-3. Although a 
recent report also showed that in the hepatoma cell line, SK-hepl, paracetamol induced 
apoptosis by caspase activation (Boulares et a l, 2002), all other in vivo and in vitro
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published reports have failed to detect caspase activation in paracetamol-induced 
apoptosis (Lawson et a l, 1999; Gujral et a l, 2002; Pierce et a l, 2002; El-Hassan et a l, 
2003). This last observation is in accordance to the results shown in Section 3.4.5 where 
caspase-3 and -7 activation were not observed in liver samples from paracetamol-dosed 
mice (Fig. 3.15) (El-Hassan et a l, 2003). Consequently, the apoptotic pathway was only 
incompletely activated in response to paracetamol treatment and therefore the ultimate 
mechanism of cell death is generally accepted as necrosis due to the switch from 
apoptotic cell death to premature secondary necrosis (El-Hassan et a l, 2003). Lawson et 
a l (1999) and Boulares et ah (2001) have argued that some possible reasons for the 
absence of caspase-3 activity could be due to the inhibition of caspase-3 activation or the 
inhibition of the transduction pathway of this enzyme by NAPQI or it could simply be as 
a result of differences in paracetamol metabolism, for example hepatocytes rapidly 
metabolize paracetamol to NAPQI while some hepatoma cell lines do this less efficiently 
(Boulares et a l, 2002). The ultimate reason needs to be further investigated.
However, both in vivo and in vitro, the importance of caspases in paracetamol-induced 
apoptosis is highlighted by the protection from liver damage and cell death afforded by 
the pan-caspase inhibitor, Z-VAD-fmk (El-Hassan et a l, 2003). In the HuH7 cells, 
caspase inhibitors, Ac-DEVD-cho and Z-VAD-fink were used. The latter significantly 
inhibited apoptosis by paracetamol. Furthermore, Z-VAD-fink was the most potent 
inhibitor of the two most likely due to its superior ability to penetrate cells and to 
irreversibly inactivate most cellular caspases compared to Ac-DEVD-cho (Margolin et 
a l, 1997).
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The importance of caspases in apoptosis is clearly established, however, there is also 
substantial evidence supporting the role of additional proteases involved in various forms 
of apoptosis (Kidd, 1998). In the liver these include, cathepsins (Guicciardi et a l, 2000; 
Foghsgaard et a l, 2001), calpains (Gressner et a l, 1997; Liu et a l, 2004), serine 
proteases (Jones et a l, 1998; Lieberman, 2003) and the proteasome (Pierce et a l, 2002) 
which have shown to contribute to the apoptotic pathway. Pharmacological inhibition of 
calpains, cathepsins and serine proteases showed no involvement in paracetamol-induced 
apoptosis in the HuH7 cells. This is an important observation, as the use of Z-FA-fmk 
(cathepsin inhibitor) and calpain inhibitors showed no protection from paracetamol- 
induced cytotoxicity, it excludes any non-specific effects of the reactive fmk moiety from 
the caspase inhibitor, Z-VAD-fink, which could lead to the non-specific inhibition of 
cathepsins and calpains (Schotte et a l, 1999). This confirms that the peptide inhibitors 
used in these studies acted by merely targeting the caspases involved in apoptosis.
A recent report has shown that the proteasome represents a physiologically significant 
target for paracetamol-induced cell death in the TAMH cell line. Their data showed that 
the proteosome inhibition by MG-132 substantially increased chromatin margination and 
complete nuclear condensation in paracetamol treatment (Pierce et a l, 2002). However, 
in the HuH7 cells no effect on paracetamol-induced apoptosis was observed, most likely 
because a full apoptotic response was already triggered by paracetamol in these cells. 
Thus in this hepatoma cell line, non-caspase proteases did not contribute to the execution 
of paracetamol-induced apoptosis, in which caspases played a leading role.
In the liver, the early signalling events leading to paracetamol-induced apoptosis have not
been well investigated. The regulatory mechanisms controlling the proliferation,
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differentiation or apoptosis of cells involve intracellular protein kinases that can 
transduce signals from the cell into changes in gene expression (Hagemann and Blank, 
2001; Kyriakis and Avruch, 2001; Hochedlinger et a l, 2002). Due to the toxic effects of 
paracetamol’s metabolism in the endoplasmic reticulum causing cellular stress, it is 
conceivable that paracetamol-induced toxicity could result from the interference with the 
enzyme kinases involved in the cell survival or cellular stress pathways. A recent report 
has shown that paracetamol activates stress JNK in a glioma cell line. Although this cell 
type does not represent a target for paracetamol toxicity in vivo, their results 
demonstrated a pro-apoptotic effect of the JNK stress kinase pathway in paracetamol- 
mediated apoptotic cell death (Bae et a l, 2001). In addition, different inducers of liver 
apoptosis have shown to activate one or more MAP kinase pathways (Lin and Dibling, 
2002; Bae and Son, 2003; Marderstein et a l, 2003). In HuH7 cells, JNK was also shown 
to be activated by detecting phospho-JNK by Western blotting prior to apoptosis by 
paracetamol. However, the pharmacological inhibition of JNK showed no protection 
from paracetamol-induced apoptosis. Similarly, the inhibition of stress p38 kinase and 
survival enzymes MEKl/2 did not alter the apoptotic pathway triggered by paracetamol. 
It is therefore demonstrated that in this hepatoma cell line both the stress MAP kinase 
pathway and the survival ERK kinase pathway were not involved in modulating the 
apoptotic cell death pathway induced by the hepatotoxin paracetamol.
A recent enzyme kinase shown to be involved in apoptosis is the enzyme, GSK-3. The 
latter is responsible for a wide range of cellular processes, ranging from glycogen 
metabolism to cell cycle regulation, proliferation and apoptosis (Doble and Woodgett, 
2003; Ryves and Harwood, 2003). GSK-3 has shown to play a critical role in the 
regulation of apoptosis and represents a key downstream target of the PI3-kinase/Akt
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survival signalling pathway (Elyaman et a l, 2002b). Although often considered to be a 
constitutively active enzyme, GSK-3 is in fact subject to regulation. The inactivation of 
GSK-3 is thought to involve phosphorylation of an N-terminal serine-9 residue whereas 
the activtion of the enzyme appears to occur through its phosphorylation at tyrosine-216 
and dephosphorylation at serine-9 (Cross et a l, 1995; Murai et a l, 1996). Activation of 
GSK-3 leads to the upregulation of a variety of pro-apoptotic genes and therefore its 
inactivation for example by Akt-mediated dephosphorylation is required for the survival 
signals (Elyaman et a l, 2002b). Bhat et a l, (2000) showed that in a neuroblastoma cell 
line treated with the apoptotic inducer staurosporine, GSK-3 was found active and the 
levels of this enzyme selectively increased in the nucleus of apoptotic cells (Bhat et a l,
2000). In addition, several in vivo and in vitro reports have demonstrated the pro- 
apoptotic effects of GSK-3 in mediating the early stress signals involved in neuronal 
apoptosis (Crowder and Freeman, 2000; Cross et a l, 2001; Smith et a l, 2001; Elyaman 
et a l, 2002b; Kang et a l, 2003). In addition, GSK-3 has shown to be a key intermediate 
in several apoptotic signalling pathways that lead to activation of caspase-3 (Song et a l, 
2002). However, the involvement of GSK-3 in the regulation of liver cell apoptosis has 
shown a different effect. Hoeflich et a l, (2000) demonstrated that the disruption of the 
murine GSK-3 gene results in embryonic lethality caused by severe liver degeneration 
during mid-gestation due to a defect in NF-kB activation (survival factor) and thus 
concluding that in the liver GSK-3 is required for cell survival (Hoeflich et a l, 2000). 
Similarly, a recent report has shown that GSK-3 protects hepatocytes from TNF-a- 
induced apoptosis through p65 phosphorylation and NF-kB transactivation (Schwabe and 
Brenner, 2002). Interestingly, the pharmacological inhibition of GSK-3 by the selective 
inhibitors LiCl (Kang et a l, 2003), SB216763 and SB415286 (Coghlan et a l, 2000;
-133-
Cross et a l, 2001; Smith et a l, 2001) in the HuH7 cells treated with paracetamol showed 
a significant prevention of apoptosis. Therefore, GSK-3 has also a pro-apoptotic function 
in liver cells. Interestingly, recent research has shown that endoplasmic reticulum (ER) 
stress-mediated caspase activation and subsequent apoptotic cell death occurs by 
activation of GSK-3 (Song et a l, 2002). Furthermore, the activation of GSK-3 which 
requires dephosphorylation of phospho-Ser-9-GSK-3, usually performed by the protein 
phosphatase 2A was shown to be mediated by ER stress (Song et a l, 2002). As the 
bioactivation of paracetamol to NAPQI occurs in the ER, predominantly by CYP2E1, this 
raises the possibility that paracetamol induces ER stress which then would lead to 
apoptotic cell death via the activation of GSK-3. In addition, recently Lorz et a l (2004) 
showed that paracetamol induces ER stress-mediated apoptosis in kidney cells (Lorz et 
a l, 2004). However, here, the link between GSK-3 activation and the activation of the 
mitochondrial pathway of apoptosis remains to be investigated.
Taken together, this study has shown that paracetamol induces apoptosis in HuH7 cells 
by activation of the mitochondrial pathway through the release of pro-apoptotic factors 
such as cytochrome c and Smac/DIABLO. This was subsequently followed by activation 
of the caspase cascade and the cleavage of key cellular substrates to cause death. A 
major modulator of this apoptotic response was identified to be GSK-3 which seems to 
represent a link between paracetamol-induced ER stress and the activation of apoptosis 
via the mitochondrial pathway.
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CHAPTER 4
ENDOPLASMIC RETICULUM STRESS INDUCED BY 
THAPSIGARGIN CAUSES APOPTOSIS IN LIVER CELLS
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4.1 Introduction
The endoplasmic reticulum (ER) plays a vital role in protein biosynthesis and folding and 
also serves as a main cellular storage for calcium (Pahl and Baeuerle, 1996; Rao et a l, 
2001; Xie et a l, 2002). Therefore, the ER constantly maintains the intracellular Ca^  ^
homeostasis tightly controlled (Xie et a l, 2002). A wide variety of conditions and agents 
(such as the exposure to xenobiotics) that block protein folding or export, affect calcium 
uptake and release from the ER. The alteration of the ER intraluminal oxidative 
environment and inhibitors of protein glycosylation from the ER can all lead to ER stress 
and cell death. Storage, release and uptake of calcium are regulated by proteins of the 
ER. Many diverse cellular functions are regulated by alterations in intracellular calcium, 
including secretion, contraction-relaxation, cell motility, cytoplasmic and mitochondrial 
metabolism, protein folding and synthesis, gene expression and cell cycle progression 
(Sambrook, 1990; Lee, 1992; Rapoport, 1992; Berridge, 1995; Kaufinann, 1999). In 
addition, research has demonstrated that disruption of ER fonction represents a severe 
stress to cells in which prolonged ER stress leads to the ultimate activation of the 
apoptotic signalling cascade (Pahl and Baeuerle, 1996; Rao et a l, 2001; Xie et a l, 2002; 
Kitamura et a l, 2003; Sohn et a l, 2003; Qu et a l, 2004).
The ER stress inducer, thapsigargin, is one of the most useful agents to identify cellular
responses to ER stress because it is a highly selective inhibitor of the sarcoplasmic/ER-
associated Ca^^-ATPase, which pumps Ca^  ^against a concentration gradient into the ER
(Putney, 1990; Thastrup et a l, 1990) Inhibition of this pump disrupts intracellular
calcium homeostasis by inducing a transient increase in cytosolic-free Ca^  ^ as it leaves
the ER down its concentration gradient (Chae et a l, 1999; Kitamura et a l, 2003; Sohn et
a l, 2003). This causes the inhibition of protein synthesis, an accumulation of
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intracellular unfolded or misfolded proteins and thus, leading to ER stress-mediated 
apoptotic cell death which is thought to occur through the activation of caspases (Kass 
and Orrenius, 1999; Xie et a l, 2002).
ER stress has shown to be an important factor in the neuropathology of a wide variety of 
neurological disorders (Aridor and Balch, 1999; Song et a l, 2002; Kitamura et a l, 2003) 
and it is thought that may contribute to the pathogenesis of several liver diseases such as 
non-alcoholic steatohepatitis, cholestasis and alcohol-induced liver disease (Xie et a l,
2002). Plus as most drugs are metabolized in the ER (by the P450 family of enzymes) of 
liver cells, it may contribute to the development of ER-stress mediated liver toxicity. 
However, the involvement of the ER in the apoptotic process is still not clear and the 
complete understanding of the ER stress-mediated cell death pathway remains to be 
investigated forther.
The induction of apoptosis may be signalled in response to calcium elevation, consistent 
with evidence that factors interfering with cytosolic calcium elevation inhibit 
thapsigargin-induced apoptosis (Chae et a l, 1999). Also, as the ER calcium pool has 
shown to be essential for a number of vital cellular functions could be possible that the 
depletion of the ER calcium pool triggers apoptosis, a concept supported by experimental 
evidence (Song et a l, 2002). In vitro studies have shown that thapsigargin caused 
calcium stress-induced cell death by apoptosis in different cell types such as osteoblasts, 
thymocytes, lymphoma cells and hematopoietic cells (Bafify et a l, 1993; Lam et a l, 
1993; Jiang et a l, 1994; Chae et a l, 1999). Furthermore, apoptotic cell death by 
thapsigargin may involve the activation of the stress-activated JNK signalling pathway
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and also the activation of GSK-3, both of these kinases have recently shown to be pro- 
apoptotic (Chae et a l, 1999; Song et a l, 2002).
In this study, the mechanism of cell death by ER stress was investigated in the human 
hepatoma cell line, HuH7, as a model for hepatic injury. In addition, for the preliminary 
studies, the induction of apoptosis by thapsigargin was investigated in primary mouse 
hepatocytes.
4.2 Thapsigargin-induced Cytotoxicity in Liver Ceiis
Initial dose ranging studies were performed to verify whether thapsigargin caused cell 
death in HuH7 cells and primary mouse hepatocytes. Both HuH7 cells and primary 
hepatocytes were incubated with various concentrations of thapsigargin including 10, 50, 
100, 500nM and IpM. Cell viability was assessed at 48 hours by the MTT reduction 
assay.
HuH7 cells and primary hepatocytes showed an apparent dose-dependent decrease in cell 
viability with clear cytotoxicity at the top dose of thapsigargin (IpM) treatment at 48 
hours (HuH7 cells, 22% of control MTT reduction) (hepatocytes, 29% of control MTT 
reduction) (Fig. 4.1). In addition, HuH7 cells were viewed by phase contrast microscopy 
and images representing the morphological changes seen at 48 hours between control and 
thapsigargin-treated cultures are shown in Figure 4.2. At 48 hours, the HuH7 control 
culture appeared healthy and confluent (Fig. 4.2a) whereas HuH7 cells exposed to IpM 
thapsigargin appeared unhealthy with most cells floating and cells showed condensed 
bright morphology, which is a common feature of cell death (Fig. 4.2b).
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Figure 4.1. Dose ranging studies of thapsigargin-induced toxicity in HuH7 cells.
HuH7 cells (red) and primary mouse hepatocytes (blue) were incubated in the presence 
o f thapsigargin (50, 100, SOOnM and IpM). Cell viability was measured at 48 hours by 
the MTT reduction assay as described under Materials and Methods. M TT results are 
expressed as % cell viability o f control. Each point is the mean o f two independent 
experiments.
Figure 4.2. Morphological changes of HuH7 cells at 48 hours post-treatment.
HuH7 cells were incubated in the absence (DMSO only) (a) or presence o f thapsigargin 
(IpM) (b) for 48 hours. The cell morphology was analysed by light microscopy as 
described under Materials and Methods, (a) control cells appeared healthy and 
confluent whereas (b) treated cells were unhealthy and most cells were detached and 
showed condensed morphology. Mag. X200.
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4.3 Induction of Apoptosis by Thapsigargin in Liver Ceiis
To confirm that the ER-stress inducer thapsigargin caused cell death via the activation of 
the apoptotic pathway, both HuH7 cells and primary hepatocytes were stained with 
Hoechst 33258 and the nuclear morphology analysed by fluorescence microscopy. The 
nuclear morphology of control cultures (Fig. 4.3a and c) of both hepatocytes and HuH7 
cells respectively, showed a homogenous blue stained nuclei of normal healthy cells. 
However, both cell types treated with thapsigargin for 48 hours showed clear apoptotic 
morphology (Kerr et a l, 1972) (as shown by white arrows). The nuclei stained bright 
and small compared to the healthy cells due to chromatin condensation and nuclear 
shrinkage during apoptosis (Fig. 4.3b and d). Analysis of the nuclear morphology 
demonstrated that thapsigargin-induced ER stress triggered cell death by apoptosis in 
both HuH7 cells and primary hepatocytes.
DNA fragmentation is a typical feature of apoptosis and it is also an irreversible event 
that commits the cell to die (Kroemer et a l, 1998; Liu et a l, 1998; Lockshin and Zakeri,
2001). In order to quantify the amount of apoptotic cell death in thapsigargin-treated 
HuH7 cultures, the cells were fixed and stained with the nuclear dye, propidium iodide, 
and samples were analysed for DNA content by flow cytometry (Fig. 4.4). The flow 
cytometry data showed that thapsigargin treatment for 48 hours caused an increase in the 
number of apoptotic cells (in the sub-Gl position (Ap) which is adjacent to the G1 peak 
of the cell cycle in the histogram) compared to control (Fig. 4.4a and b). Figure 4.4c, 
shows a steady time-dependent increase in the amount of apoptosis-induced by 
thapsigargin treatment. This investigation confirmed that thapsigargin-induced ER stress 
caused significant apoptotic cell death in the HuH7 cells.
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Figure 4.3. Analysis of nuclear morphology changes of HuH7 cells and primary 
mouse hepatocytes at 48 hours post-treatment with thapsigargin.
HuH7 cells (c & d) and primary hepatocytes (a & b) were incubated in the absence 
(DMSO only) (a & c) or presence o f thapsigargin (IpM) fo r 48 hours (b & d). Cells 
were fixed and stained with Hoechst 33258 cfye before visualization by fluorescence 
microscopy as described under Materials and Methods. White arrows show apoptotic 
cells that appear small and bright compared to control cells (a & c) due to nuclear 
shrinkage and chromatin condensation during apoptosis. Mag. X400.
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Figure 4.4. Induction of apoptosis by thapsigargin-mediated toxicity.
At specific time points o f thapsigargin (IpM) treatment, HuH7 cell samples were fixed, 
stained with PI and analysed for DNA content by flow cytometry as described under 
Materials and Methods. Panels (a & b) represent the DNA histograms. Cells were 
incubated in the absence (DMSO only) (a) or presence o f thapsigargin (IpM) (b) fo r 48 
hours. Red fluorescence (PI/DNA) was recorded after gating to exclude any clumped 
cells. The positions o f the apoptotic cells (Ap) and the different cell cycle phases (Gl, S, 
G2/M) are marked, (c) Summary o f flow cytometry data. HuH7 cells were incubated in 
the absence (black) or presence o f thapsigargin (IpM) (red) for specific times points as 
shown in the graph. Each time point is the mean ±SEM o f at least three independent 
experiments. Statistical analyses were performed using Bonferroni (all means) one-way 
AND VA post hoc test. Statistical significant levels are shown in graph. ** Significantly 
different from control, P< 0.01.
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4.4 The Role of Caspases In Thapsigargin-induced Apoptosis
4.4.1 Effect of caspase inhibitors
Due to the important role of caspases in apoptotic cell death, the role of these proteases in 
mediating apoptosis triggered by thapsigargin-induced ER stress was investigated in 
HuH7 cells using specific peptide inhibitors that are directed against the substrate 
cleavage site. Cells were pre-treated with two different general caspase inhibitors, Z- 
VAD-fmk and Ac-DEVD-cho for 30 minutes prior to addition of thapsigargin (IpM). 
The level of cytotoxicity was measured at the specific time points by the LDH toxicity 
assay.
The pan-caspase inhibitor, Z-VAD-fmk, showed near complete protection fi'om 
thapsigargin-induced ER stress and cell death at 48 and 54 hours of treatment (Fig. 4.5). 
Likewise, the caspase-3/7 inhibitor, Ac-DEVD-cho, prevented fi’om thapsigargin-induced 
cell death but was less potent (Fig. 4.6).
4.4.2 Effect of non-caspase protease inhibitors
Non-caspase proteases and in particular calpains have been shown to play an important 
role in thapsigargin-induced apoptosis (Xie et a l, 2002). In HuH7 cells, the role of non- 
caspase proteases in modulating apoptosis due to ER stress damage by thapsigargin was 
investigated. Cells were pre-treated with the calpain inhibitor, ALLN (IpM), proteasome 
inhibitor (MG-132) (0.5pM), the serine protease, TPCK (lOpM) and the cathepsin 
inhibitor, Z-FA-fink (50pM) for 30 minutes prior to the addition of thapsigargin (IpM). 
As mentioned in Section 3.3.2, the investigation into Z-FA-fmk was important to rule out 
any non-specific effect of the reactive fink moiety of the caspase inhibitor, Z-VAD-fink 
toward cathepsins. Again the cytotoxicity was assessed by the LDH toxicity assay.
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Analysis of the data showed that none of the proteases under investigation protected from 
thapsigargin-induced cytotoxicity and apoptosis with significance (Fig. 4.7, 4.8, 4.9,
4.10). Taken together, these results demonstrated that caspases and not other proteases 
contribute to HuH7 cell apoptosis which seems the main cell death mechanism of 
thapsigargin-induced cytotoxicity.
4.4.3 Detection of caspase-3 and -7 activation
The general caspase inhibitor, Z-VAD-fmk, showed that caspases play an important role 
in ER stress-induced cell death in the HuH7 cells. Therefore, cell extracts fi’om HuH7 
cells treated with thapsigargin were analysed by Western blotting for the processing and 
activation of the execution caspases-3 and -7 which are critical for the apoptotic 
execution phase.
The catalytically active small fi’agment of caspase-3, p i7, was detected both in 
thapsigargin- and paracetamol-treated samples for 48 hours (Fig. 4.11a). However, the 
band for pl7 was not observed in the solvent (DMSO) control sample. Again, as 
mentioned in Section 3.4.3, the analysis of the pattern of caspase-3 degradation reveals 
that the p29 fragment (caspase-3 without pro-domain) was constitutively present in these 
cells.
In the case of caspase-7, the appearance of a band that corresponded to the size of the 
large catalytically active fi’agment (pi9) (the smaller fi’agment is not recognised by the 
antibody) was detected in HuH7-treated samples with various concentrations of 
thapsigargin including, 0.1, 0.5 and IpM for 48 hours. There was no pl9 fi’agment 
observed in the control (DMSO) lane (Fig. 4.1 lb). These data evidenced the activation
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of caspases-3 and -7 in response to ER stress to cause cell death in HuH7 cells by 
apoptosis.
Detection of caspase-3 activation was further analysed by flow cytometry using a PE- 
conjugated active-caspase-3 antibody which recognizes the p20/pl7 active large 
fragments of caspase-3 and not the inactive pro-form. The summary of the data, as a time 
course, showed a time-dependent increase in the cleavage and activation of caspase-3 in 
thapsigargin treatment. At the 48 hour time point of treatment, there was a significant 
caspase-3 activation compared to control (Fig. 4.12). As mentioned in Section 3.4.3, 
again the lack of immunoreactivity in control cells (Fig. 4.12) demonstrates that the 
20kDa band detected by Western blot (Fig. 4.11a) is unrelated to the p20 large subunit of 
caspase-3. Interestingly, at the 48 hour time point in which cells were pre-treated with Z- 
VAD-fmk before treatment with thapsigargin, there was an evident inhibition of caspase- 
3 activation which was found significant compared to thapsigargin treatment alone (Fig.
4.10). These data confirmed that the executioner caspase-3 is activated in HuH7 cells 
treated with thapsigargin.
4.4.4 Cleavage of caspase-3 substrates in apoptosis
To confirm that caspase-3 was catalytically active in thapsigargin-treated HuH7 cells to 
cause cell death by apoptosis, the cleavage of two specific caspase-3 substrates, a-fodrin 
and cytokeratin 18, was investigated.
First, the in situ cleavage of a-fodrin to a pl20 fragment by caspase-3 was performed by
Western blotting. Analysis of the blot showed the caspase-3 cleaved fragment of a-
fodrin (pl20) in thapsigargin-treated HuH7 cells as well as in the treatments with
paracetamol and the apoptosis inducers staurosporine and puromycin (Fig. 4.13). There
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was no pl20 fragment of a-fodrin observed in the control sample (DMSO control). 
Calpains have shown also to cleave a-fodrin to produce a pl45 fragment. The results 
revealed that the p i45 fragment of a-fodrin, which was observed in the control lane, was 
constitutively present in these cells (Fig. 4.13).
The immunoreactive neoepitopes formed as a result of cytokeratin 18 cleavage by 
caspase-3 was examined by flow cytometry. The analysis of the time course study 
showed a time-dependent increase in cytokeratin-18 cleavage by caspase-3 in 
thapsigargin-induced apoptosis (Fig. 4.14). At the 48 hour time point, the cleavage of 
cytokeratin 18 was significant compared to control. In addition, the pre-treatment of 
HuH7 cells with Z-VAD-fmk before normal treatment with thapsigargin showed a 
significant reduction in cytokeratin 18 cleavage due to the inhibition of caspase-3 
activation by the pan-caspase inhibitor (Fig. 4.14).
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Figure 4.5. Effect of Z-VAD-fmk on thapsigargin-induced cell death in HuH7 cells.
HuH7 cells were incubated in the absence (DMSO only) (light blue), Z-VAD-fink 
(100fiM) (green) or presence o f thapsigargin (IpM) (blue) after pre-treatment with Z- 
VAD-fmk (100pM) (red). Cytotoxicity was assessed by the LDH toxicity assay as 
described under Materials and Methods. Each time point is the mean ±SEM o f three 
independent experiments. Statistical analyses were performed using Bonferroni (all 
means) one-way AN OVA post hoc test. * Significantly different from thapsigargin 
treatment, P< 0.05. *** Significantly different from thapsigargin treatment, P< 0.001.
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Figure 4.6. Effect of Ac-DEVD on thapsigargin-induced apoptosis in HuH7 cells.
HuH7 cells were incubated in the absence (DMSO) (light blue), Ac-DEVD-cho (lOOpM) 
(orange) or presence o f thapsigargin (IpM) (blue) after pre-treatment with Ac-DEVD- 
cho (lOOpM) (grey). Cytotoxicity was assessed by the LDH toxicity assay as described 
under Materials and Methods. Each time point is the mean ±SEM o f three independent 
experiments. Statistical analyses were performed using LSD (all means) one-way 
ANOVA post hoc test. * Significantly different from thapsigargin treatment, P< 0.05.
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Figure 4.7. EfTect of calpain inhibition on thapsigargin-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) (light blue), calpain inhibitor 
(ALLN) (IpM) (green) or presence o f thapsigargin (IpM) (blue) after pre-treatment with 
calpain inhibitor (ALLN) (IpM) (pink). Cytotoxicity was assessed by the LDH toxicity 
assay as described under Materials and Methods. Each time point is the mean ±SEM o f 
at least three independent experiments.
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Figure 4.8. Effect of proteasome inhibition on thapsigargin-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) (light blue), proteasome 
inhibitor (IpM) (cream) or presence o f thapsigargin (IpM) (blue) after pre-treatment 
with proteasome inhibitor (IpM) (purple). Cytotoxicity was assessed by the LDH toxicity 
assay as described under Materials and Methods. Each time point is the mean ±SEM o f 
at least three independent experiments.
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Figure 4.9. EfTect of TPCK on thapsigargin-induced apoptosis in HuH7 cells.
HuH7 cells were incubated in the absence (DMSO only) (light blue) or presence o f 
thapsigargin (IpM) (blue) after pre-treatment with TPCK (lOpM) (red). Cytotoxicity 
was assessed by the LDH toxicity assay as described under Materials and Methods. 
Each time point is the mean ±SEM o f three independent experiments.
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Figure 4.10. Effect of Z-FA-fmk on thapsigargin-induced apoptosis in HuH7 cells.
HuH7 cells were incubated in the absence (DMSO) (light blue), Z-FA-fmk (IpM) (green) 
or presence o f thapsigargin (IpM) (blue) after pre-treatment with Z-FA-fmk (IpM) 
(grey). Cytotoxicity was assessed by the LDH toxicity assay as described under Materials 
and Methods. Each time point is the mean ±SEM o f three independent experiments.
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Figure 4.11. Activation of caspases-3 and -7 in thapsigargin-induced apoptosis.
HuH7 cells were incubated (a) in the absence (DMSO only) or presence o f thapsigargin 
(IpM) for 24 and 48 hours and (b) in the absence (DMSO only) or presence o f 
thapsigargin (0.1, 0.5, 0.5pM) for 48 hours. Cell samples were subjected to SDS-PAGE 
followed by immunoblotting with an antibody directed against caspase-3 (a) or caspase-7 
(b) as directed under Materials and Methods. The blots (a) and (b) are representative o f 
three independent experiments. Fifty pg o f protein was loaded in each lane. 
Abbreviation (a): para, paracetamol (lOmM) treatment for 48 hours as a positive 
control.
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Figure 4.12. Cleavage of caspase-3 by thapsigargin-induced apoptosis.
At specific time points o f thapsigargin (IpM) treatment, HuH7 cell samples were 
immunostained with a PE-conjugated active caspase-3 antibody and samples were 
analysed by flow cytometry as described under Materials and Methods. HuH7 cells were 
incubated in the absence (DMSO only) (red) or presence o f thapsigargin (blue) after pre­
treatment with Z-VAD-fmk (lOOpM) (grey) for specific times points as shown in the 
graph. pMch time point is the mean ±SEM o f at least three independent experiments. 
Statistical analyses were performed using Bonferroni (all means) one-way ANOVA post
hoc test. *** Significantly different from control (red) and 
thapsigargin treatment (blue), P< 0.001.
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Figure 4.13. Analysis of fodrin cleavage following thapsigargin-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) or presence o f thapsigargin 
(IpM) for 48 hours. Cells were lysed and subjected to SDS-PAGE followed by 
immunoblotting with anti-fodrin (all-spectrin) monoclonal antibody as described under 
Materials and Methods. The blot showed fodrin cleavage by caspase-3 with the 
appearance o f a llOkDa band and it is representative o f three independent experiments. 
Fifty pg o f protein was loaded in each lane. Abbreviations: stauro, staurosporine (IpM) 
and puro, puromycin (20pM) treatments for 24 hours as positive controls. Para, 
paracetamol (lOmM) and thapsi, thapsigargin (IpM) treatments fo r 48 hours.
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Figure 4.14. Cytokeratin 18 cleavage following thapsigargin-induced apoptosis.
Cells were incubated in the absence (DMSO only) (orange) or presence o f thapsigargin 
(IpM) (blue) after pre-treatment with Z-VAD-fmk (lOOpM) (green) for the times 
indicated. Samples were fixed and immunostained with an antibody directed against the 
caspase-3 cleaved fragment o f cytokeratin 18 and then analysed by flow cytometry as 
described under Materials and Methods. Each time point is the mean ±SEM o f three 
independent experiments. Statistical analyses were performed using Bonferroni (all 
means) one-way ANOVA post hoc test. *** Significantly different from control, P< 
0.001. ^  Significantly different from thapsigargin treatment (blue), P<0.01.
4.5 Activation of the Mitochondrial Pathway of Apoptosis
ER stress mediated by thapsigargin-induced toxicity has shown to induce apoptosis in the 
hepatoma cell line, HuH7. Thus, it was next important to verify whether apoptosis- 
induced by thapsigargin occurred via the mitochondrial pathway.
4.5.1 Release of pro-apoptotic factors from mitochondria
The first important mediator of the mitochondrial pathway to investigate was cytochrome 
c which is released from the mitochondria to the cytosol during apoptosis to cause cell
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death (Bemardi et a l, 1999; Desagher and Martinou, 2000). The translocation of 
cytochrome c from the mitochondria to the cytosol in thapsigargin-induced apoptosis in 
HuH7 cells was examined by immunocytochemistiy and Western blotting.
HuH7 cells incubated with thapsigargin for 24 hours were immunostained with a 
monoclonal cytochrome c antibody and counterstained with the Hoechst 33258 nuclear 
dye before viewed the results by fluorescence microscopy. As mentioned earlier in 
Section 3.5.1, healthy cells showed a distinctive punctuate green staining of cytochrome c 
in the mitochondria surrounding the nuclei of cells (red arrow) (Fig. 4.15a). In addition, 
the Hoechst nuclear counterstain of these cells showed homogenous blue stained nuclei 
typical of healthy cells (red arrow). However, apoptotic cells (white arrows) showed 
homogenous green staining due to the release of cytochrome c which spreads throughout 
the cytosol (Fig. 4.15a). Again the counterstain of these cells showed small bright 
stained nuclei typical of apoptotic cells due to the chromatin condensation (white arrow).
The Western blot showed a strong band for cytochrome c in the pellet fraction 
(mitochondrial proteins) of the control and a weak band in the supernatant (cytosolic 
proteins) (due to some endogenous cell death in the control sample) (Fig. 4.15b). 
However, thapsigargin-treated sample showed a cytochrome c band in the pellet fraction 
(mitochondrial proteins) but also a strong band for cytochrome c was observed in the 
supernatant fraction (cytosolic proteins) (Fig.4.15b). Therefore, these data demonstrated 
that ER stress-induced apoptotic cell death by thapsigargin occurred via the 
mitochondrial pathway with the release of cytochrome c from the mitochondria to the 
cytosol to cause cell death. Anti-Hsc70 was used to confirm equal loading in each lane.
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Like cytochrome c, the pro-apoptotic protein, Smac is also released from the 
mitochondria to the cytosol to promote apoptotic cell death. The translocation of Smac in 
thapsigagin-induced apoptosis in HuH7 cells was investigated by Western blotting.
These results showed as expected for the control samples a strong band for Smac in the 
pellet fraction (mitochondrial proteins) and no band was observed in the supernatant 
fraction (cytosolic proteins) (Fig. 4.15b). Thapsigargin-treated samples showed a strong 
band in the pellet fraction corresponding to Smac but also a band was detected in the 
supernatant fraction. These results demonstrated that Smac translocates into the cytosol 
at the early time point of 24 hour thapsigargin treatment (Fig.4.15b).
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Figure 4.15. Translocation of cytochrome c and Smac from mitochondria.
HuH7 cells were incubated in the absence (DMSO only) or presence o f thapsigargin 
(IpM) fo r 24 hours, (a) Cells were fixed, stained with a monoclonal cytochrome c 
antibody and counterstained with Hoechst nuclear dye and analysed by fluorescence 
microscopy as described under Materials and Methods. Apoptotic cells are shown by 
white arrows. Mag. X400. (b) Cell samples were subjected to SDS-PAGE followed by 
immunoblotting with a monoclonal antibody against cytochrome c as mentioned in the 
Methods section. The blot is representative o f at least three independent experiments.
pg o f protein was loaded in each lane. Super, supernatant fraction containing 
cytosolic proteins and pellet, pellet fraction which contains membrane-bound proteins. 
Anti-Hsc70 was used as a loading control.
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4.5.2 Detection of mitochondrial membrane potential
The loss of mitochondrial membrane potential as a marker for mitochondrial damage in 
apoptosis was examined in HuH7 cells treated with thapsigargin for 24 hours. For this 
investigation, the hepatoma cells were stained with the mitochondrial marker TMRE, 
counterstained with Hoechst and analysed by fluorescence microscopy.
As shown in Figure 4.16, the apoptotic cells stained with Hoechst (shown by white 
arrows) (Fig. 4.16b) showed no TMRE staining (Fig. 4.16a). Thus, healthy cells with 
functional mitochondria stained red whereas apoptotic cells showed no TMRE staining 
due to the loss of mitochondrial membrane potential and mitochondrial damage during 
the apoptotic cell death process induced by thapsigargin.
4.5.3 Inhibition of the mitochondrial permeability transition pore
Both the release of pro-apoptotic proteins from mitochondria and the loss of 
mitochondrial membrane potential could have resulted from the opening of the 
mitochondrial FTP which has shown previously to be involved in apoptosis (Desagher 
and Martinou, 2000).
To investigate the involvement of the mitochondrial FTP in thapsigargin-induced
apoptosis, the HuH7 cells were pre-treated for 1 hour with the FTP inhibitors,
cyclosporin A (IpM) and bongkrekic acid (50pM) before normal treatment with
thapsigargin. Cytotoxicity was measured by LDH leakage. The assay showed that the
inhibition of the mitochondrial FTP caused no prevention or delay in thapsigargin-
induced loss of cell viability by apoptosis (Fig.4.17). These data suggested that the
mitochondrial FTP is not involved in the initial release of cytochrome c to cause
apoptosis and therefore, this process must occur via an alternative route.
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Figure 4.16. Analysis of mitochondrial membrane potential.
HuH7 cells were treated with thapsigargin (IpM) for 24 hours. Cells were stained with 
the TMRE mitochondrial dye (a) and counter stained with the Hoechst nuclear dye (b) 
and samples were viewed by fluorescence microscopy as described under Materials and 
Methods. White arrows indicate apoptotic cells on right and left panels. Apoptotic cells 
showed no TMRE staining on left panel. Magnification, X400.
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Figure 4.17. Inhibition of the mitochondrial FTP.
HuH7 cells were treated with thapsigargin (IpM) in the absence (blue) or presence o f (a) 
cyclosporin A (CSP) (IpM) (yellow) or (b) bongkrekic acid (50pM) (orange). 
Cytotoxicity was assessed by the LDH toxicity assay as described under Materials and 
Methods. Each time point is the mean ±SEM o f at least three independent experiments.
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4.6 The Role of BAX In ER Stress-Induced Apoptosis
The role of Bax as a possible mediator for cytochrome c release from the mitochondria in 
apoptosis triggered by thapsigargin was investigated in HuH7 cells by Western blotting. 
Analysis of the blot showed a strong band for Bax in the supernatant fraction (containing 
cytosolic proteins) of the control sample. However, the thapsigargin-treated sample 
showed a weak band for Bax was detected in the supernatant but also a strong band 
corresponding to Bax was observed in the pellet fraction (containing mitochondrial 
proteins) (Fig. 4.18). Thus, these data suggested that Bax is translocated from the cytosol 
to the mitochondria in thapsigargin-induced ER stress to cause cytochrome c release and 
apoptotic cell death. The proteins, Hsc70 and COX were used as loading controls for the 
Western blots. In addition, the detection of the mitochondrial COX protein was 
performed to ensure no contamination between fractions (Fig. 4.18).
4.7 The Importance of Calcium In ER Stress-Induced Apoptosis
Various reports have mentioned that the disruption of calcium homeostasis due to a 
sustained elevation of cytosolic calcium by thapsigargin-mediated ER toxicity is the 
initial trigger of the apoptotic cell death pathway (Xie et a l, 2002; Kitamura et a l, 2003). 
To verify the importance of calcium signalling in thapsigargin-induced apoptosis in 
HuH7 cells, the cultures were pre-treated with the calcium chelator, EGTA which inhibits 
the elevation of cytosolic calcium, for 1 hour before normal treatment with thapsigargin. 
Cell viability was measured by LDH leakage.
As shown in Figure 4.19, the use of EGTA to inhibit the elevation of calcium in the
cytoplasm did not protect from cytotoxicity and apoptosis by thapsigargin. This
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suggested that thapsigargin-induced apoptosis was initiated merely by signals from the 
ER due to ER stress and not to the disruption of calcium homeostasis.
4.8 Inhibition of JNK Signalling in Apoptosis
The pro-apoptotic signalling of the stress-activated MAP kinase enzyme, JNK was 
investigated in thapsigargin-induced toxicity as a possible initial mediator between ER 
stress and the activation of the mitochondrial pathway of apoptosis in the hepatoma cells.
First, the activation of JNK in these cells was analysed by Western blotting using a JNK 
and a phospho-JNK monoclonal antibodies. The phospho-JNK antibody only detects 
JNK when activated by phosphorylation at Thrl83/Tyrl85. The study showed that JNK 
was activated in thapsigargin-treated HuH7 cells for 48 hours as both phosphorylated 
bands of active JNK were detected (Fig. 4.20). In addition, no phosphorylated bands of 
JNK were observed in the control (DMSO) sample. The results were confirmed by the 
positive control sample, containing 293 cell extracts treated with UV (40J/m^), purchased 
from Cell Signalling Technology and also paracetamol-treated HuH7 cells (Fig. 4.20). 
These data suggested that stress-induced JNK was activated by thapsigargin treatment of 
HuH7 cells.
Following the confirmation that JNK activation occurred with treatment of HuH7 cells 
with thapsigargin, the role of JNK in ER stress-induced apoptosis was investigated using 
a selective inhibitor. HuH7 cells were pre-treated with a JNK inhibitor for 1 hour before 
normal treatment with thapsigargin. Cytotoxicity was measured by assaying for LDH 
leakage. Interestingly, the inhibition of JNK activation showed no protection from
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thapsigargin-induced ER stress cell death by apoptosis (Fig. 4.21). Thus, although JNK 
activation occurred by thapsigargin treatment, the data verified that JNK activation is not 
involved in the apoptotic signalling pathway of ER stress triggered by thapsigargin.
4.9 The Role of GSK-3 In ER stress-mediated Apoptosis
Recent research has shown that ER stress-induced by thapsigargin causes the activation 
of the enzyme kinase, GSK-3 which was showed to be involved in the induction of 
apoptosis (Song et a l, 2002). Furthermore, as shown in Chapter 3, paracetamol-induced 
apoptosis was regulated by the activation of GSK-3 (Section 3.7.2). Here, the role of 
GSK-3 in thapsigargin-treated HuH7 cells was analysed by the pre-treatment of the cells 
with the selective GSK-3 inhibitor, SB415286, for 1 hour prior to normal treatment with 
thapsigargin. The leakage of LDH was measured as a direct marker of cell toxicity. 
Interestingly, the GSK-3 inhibitor caused a significant cell death protection fi’om 
thapsigargin-induced toxicity both at 48 and 54 hours of treatment (Fig. 4.22). The data 
demonstrated that GSK-3 plays a critical role in the events leading to the apoptotic cell 
death pathway caused by thapsigargin-induced toxicity.
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Figure 4.18. Translocation of Bax to the mitochondria in ER stress-induced 
apoptosis.
HuH7 cells were incubated in the absence (DMSO control) or presence o f thapsigargin 
(IpM) fo r 24 hours. Cell samples were subjected to SDS-PAGE followed by 
immunoblotting with a monoclonal antibody against Bax as described under Materials 
and Methods. The blot is representative o f three independent experiments. Fifty pg o f 
protein was loaded in each lane. Super, supernatant fraction which contained cytosolic 
proteins and pellet, pellet fraction which contained membrane-bound proteins. The 
membrane was re-probed with anti-Hsc70 and COX as loading controls.
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Figure 4.19. Inhibition of calcium elevation in the cytosol by thapsigargin-induced 
toxicity.
HuH7 cells were incubated in the absence (DMSO control) (light blue), EGTA (1.9mM) 
(yellow) or presence o f thapsigargin (IpM) (blue) after pre-treatment with EGTA 
(1.9mM) (red). Cytotoxicity was assessed by the LDH toxicity assay as described under 
Materials and Methods. Each time point is the mean ±SEM o f three independent 
experiments.
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Figure 4.20. Phosphorylation of JNK in thapsigargin-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO control) or presence o f paracetamol 
(Para) (lOmM) or thapsigargin (IpM) for 48 hours. Cell samples were subjected to 
SDS-PAGE followed by immunoblotting with a monoclonal antibody against JNK and 
phospho-JNK as described under Materials and Methods. The blot is representative o f 
three independent experiments. Eighty pg o f protein was loaded in each lane. Positive 
control is 293 cell extract treated with UV (40J/m^) purchased from Cell Signalling 
Technology.
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Figure 4.21. Effect of JNK inhibition in cell death induced by thapsigargin.
HuH7 cells were incubated in the absence (DMSO control) (light blue), JNK inhibitor 
(30pM) (yellow) or presence o f thapsigargin (IpM) (blue) after pre-treatment with JNK 
inhibitor (30pM) (pink). Cytotoxicity was assessed by the LDH toxicity assay as 
described under Materials and Methods. Each time point is the mean ±SEM o f three 
independent experiments.
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Figure 4.22. Inhibition of GSK-3 by SB415286 in thapsigargin-induced cell death.
HuH7 cells were incubated in the absence (DMSO control) (light blue), SB415286 
(SOpM) (cream) or presence o f thapsigargin (IpM) (blue) after pre-treatment with 
SB415286 (30pM) (green). Cytotoxicity was assessed by the LDH toxicity assay as 
described under Materials and Methods. Each time point is the mean ±SEM o f three 
independent experiments. Statistical analyses were performed using Bonferroni (all 
means) one-way ANOVA post hoc test. Significantly different from thapsigargin 
treatment (blue), P<0.01.
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4.10 Discussion
Apoptosis has shown to play an important role in ER stress-induced cell death (Rao et a l, 
2001; Sohn et a l, 2003). However, the complete signalling pathway of ER stress- 
induced apoptotic cell death remains controversial. In addition, as apoptotic cell death 
triggered by ER-stress is thought to contribute to some hepatic damage and disease, it 
would be beneficial to develop an in vitro model for the investigation and understanding 
of ER-stress-mediated liver cell apoptosis.
In the present Chapter, the data demonstrated that the ER stress-induced by thapsigargin 
(IpM) caused induction of the apoptotic cell death pathway both in the hepatoma cell 
line, HuH7 and the primary mouse hepatocytes. ER-stress mediated apoptosis was first 
confirmed by the identification of the typical morphological changes of apoptosis 
including nuclear shrinkage, chromatin condensation and DNA fi-agmentation as 
mentioned by Kerr et a l (1972). These findings are in agreement with other in vitro 
reports which have also confirmed the induction of apoptosis by thapsigargin in a wide 
variety of cell lines including liver cells (Chae et a l, 1999; Elyaman et a l, 2002a; Xie et 
a l, 2002; Kitamura et a l, 2003; Sohn et a l, 2003).
The activation of the apoptotic process by ER stress occurred in the HuH7 cells by the 
activation of the mitochondrial pathway. This was confirmed by the release of important 
mitochondrial pro-apoptotic factors such as cytochrome c and Smac. These data are 
supported with recent published results in which evidence was presented that ER stress 
may activate the mitochondrial apoptosis pathway (Hacki et a l, 2000; Annis et a l, 2001; 
Wei et a l, 2001; Elyaman et a l, 2002a; Sohn et a l, 2003). However, Xie et a l (2002) 
showed that cytochrome c release in the HuH7 cells by thapsigargin treatment occurred
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without loss of mitochondrial membrane potential whereas in the present investigation 
cytochrome c release and loss of mitochondrial membrane potential were detected in 
these hepatoma cells at the early treatment with thapsigargin which was indicative of 
apoptosis and mitochondrial damage (Figures 4.16 and 4.17). These contrasting findings 
would need further investigation to be fiilly explained although they are probably related 
to the different thapsigargin concentrations used for the studies.
Interestingly, recent papers indicated that close contacts exist between mitochondria and 
sites of ER calcium release such as that ER calcium release by thapsigargin is thought to 
lead to rapid accumulation of calcium in the mitochondria which is thought to stimulate 
the opening of the mitochondrial FTP for the release of cytochrome c and the initiation of 
the caspase cascade (Szalai et a l, 1999; Brustovetsky et a l, 2002; Nutt et a l, 2002; Xie 
et a l, 2002; Kitamura et a l, 2003). However, as shown in this Chapter, the initiation of 
apoptotic cell death was not dependent on mitochondrial FTP opening in the HuH7 cells 
treated with thapsigargin.
The detection of Bax translocation to the mitochondria in the HuH7 cells afl:er 
thapsigargin treatment provided an alternative mechanism for the release of cytochrome c 
to induce caspase activation and apoptosis. This Bcl-2 pro-apoptotic protein is thought to 
undergo a conformational change at the mitochondrial membrane with other Bax 
monomers to cause an increase in outer mitochondrial membrane permeability that would 
trigger the release of cytochrome c release and other proteins of the inter-membrane 
space of mitochondria, such as Smac (Desagher and Martinou, 2000; Wei et a l, 2001; 
Scorrano and Korsmeyer, 2003). A recent study by Reimertz et a l (2003), into the gene 
expression profile during ER stress-induced apoptosis in a neuroblastoma cell line model,
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showed that the BH3-only gene bhc/PUMA (encoding for a Bcl-2 pro-apoptotic protein) 
was up-regulated. This gene is thought to be involved in the activation of the 
mitochondrial pathway of apoptosis. Furthermore, cells deficient of this protein were 
significantly resistant to apoptosis by ER stress (Reimertz et a l, 2003).
Downstream of the mitochondrial pathway of apoptosis, thapsigargin-induced ER stress 
caused the activation of the executioner caspases-3 and -7 which ultimately cause the 
breakdown of cellular substrates leading to cell death. The importance of these proteases 
in ER stress-induced apoptosis in the HuH7 cells was highlighted in the present study as 
the pan-caspase inhibitor Z-VAD-fink completely prevented apoptotic cell death by 
thapsigargin. Various reports have also demonstrated caspase activation and in particular 
caspase-3 and -7 in response to ER stress (Chae et ah, 1999; Rao et ah, 2001; Elyaman et 
a l, 2002a; Xie et a l, 2002; Sohn et a l, 2003). Besides, Nutt et a l (2002) and Kitamura 
et al. (2003), showed also protection from ER stress-induced cell death and apoptosis in 
neuronal cells by the pan-caspase inhibitor, Z-VAD-fink.
Recent studies have suggested that caspase-12 participates in ER stress-induced 
apoptosis. Caspase-12 is thought to exist as a pro-form on the cytoplasmic side of ER. 
The activation of this protease may require the cleavage of the pro-form from the ER 
membrane surface by proteases such as calpains (Nakagawa and Yuan, 2000; Nakagawa 
et a l, 2000; Elyaman et a l, 2002a; Xie et a l, 2002; Kitamura et a l, 2003; Sohn et a l, 
2003) or caspase-7 (Rao et a l, 2001). fri addition, although the role of caspase-12 in ER 
stress-induced apoptosis is well established in the mouse model (Nakagawa et a l, 2000; 
Rao et a l, 2001), a recent study reported evidence that the human caspase-12 gene, 
llq22.3, is non-fimctional due to the acquisition of inactivating gene mutations which
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may prelude the expression of a fiill length active caspase protein (Fischer et a l, 2002). 
Therefore, the involvement of caspase-12 in ER stress mediated apoptosis is still 
controversial and it was not investigated in the present study.
A report published by Sohn et ah (2003) mentioned that calpain activation was involved 
in thapsigargin-induced apoptosis by ER stress in the HuH7 cells. However, their only 
experimental evidence to demonstrate calpain activity was the intracellular proteolytic 
cleavage of fodrin (oll-spectrin) by Western blotting. As shown in this chapter, in Figure 
4.13, calpain-mediated fodrin cleavage was also examined by Western blotting. These 
results revealed that the pl45 fragment of a-fodrin by calpain cleavage was constitutively 
present in the HuH7 cells. In addition, here, calpain activity was further investigated 
using a potent selective inhibitor of this protease which caused no significant prevention 
of apoptotic cell death in the HuH7 cells. Additionally, the pharmacological inhibition of 
cathepsin B, serine proteases and the proteosome demonstrated that non-caspase 
proteases were not involved in the mediation of apoptosis by ER stress and therefore 
caspases are the main mediators of ER-stress-induced apoptosis by thapsigargin in these 
hepatoma cells.
Over the years, it has been shown that calcium release from the ER or calcium influx 
through calcium release-activated channels induce apoptosis (Jiang et a l, 1994; Kass and 
Orrenius, 1999; Wertz and Dixit, 2000). This intracellular calcium levels are 
continuously controlled by a combination of actions of calcium binding proteins, calcium 
channels and sequestration to the ER and other intracellular compartments. Recent 
reports have mentioned that thapsigargin-induced ER stress which causes the disruption 
of intracellular calcium homeostasis by the sustained elevation of free calcium in the
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cytoplasm might be involved in the initial pro-apoptotic communication signals for the 
initiation of the apoptotic process which ultimately leads to the activation of caspases and 
cell death by apoptosis (Elyaman et a l, 2002a; Nutt et ah, 2002; Xie et a l, 2002; 
Kitamura et a l, 2003). In this investigation, the use of a calcium chelator, EGTA to 
inhibit the elevation of intracellular cytosolic calcium showed no prevention of the 
apoptotic cell death process by thapsigargin which demonstrated that in HuH7 cells the 
mechanism of apoptosis initiation by ER stress did not require an increase in cytosolic 
calcium concentration and it is therefore initiated only by ER stress signals. This is in 
agreement with other published data (Rao e ta l, 2001; Sohn et a l, 2003).
In recent years, c-jun N-terminal kinase, which is activated by a variety of stress signals 
has been shown to induce apoptotic cell death in liver cells (Bae et a l, 2001; Lin and 
Dibling, 2002; Meisse et a l, 2002; Marderstein et a l, 2003). Chae et a l (1999), showed 
evidence for the involvement of JNK in thapsigargin-induced apoptosis by the detection 
of JNK phosphorylation and activation in thapsigargin-treated osteoblasts. Here, in this 
study, the role of JNK in thapsigargin-mediated apoptosis by ER stress in the HuH7 cells 
was also investigated. Similarly, activation of JNK by phosphorylation was detected in 
HuH7 cells treated with thapsigargin. However, the pharmacological inhibition of JNK 
demonstrated that this stress kinase was not involved in the initiation of apoptosis by ER 
stress as it caused no prevention of cell death by thapsigargin.
GSK-3 has recently shown to be an important pro-apoptotic key intermediate in several 
apoptotic signalling pathways (Crowder and Freeman, 2000; Cross e ta l, 2001; Smith et 
a l, 2001; Elyaman et a l, 2002a; Kang et a l, 2003). In addition, GSK-3 was shown to 
induce apoptosis by paracetamol-induced toxicity in the HuH7 cells (Chapter 3, Fig.
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3.26) (Macanas-Pirard et ah, 2005). Recent research has shown that GSK-3 promotes 
apoptosis-mediated by thapsigargin-induced ER stress in neuronal cells and this response 
was found to be due to the dephosphorylation of phosphor-Ser-9-GSK-3 (Song et a l,
2002). The latter investigation was the first to demonstrate that GSK-3 is activated in 
response to ER stress in neuronal cells. Similarly, in the present study, GSK-3 was 
shown to play a major role in the initiation of apoptosis as this kinase may represent a 
critical intermediate step coupling ER stress signals with the activation of the 
mitochondrial pathway of apoptosis which lead to caspase activation and cell death. 
However, the molecular mechanism of GSK-3 activation by thapsigargin in the HuH7 
cells whether through the inhibition of Akt-mediated phosphorylation or protein 
phosphatase-mediated dephosphorylation of phospho-Ser-9-GSK-3 remains to be fully 
investigated together with the link between GSK-3 activation and the activation of the 
mitochondrial pathway of apoptosis.
In summary, thapsigargin-induced ER stress caused the activation of the mitochondrial 
pathway of apoptosis through Bax-mediated release of pro-apoptotic factors such as 
cytochrome c and Smac/DIABLO which lead to the downstream caspase activation and 
cell death by apoptosis of the HuH7 cells. Interestingly, GSK-3 was found as an 
important regulator of the apoptotic process in response to ER stress and this kinase 
enzyme represents a potential link between thapsigargin-induced ER stress and the 
mitochondrial apoptosis pathway. This data provide a new insight into the mechanisms 
of ER-stress mediated liver cell death by apoptosis and it would be important to verify 
whether this signalling apoptotic process occurs in vivo in response to ER stress.
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CHAPTER 5
OXIDATIVE STRESS MEDIATED BY DUROQUINONE 
INDUCES APOPTOSIS IN LIVER CELLS
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5.1 Introduction
Among the most established inducers of oxidative stress are redox cycling quinones 
(Hampton et a l, 1998). Reactive oxygen species (ROS) include free radicals such as the 
superoxide anion, hydroxyl radicals COH) and the nonradical hydrogen peroxide (H2 O2). 
These are particularly transient species due to their high chemical reactivity which makes 
them capable of reacting with many cellular components such as DNA, lipids, 
carbohydrates and proteins in a very destructive manner which leads to cell death by 
either apoptosis or necrosis (Montagna and Wilson, 1955; Lennon et a l, 1991; Kass et 
a l, 1992a; Sies, 1993; Zhivotovsky e/ûr/., 1993; Halliwell, 1994; Slater a/., 1995; Ueda 
e ta l, 2002; Chiou e ta l, 2003; Higuchi, 2003; Wang e ta l, 2003), The major sources of 
ROS production include the endoplasmic reticulum, mitochondria, plasma membrane and 
cytosol (Curtin et a l, 2002).
Initially, it was believed that necrosis was the characteristic endpoint of oxidative stress; 
however, the first studies reversing these findings were undertaken by Lennon et a l 
(1991) who demonstrated that such a disturbance in cell homeostasis can also induce 
apoptotic cell death and various antioxidants such as N-acetylcysteine (NAC) can inhibit 
cell death by apoptosis (Lennon et a l, 1991; Slater et a l, 1995; McGowan et a l, 1996). 
Additionally, ROS generation has been reported to occur in TNF- and Fas-mediated 
apoptosis (Suzuki et a l, 1998; Curtin et a l, 2002) as well as following treatment of cells 
with various agents including ultraviolet irradiation and chemotherapeutic drugs 
(Zamzami et a l, 1995; Gorman et a l, 1997)
Quinones exist both naturally and as environmental toxins and also as therapeutic drugs 
that in cells can undergo one- and/or two-electron reduction to form a variety of harmless
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and harmful by-products. Reactive quinones produce a variety of reactive oxygen 
species (ROS) as a by-product of the reduction to hydroquinones. In addition, the 
cellular redox levels are controlled by the thioredoxin and glutathione systems 
(Holmgren, 1989; Ueda et a l, 2002). In fact, quinone metabolism in hepatocytes has 
been shown to lead to the oxidation and depletion of glutathione (GSH) (which will lower 
the cell’s capacity to buffer against endogenous oxidants) which was accompanied by 
oxidised glutathione (GSSG) formation (Di Monte et a l, 1984a; Di Monte et a l, 1984b; 
Gant et a l, 1988; Kass et a l, 1989; Slater et a l, 1995; Hentze et a l, 2003; Seanor et a l, 
2003). There are four main enzymes including superoxide dismutase (SOD), glutathione 
peroxidase (Gpx), catalase and thioredoxin reductase that function primarily to prevent 
oxidative damage directly by intercepting ROS before they can damage intracellular 
targets. These enzymes destroy the free radical superoxide by converting it to hydrogen 
peroxide. Hydrogen peroxide is one of the major ROS in the cell. The primary defence 
mechanisms against hydrogen peroxide is catalase, one of the most efficient enzymes 
known and can not be saturated by hydrogen peroxide at any concentration. Catalase 
reacts with hydrogen peroxide to fomi water and molecular oxygen (Reed, 1990; Curtin 
e ta l, 2002).
ROS production by quinones has been shown to trigger apoptosis in hepatocytes, colon
adenocarcinoma cells, endothelial cells, lymphocytes, glial cells and RIMm5F insulinoma
cells (Dypbukt et a l, 1994; Sun and Ross, 1996; Hollensworth et a l, 2000; Warren et a l,
2000; Laux and Nel, 2001; Chiou et a l, 2003). Likewise, the direct addition of the
oxidant hydrogen proxide to a range of cells such as hepatocytes, endothelial cells, renal
epithelial cells, oligodendrocytes and cells of haematological origin causes cell death by
apoptosis (Gramzinski et a l, 1990; Lennon et a l, 1991; Ueda and Shah, 1992; De Bono
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and Yang, 1995; Marini et a l, 1996; Gardner et a l, 1997; Hampton and Orrenius, 1997; 
Bhat and Zhang, 1999; Tamura e ta l, 2003).
Duroquinone (2,3,5,6-tetramethyl-p-benzoquinone) is an effective redox cycler shown 
before to cause DNA damage in vitro (Kappus, 1986; Solveig Walles, 1992; Higuchi,
2003) (Fig. 5.1). Duroquinone is known to undergo autoxidation in which process 
oxygen is consumed and a semiquinone radical is formed by a one-step electron reaction 
catalysed by the NADPH-cytochrome P4 50 reductase (lyanagi, 1970). The semiquinone 
radical can then react with another oxygen molecule to form the corresponding quinone. 
However, this process leads to superoxide anion radicals and hydroxyl radicals formed 
which are subsequently converted to hydrogen peroxide (H2O2). Hydrogen peroxide can 
also be oxidised to harmful hydroxyl radicals in the presence of metal ions via the Fenton 
reaction (Fe^* + H2O2 ->■ + OH + OH) (Curtin et a l, 2002). Therefore,
duroquinone causes cytotoxic effects which are mediated through oxidative stress.
C H 3  n A D P H :  q u i n o n e  
r e d u c t a s e
O H
S e m i q u i n o n e  r a d i c a lD u r o q u i n o n e
Figure 5.1. Chemical structure of duroquinone and the semiquinone radical.
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Oxygen radicals have shown to cause disruption of calcium homeostasis in hepatocytes 
and lead to oxidation of DNA (Jewell et a l, 1982; Solveig Walles, 1992). Oxidative 
stress can also result in lipid peroxidation which is a free-radical-mediated reaction that 
requires oxygen for initiation and propagation. The lipid peroxides formed can 
decomponse in the presence of transition metals such as iron to give lipid free radicals 
(alkoxy radicals) which impair membrane fluidity and fimction leading to severe cellular 
damage and apoptosis or necrosis (Chiou et a l, 2003).
Intracellular ROS can influence important cellular processes such as proliferation, 
development and apoptosis (Seanor et a l, 2003). However the extent of oxidative stress 
may determine the ultimate mode of cell death either apoptosis or necrosis or even a 
combination of both (Samali et a l, 1999; Wang et a l, 2003). Reports have shown that 
oxidative stress has the capacity to trigger either of these responses to induce cell death. 
It seems that high levels or prolonged exposure times to oxidative stress predominantly 
leads to necrosis whereas low levels or relatively low exposure to oxidative stress favours 
the induction of apoptosis over necrosis (Slater et a l, 1995; Gardner et a l, 1997; 
Hampton and Orrenius, 1997; Ueda e ta l, 2002).
Previous work by Samali et a l (1999) showed that the quinone, menadione caused cell 
death by necrosis in the hepatoma cell line, HepG2. Menadione inhibited caspase 
activity by the generation of hydrogen peroxide through redox cycling and the caspase 
inactivation by this mechanism prevented the development of apoptosis. Thus in this 
chapter, the mechanism of cell death by duroquinone-induced oxidative stress was 
investigated in the human hepatoma cell line, HuH7, as a model for hepatic injury. In
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addition, for the preliminary studies, the induction of apoptosis by duroquinone was also 
investigated in primary mouse hepatocytes.
5.2 Duroquinone-induced Cytotoxicity in Liver Ceiis
Preliminary studies were performed to confirm that duroquinone caused cell death in 
hepatoma HuH7 cells and primary mouse hepatocytes. Cells were incubated with various 
concentrations of duroquinone including 0.05, 0.1, 0.5, 1 and 2mM and cell viability was 
assessed by the MTT cell cytotoxicity assay.
The MTT data showed a steady dose-dependent decrease in cell viability with increasing 
concentration of duroquinone in both HuH7 and primary hepatocytes (Fig. 5.2). For 
example, cell death was observed with the 0.5mM drug concentration that caused 66% 
cytotoxicity in HuH7 cells and 44% cytotoxicity in the primary mouse hepatocytes. The 
HuH7 cells appeared more sensitive to duroquinone-induced toxicity than mouse 
hepatocytes. From this initial study, the concentration of 0.5mM duroquinone was 
chosen for all further experiments into the mechanisms of duroquinone-induced cell 
death. Further examination of the HuH7 cell morphology by contrast microscopy 
revealed healthy confluent untreated control cells (Fig. 5.3a) whereas HuH7 cells 
exposed to 0.5mM duroquinone for 24 hours showed an unhealthy monolayer with 
considerable floating dead cells and other cells still attached to the flask were unhealthy 
with common condensed bright morphology (Fig. 5.3b).
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Figure 5.2. Dose ranging studies of duroquinone-induced toxicity in HuH7 cells.
HuH7 cells (red) and primary mouse hepatocytes (blue) were incubated in the presence 
o f 0.05, 0.1, 0.5, 1 and 2mM duroquinone. Cell viability was measured at 24 hours by 
the MTT reduction assay as described under Materials and Methods. MTT results are 
expressed as % cell viability o f control. Each point is the mean o f two independent 
experiments.
Figure 5.3. Morphological changes of HuH7 cells at 24 hours post-treatment.
HuH7 cells were incubated in the absence (DMSO only) (a) or presence o f duroquinone 
(0.5mM) for 24 hours (b). The cell morphology was analysed by light microscopy as 
described under Materials and Methods, (a) control cells appeared healthy and 
confluent whereas (b) treated cells were unhealthy and most cells were detached and 
showed condensed morphology. Mag. X200.
- 176
5.3 Duroquinone-induced Apoptosis in Liver Cells
The preliminary data demonstrated that duroquinone-induced oxidative stress caused cell 
death in the hepatoma cells and the primary mouse hepatocytes, and therefore, it was 
essential as a next step to investigate whether duroquinone-mediated toxicity occurred via 
the induction of apoptotic or necrotic cell death. First of all, the HuH7 cells and primary 
hepatocytes were fixed and stained with Hoechst 33258 and the nuclear morphology 
analysed by fluorescence microscopy.
The control cultures of both primary and HuH7 cells showed homogenous blue stained 
nuclei representing healthy liver cells respectively (Fig. 5.4a and c). However, the 
primary hepatocytes and HuH7 cells exposed to duroquinone (0.5mM) for 24 hours 
showed some characteristically stained apoptotic nuclei (as shown by white arrows) 
which appeared small and bright blue due to nuclear shrinkage and chromatin 
condensation which are very common apoptotic features (Kerr et a l, 1972) (Fig. 5.4b and 
d). HuH7 cells were further analysed for the detection of DNA degradation which is a 
typical marker for apoptosis and it also represents an irreversible step of the cell death 
process (Nagata, 2000; Lockshin and Zakeri, 2001). Cells were exposed to duroquinone 
for 24 hours, then fixed and stained with PI before samples were analysed for DNA 
content by flow cytometry. As shown by the histograms (Fig. 5.5a and b), duroquinone 
treatment caused an increase in cells with <2N DNA that were grouped in the sub-Gl 
area (Ap) of the histogram. Analysis of the complete study showed that treatment of 
HuH7 cells with duroquinone for 24 hours caused significant DNA fi-agmentation (Fig. 
5.5c). These data supported that duroquinone induced apoptosis in the HuH7 cells.
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Figure 5.4. Examination of the nuclear morphology of HuH7 cells and primary 
mouse hepatocytes exposed to duroquinone for 24 hours.
HuH7 cells (c & d) and primary hepatocytes (a & b) were incubated in the absence 
(DMSO only) (a & c) or presence o f duroquinone (0.5mM) fo r 24 hours (b & d). Cells 
were fixed and stained with Hoechst 33258 dye before visualization by fluorescence 
microscopy as described under Materials and Methods. White arrows show apoptotic 
cells that appear small and bright compared to control cells (a & c) due to nuclear 
shrinkage and chromatin condensation during apoptosis. Mag. X400.
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Figure 5.5. DNA fragmentation by duroquinone-induced apoptosis in HuH7 cells.
At specific time points o f duroquinone (0.5mM) treatment, cell samples were fixed, 
stained with PI and analysed for DNA content by flow cytometry as described under 
Materials and Methods, (a & b) Represent DNA histograms o f two samples. Cells were 
incubated in the absence (DMSO only) (a) or presence o f duroquinone fo r 24 hours (b). 
Red fluorescence (PI/DNA) was recorded after gating to exclude any clumped cells. The 
positions o f the apoptotic cells (Ap) and the different cell cycle phases (Gl, S, G2/M) are 
marked, (c) Summary o f flow cytometry data. HuH7 cells were incubated in the absence 
(black) or presence o f duroquinone (red) fo r specific times points as shown in the graph. 
Each time point is the mean ±SEM o f at least three independent experiments. Statistical 
analyses were performed using Bonferroni (all means) one-way ANOVA post hoc test. 
** Significantly different from control, P< 0.01.
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5.4 The Role of Caspases in Duroquinone-induced Apoptosis
5.4.1 Activation of caspases-3 and -7 during apoptosis
Processing and activation of the executioner caspases-3 and -7 has shown to be essential 
for the dismantling of the cellular architecture to cause death by apoptosis (Cohen, 1997; 
Salvesen and Dixit, 1997; Villa et a l, 1997). Here, the activation of these downstream 
effector caspases by the effect of duroquinone treatment in the HuH7 cells was first 
investigated by Western blotting using specific polyclonal antibodies.
The catalytically small active fragment of caspase-3, pl7 was detected in the 
duroquinone-treated sample whereas the control DMSO sample (vehicle control) showed 
no pi 7 band (Fig. 5.6a). As mentioned in earlier chapters, the p29 fragment of caspase-3 
was found constitutively present in these cells.
Analysis of the caspase-7 blot showed clearly the detection of the p 19 active fragment of 
this protease in duroquinone-treated sample whereas this band was not observed in the 
control lane (Fig. 5.6b). These data demonstrate that both caspase-3 and -7 were 
activated by duroquinone-induced oxidative stress.
The activation of caspase-3 was further analysed by flow cytometry investigation using a 
monoclonal PE-conjugated caspase-3 antibody directed to detect only the active caspase- 
3 fragments. As shown in Figure 5.7, the time-course study of caspase-3 activation 
showed at the 24 hour treatment with duroquinone significant caspase-3 activation 
compared to control cells. Therefore, this investigation further confirmed that caspase-3 
is processed and activated in HuH7 cells when exposed to duroquinone for 24 hours.
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Figure 5.6. Activation of caspase-3 and -7 by duroquinone-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) or presence o f duroquinone 
(0.5mM) for 24 hours. Cell samples were subjected to SDS-PAGE followed by 
immunoblotting with an antibody directed against caspase-3 (a) or caspase-7 (b) as 
directed under Materials and Methods. The blots (a) and (b) are representative o f three 
independent experiments. Fifty pg o f protein was loaded in each lane.
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Figure 5.7. Cleavage of caspase-3 by duroquinone-induced apoptosis.
At specific time points o f duroquinone (0.5mM) treatment, HuH7 cell samples were 
immunostained with a PE-conjugated active caspase-3 antibody and samples were 
analysed by flow cytometry as described under Materials and Methods. HuH7 cells 
were incubated in the absence (DMSO only) (red) or presence o f duroquinone (0.5mM) 
(blue). Each time point is the mean ±SEM o f at least three independent experiments. 
Statistical analyses were performed using Bonferroni (all means) one-way ANOVA post 
hoc test. * Significantly different from control (red) P< 0.05.
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5.4.2 Cleavage of caspase-3 substrates in apoptosis
This investigation focused on the detection of fodrin and cytokeratin 18 cleavage which 
is known to occur by caspase-3 during apoptosis. The proteolytic cleavage of fodrin was 
investigated by Western blotting using a monoclonal antibody directed against fodrin 
(oll-spectrin). Fodrin cleavage by caspase-3 causes the formation of a pl20 fragment 
which is known to be caspase-3 specific (Martin et a l, 1995). Duroquinone-treated cells 
showed a pl20 fragment corresponding to the caspase-mediated fodrin cleaved product 
whereas this band was not observed in the control sample (DMSO vehicle control) (Fig. 
5.8).
Cleavage of the cytoskeletal protein, cytokeratin 18, was analysed by flow cytometry 
using a monoclonal antibody directed against the immunoreactive neoepitopes formed as 
a result of cytokeratin 18 cleavage. The time-course study of cytokeratin 18 cleavage 
revealed significant cleavage of this protein by duroquinone treatment of HuH7 cells for 
24 hours compared to the untreated (control) cells (Fig. 5.9). Furthermore, the pre­
incubation of cells with the general caspase inhibitor, Z-VAD-fink showed a significant 
prevention of cytokeratin 18 cleavage by caspase-3 (Fig. 5.9).
These results further demonstrated that caspase-3 activation occurred in this hepatoma 
cells treated with duroquinone. In addition, caspases-3 triggered the proteolytic cleavage 
of cellular substrates fodrin and cytokeratin 18 to cause cell death by apoptosis. 
Cleavage of the latter was significantly prevented by the caspase inhibitor, Z-VAD-fink.
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Figure 5.8. Analysis of Fodrin cleavage following dnroqninone-indnced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) or presence o f duroquinone 
(Duro) (0.5mM) fo r 24 hours. Cells were lysed and subjected to SDS-PAGE followed by 
immunoblotting with anti-fodrin (cdl-spectrin) monoclonal antibody as described under 
Materials and Methods and showed fodrin cleavage by caspase-3 with the appearance o f 
the 120kDa band. The blot is representative o f three independent experiments. Fifty pg  
o f protein was loaded in lane.
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Figure 5.9. Analysis of cytokeratin 18 cleavage following dnroqninone-indnced 
apoptosis.
Cells were incubated in the absence (DMSO only) (orange) or presence o f duroquinone 
(0.5mM) (blue) after pre-treatment with Z-VAD-fmk (lOOpM) (green) fo r the times 
indicated. Samples were fixed and immunostained with an antibody directed against the 
caspase-3 cleaved fragment o f cytokeratin 18 and then analysed by flow cytometry as 
described under Materials and Methods. Each time point is the mean ±SEM o f at least 
three independent experiments. Statistical analyses were performed using Bonferroni 
(all means) one-way ANOVA post hoc test. *** Significantly different from control, P< 
0.001. ^  Significantly different from duroquinone treatment (blue), P<0.01.
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5.4.3 Caspase inhibition in apoptosis-induced by duroquinone
Due to the importance of caspases in mediating apoptotic cell death, and as shown 
previously duroquinone-treated cells caused the activation of caspases-3 and -7, the role 
of caspases in oxidative stress-mediated apoptosis by duroquinone was further 
investigated using specific peptide inhibitors that are directed against their substrate 
cleavage site. The cells were pre-treated with two caspase inhibitors, Z-VAD-fmk or Ac- 
DEVD-cho for 30 minutes prior to addition of duroquinone (O.SmM). Cell viability was 
measured at the specific time points by the LDH toxicity assay.
The data showed that both caspase inhibitors failed to protect fi’om cell death by 
apoptosis caused by the oxidative stress damage mediated by duroquinone at 8,24 and 30 
hours of treatment (Fig. 5.10 and 5.11). The data demonstrated that caspases did not alter 
oxidative stress-mediated cell death by duroquinone in the HuH7 cells. Therefore, the 
cell death process-induced by duroquinone seems to occur by a caspase-independent 
mechanism and also necrosis in the HuH7 cells.
5.4.4 Inhibition of non-caspase proteases in apoptosis
Here, the role of non-caspase proteases in duroquinone-mediated cell death was 
investigated in the HuH7 cells. Cells were pre-treated with calpain inhibitor (ALLN) 
(IpM) and serine protease inhibitor, TPCK (lOpM) for 30 minutes prior to the treatment 
with duroquinone (0.5mM). Cytotoxicity was measured by the LDH toxicity assay. 
Calpain inhibition failed to prevent duroquinone-induced cell death whereas TPCK 
caused significant, albeit incomplete protection fi’om apoptosis at the 30 hour treatment 
with duroquinone (Fig. 5.12). The data demonstrated that serine proteases played a role 
in the apoptotic cell death pathway triggered by duroquinone. However, in addition to
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the TPCK significant inhibition of cell death, HuH7 cells showed still considerable cell 
death (68% cytotoxicity) by duroquinone compared to control cultures (DMSO control) 
which suggests that other non-caspase proteases were involved in modulating the 
apoptotic process by duroquinone and/or the cell death process occurred mainly by 
necrosis. HuH7 cells were also exposed to the proteosome inhibitor (MG-132) (IpM) 
however, it failed to prevent apoptosis in the HuH7 cells and as mentioned in earlier 
chapters, this inhibitor caused major toxicity to the hepatoma cells (data not shown).
5.5 Activation of the Mitochondriai Pathway of Apoptosis
5.5.1 Transiocation of mitochondrial cytochrome c and Smac
To verify whether the mitochondrial pathway of apoptosis was involved in duroquinone- 
induced cell death by oxidative stress, the first study focused on the detection of 
cytochrome c and Smac/DIABLO release from the mitochondria to the cytosol to induce 
cell death by apoptosis at the 24 hour duroquinone treatment. First of all, cytochrome c 
translocation to the cytosol after duroquinone exposure was investigated by 
immunocytochemistry using a monoclonal antibody directed against cytochrome c and 
counterstained with Hoechst 33528. As shown in Figure 5.13a, healthy HuH7 cells 
showed a characteristic and distinctive punctuate green staining of cytochrome c in the 
mitochondria (shown by the red arrow) and the counterstain appeared a homogenous blue 
stained nucleus of viable cells. However, apoptotic cells as shown by the brightly blue 
stained nuclei showed a homogenous green stain for cytochrome c due to its release from 
the mitochondria and its spread throughout the cytoplasm (white arrows) (Fig. 5.13a).
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The release of cytochrome c together with the translocation of the pro-apoptotic protein 
Smac was further investigated by Western blotting using specific antibodies against both 
pro-apoptotic proteins. Analysis of the results showed for the control sample (solvent 
control) a strong main band in the pellet fraction (mitochondrial proteins) whereas in the 
supernatant fraction (cytosolic proteins) only a very weak band for cytochrome c was 
observed. In contrast, the duroquinone-treated sample for 24 hours showed bands for 
cytochrome c and Smac in the pellet fraction (mitochondrial proteins) however strong 
bands were also detected in the supernatant fraction for both pro-apoptotic proteins (Fig. 
5.13b). Paracetamol (10mM)-treated HuH7 cells were used as a positive control.
Thus, these data together with the immunocytochemistry results confirmed that 
cytochrome c is released from the mitochondria to the cytosol after the exposure to 
duroquinone to cause cell death by apoptosis. In addition, together with cytochrome c, 
the data showed that pro-apoptotic Smac is also released to the cytosol to promote 
apoptosis. The cellular protein, Hsc70 was also detected as a loading control.
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Figure 5.10. 
cells.
Effect of Z-VAD-fmk on duroquinone-induced apoptosis in HuH7
HuH7 cells were incubated in the absence (DMSO only) (light blue) or presence o f 
duroquinone (O.SmM) (blue) after pre-treatment with Z-VAD-fmk (100pM) (green). 
Cytotoxicity was assessed by the LDH toxicity assay as described under Materials and 
Methods. Each time point is the mean ±SEM o f three independent experiments.
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Figure 5.11. Effect of Ac-DEVD-cho on duroquinone-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) (light blue) or presence o f 
duroquinone (O.SmM) (blue) after pre-treatment with Ac-DEVD (lOOpM) (yellow). 
Cytotoxicity was assessed by the LDH toxicity assay as described under Materials and 
Methods. Each time point is the mean ±SEM o f three independent experiments.
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Figure 5.12. Effect of calpain inhibition and TPCK on duroquinone-induced 
apoptosis.
HuH7 cells were incubated in the absence (DMSO only) (light blue) or presence o f 
duroquinone (O.SmM) (blue) after pre-treatment with calpain inhibitor (ALLN) (IpM) 
(orange) or TPCK (lOpM) (green). Cytotoxicity was assessed by the LDH toxicity assay 
as described under Materials and Methods. Each time point is the mean ±SEM o f at 
least three independent experiments. Statistical analyses were performed using 
Bonferroni (all means) one-way ANOVA post hoc test. * Significantly different from  
duroquinone treatment (blue), P< 0. OS.
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Figure 5.13. Translocation of cytochrome c and Smac from mitochondria to the 
cytosol in duroquinone-induced apoptosis.
HuH7 cells were incubated in the absence (DMSO only) or presence o f duroquinone 
(O.SmM) or paracetamol (lOmM) for 24 hours, (a) Cells were fixed stained with a 
monoclonal cytochrome c antibody and counter stained with Hoechst nuclear dye and 
analysed by fluorescence microscopy as described under Materials and Methods. 
Apoptotic cells are shown by white arrows. Mag. X400. (b) Cell samples were subjected 
to SDS-PAGE followed by immunoblotting with a monoclonal antibody against 
cytochrome c or Smac as mentioned in the Methods section. The blot is representative o f 
three independent experiments. Fifty pg o f protein was loaded in each lane. Super, 
supernatant fraction containing cytosolic proteins and pellet, pellet fraction which 
contains membrane-bound proteins. Anti-Hsc70 was used as a loading control.
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5.5.3 Opening of the mitochondrial permeability transition pore
The role of the mitochondrial PTP in apoptosis-induced by duroquinone was investigated 
in the HuH7 cells by using two potent inhibitors of this mitochondrial megachannel 
(Chernyak et a l, 1995). Cells were pre-treated with cyclosporine A (IpM) and 
bongkrerkic acid (50pM) for 30 minutes before treatment with duroquinone (0.5mM) for 
8, 24 and 30 hours. Cell viability was measured by the LDH assay. Inhibition of the 
mitochondrial PTP by both cyclosporine A and bongkrekic acid failed to protect and 
prevent HuH7 cells from apoptosis-induced by oxidative stress (Fig. 5.14 and 5.15). This 
finding suggested that opening of the mitochondrial PTP was not primarily involved in 
the cell death process initiated by duroquinone and therefore the pro-apoptotic 
mitochondrial factors had to be released via an alternative route.
5.6 Translocation of Pro-apoptotic Bax to the Mitochondria
The pro-apoptotic Bcl-2 family protein, Bax is known to translocate fi’om the cytosol to 
the mitochondria to induce cytochrome c release and apoptosis (Kuwana et ah, 2002; 
Scorrano and Korsmeyer, 2003). The role of Bax in apoptosis mediated by duroquinone- 
induced oxidative stress in the HuH7 cells was investigated by Western blotting with a 
monoclonal antibody directed against Bax. The control sample showed a band 
corresponding to Bax in the supernatant fi'action (cytosolic proteins) and also a band was 
observed in the pellet fi’action, most likely due to some loosely attached Bax to the 
membranes (Fig. 5.16). However, duroquinone-treated sample showed a strong band 
corresponding to Bax in the pellet but not the supernatant fraction which suggests that the 
exposure to duroquinone caused Bax migration to the mitochondria to induce cytochrome 
c release and cell death by apoptosis (Fig. 5.16). Both COX and Hsc70 were used as 
loading controls for the Western Blots.
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Figure 5.14. Inhibition of the mitochondrial PTP by cyclosporine A.
HuH7 cells were incubated in the absence (DMSO control) (light blue) or presence o f 
duroquinone (0.5mM) (blue) after pre-treatment with cyclosporine A (CSP) (IpM) (pink). 
Cytotoxicity was assessed by the LDH toxicity assay as described under Materials and 
Methods. Each time point is the mean ±SEM o f three independent experiments.
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Figure 5.15. Inhibition of the mitochondrial PTP by bongkrekic acid.
HuH7 cells were incubated in the absence (DMSO control) (light blue) or presence o f 
duroquinone (O.SmM) (blue) after pre-treatment with bongkrekic acid (BA) (SOpM) 
(purple). Cytotoxicity was assessed by the LDH toxicity assay as described under 
Materials and Methods. Each time point is the mean ±SEM o f three independent 
experiments.
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Figure 5.16. Transiocation of Bax to the mitochondria by duroquinone-induced 
apoptosis.
HuH7 cells were incubated in the absence (DMSO control) or presence o f duroquinone 
(O.SmM) for 24 hours. Cell samples were subjected to SDS-PAGE followed by 
immunoblotting with a monoclonal antibody against Bax as described under Materials 
and Methods. The blot is representative o f three independent experiments. Fifty pg o f 
protein was loaded in each lane. Super, supernatant fraction which contained cytosolic 
proteins and pellet, pellet fraction which contained membrane-bound proteins. The 
membrane was re-probed with anti-Hsc70 and COX as loading controls.
5.7 The Role of Enzyme Kinases in cell death by duroquinone
5.7.1 Effect of J N K activation
In this study, the phosphorylation and activation of the stress kinase enzyme, INK was 
investigated in the HuH7 cells treated with duroquinone (O.SmM) for 24 hours, as a 
possible mediator of the cell death process-induced by oxidative stress.
First, the activation of INK was analysed by Western blotting with the INK and phospho- 
JNK monoclonal antibodies. The phospho-JNK antibody only detects INK when 
activated by phosphorylation at Thrl83/Tyrl85.
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The constitutively expression of JNK in the HuH7 cells was confirmed as the bands 
corresponding to JNK were strongly detected in all the samples including the control 
(vehicle control), duroquinone-treated cells and the positive control sample (293 cell 
extracts treated with UV (40J/m^) purchased fi'om Cell Signalling Technology) (Fig. 
5.17). Both bands for phosphorylated and activated JNK were observed for duroquinone 
treated cells whereas no phospho-JNK bands were detected in the control sample. This 
result was supported by the positive control sample in which strong bands for active 
phosphorylated JNK were also detected (Fig. 5.17).
To verify whether activated JNK played a role in duroquinone-induced cell death by 
oxidative stress, the cells were pre-treated with a specific JNK inhibitor (30pM) for 30 
minutes before normal treatment with duroquine and cell viability was assessed at 
specific time-points including 8, 24 and 30 hours by the LHD cytotoxicity assay.
The data showed that the JNK inhibitor caused no protection fi’om cell death-induced by 
duroquinone treatment (Fig. 5.18). Thus, this investigation demonstrated that JNK is 
activated in the HuH7 cells in response to the oxidative stress damage caused by 
duroquinone however JNK plays no important role in the cell death process-induced by 
duroquinone.
5.7.2 Signalling of GSK-3 in apoptosis-induced by duroquinone
The role of GSK-3 signalling also as a possible mediator between oxidative stress-
mediated cell death by duroquinone and the induction apoptosis was investigated. The
hepatoma cells were pre-treated with several selective GSK-3 inhibitors such as LiCl
(20mM), SB216763 (25pM) and SB415286 (3pM) prior to duroquinone treatment of
HuH7 cells. Cell viability was assessed by LDH leakage at 8, 24 and 30 hours of
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treatment. As shown in Figure 5.19, all three JNK inhibitors failed to protect from 
duroquinone-induced cell death. Therefore, GSK-3 pro-apoptotic signalling was not 
involved in the cell death process caused by duroquinone-induced toxicity by oxidative 
stress in the HuH7 cells.
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Figure 5.17. Phosphorylation of JNK by duroquinone-induced oxidative stress.
HuH7 cells were incubated in the absence (DMSO control) or presence o f duroquinone 
(Duro) (O.SmM) for 24 hours. Cell samples were subjected to SDS-PAGE followed by 
immunoblotting with a monoclonal antibody against JNK and phospho-JNK as described 
under Materials and Methods. The blot is representative o f three independent 
experiments. Eighty pg o f protein was loaded in each lane. Positive control is 293 cell 
extracts treated with UV (40J/m^) purchased from Cell Signalling Technology.
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Figure 5.18. Effect of JNK inhibition in apoptosis induced by duroquinone.
HuH7 cells were incubated in the absence (DMSO control) (light blue), JNK inhibitor 
(30pM) (green) or presence o f duroquinone (O.SmM) (blue) after pre-treatment with JNK 
inhibitor (30pM) (red). Cytotoxicity was assessed by the LDH toxicity assay as 
described under Materials and Methods. Each time point is the mean ±SEM o f three 
independent experiments.
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Figure 5.19. Inhibition of GSK-3 by LiCl, SB216763 and SB415286 in duroquinone- 
induced apoptosis.
HuH7 cells were incubated in the absence (DMSO control) (light blue) or presence o f 
duroquinone (O.SmM) (blue) after pre-treatment with LiCl (20mM) (red), SB216763 
(2SpM) (grey) or SB41S2S6 (3pM) (yellow). Cytotoxicity was assessed by the LDH 
toxicity assay as described under Materials and Methods. Each time point is the mean 
±SEM o f three independent experiments.
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5.8 Discussion
Research has demonstrated that cells have potent antioxidant systems to protect 
themselves from dangerous ROS. Although at first it was considered that ROS only 
induced cellular damage, over the years evidence has shown that ROS-induced cellular 
oxidative stress evokes many different intracellular events which inevitably lead to gene 
activation, proliferation, cell cycle arrest and cell death by apoptosis (Nakamura et a l, 
1997; Masutani et a l, 2000; Ueda et a l, 2002). However, at present the complete 
molecular mechanism ofhepatocyte apoptosis in the induction of oxidative stress remains 
unknown. Thus, the purpose of the present study was to elucidate the intracellular signal 
transduction system involved in oxidative stress-induced cell death in liver cells by the 
exposure to the redox cycler, duroquinone.
In the present investigation, the data demonstrated that oxidative stress-induced by 
duroquinone caused induction of apoptotic cell death both in the hepatoma cell line, 
HuH7 and primary mouse hepatocytes. This was confirmed by the observation of 
chromatin condensation and DNA fragmentation which are typical features of apoptosis 
(Kerr et a l, 1974; Kerr et a l, 1987). However, due to the high levels of cell death 
observed in the HuH7 cells after 24 hours exposure to duroquinone (Fig. 5.2), it was 
evident that some cells died by necrosis.
Oxidative stress-induced apoptosis in the HuH7 cells exposed to duroquinone for 24 
hours occurred via the mitochondrial pathway. This was first demonstrated by the 
findings that the pro-apoptotic proteins, cytochrome c and Smac were released from the 
mitochondria to the cytosol to induce apoptosis following exposure to duroquinone. 
Other reports have also demonstrated that cytochrome c is released into the cytosol
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caused by the exposure to oxidative stress in kidney and liver cells (Ueda et a l, 1998; 
Samali et a l, 1999; Ueda et a l, 2002). However, it has been shown that cytochrome c is 
released into the cytosol after cells are exposed to oxidative stress regardless of whether it 
induces apoptosis or necrosis (Ueda e ta l, 1998; Samali e ta l, 1999) (Fig. 5.19).
ROS have demonstrated for many years to cause mitochondrial damage, particularly 
through the activation of the mitochondrial permeability transition pathway which 
involves the opening of the mitochondrial PTP to cause cell death (Kass et a l, 1992b; 
Lemasters et a l, 1997; Ueda et a l, 2002). A report has shown that duroquinone is an 
inducer of the mitochondrial PTP in isolated rat liver mitochondria which is thought to 
allow the release of cytochrome c to induce apoptosis (Chernyak et a l, 1995; Chauvin et 
a l, 2001). However, the mitochondrial PTP played no role in apoptosis by the oxidative 
stress-induced by duroquinone in the HuH7 cells. An additional mechanism for the 
release of cytochrome c during apoptosis is the translocation of the pro-apoptotic protein, 
Bax from cytosol to the mitochondria where it is thought to form a mitochondrial pore 
(Epand et a l, 2002; Kuwana et a l, 2002; Nutt et a l, 2002; Scorrano and Korsmeyer, 
2003). fri this investigation, Bax was shown to translocate to the mitochondria to induce 
apoptosis after the exposure to duroquinone. Similarly, Tamura et al. (2003) 
demonstrated that the induction of oxidative stress caused Bax translocation to the 
mitochondria which was shown to occur before caspase activation and the onset of 
apoptosis in liver cells.
Caspases have shown to play a pivotal role in the process of apoptosis. Various groups 
have independently reported that oxidative stress induced cellular damage causes 
apoptosis by the activation of caspases and in particular the activation of the protease
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executioner caspase-3 both in vivo and in vitro (Hampton and Orrenius, 1997; Ueda et 
a l, 1998; Sun et a l, 2003; Tamura et a l, 2003). ROS-dependent activation of caspase-9 
via cytochrome c release from the mitochondria leads to the subsequent activation of 
caspase-3 (Tamura et a l, 2003). The HuH7 cells exposed to duroquinone also resulted in 
the activation of the executioner caspase-3 and also caspase-7. Caspase activation was 
confirmed in this study by the finding that two major cellular substrates of caspase-3, 
fodrin and cytokeratin 18 were cleaved as a result of caspase-3 activation by the oxidative 
stress caused by duroquinone. So far, it seems that ROS-induced cellular oxidative stress 
can cause apoptosis with caspase activation, however, it has been shown that prolonged 
or excessively generated oxidative stress can decrease and/or inhibit caspase activity in 
vitro (Slater et a l, 1995; Hirsch et a l, 1997; Ueda et a l, 1998; Ueda et a l, 2002) 
(Fig.5.19). Caspases contain an active site, cysteine nucleophile which is sensitive to 
inhibition through covalent and oxidative modification of one or more critical residues 
which can be converted to disulfides and mixed disulfides. As a result, it is therefore not 
surprising that the activity of caspases is optimal under a reducing environment otherwise 
caspases become inactive. Disulphides such as disulfiram and GSSG can readily 
inactivate caspases in vitro (Nobel et a l, 1997). The inhibition of caspase activity in 
cells that would otherwise undergo apoptosis has recently been shown to drive cells into 
necrosis (Ueda e ta l, 1998; Samali e ta l, 1999; Kaplowitz, 2000; Ueda e ta l, 2002).
It is thought that the initial disruption of caspase activity induced by oxidative stress
causes the shift from apoptosis to necrosis and it depends on the intracellular redox state
and redox-sensitive caspase activity to regulate the morphological changes of cell death
(Slater et a l, 1995; Hampton et a l, 1998; Samali et a l, 1999; Curtin et a l, 2002; Ueda et
a l, 2002; Chiou et a l, 2003). fri cells exposed to levels of oxidative stress that induce
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cell death by necrosis instead of apoptosis, there was no activation of caspase-3 
(Hampton and Orrenius, 1997; Hampton et a l, 1998; Ueda et a l, 1998; Samali et a l, 
1999; Ueda et a l, 2002). In addition, cellular ATP has been shown to be essential for the 
induction of apoptosis and it has been suggested that ATP acts as a major decision switch 
between apoptosis and necrosis (Eguchi et a l, 1997; Leist et a l, 1997; Ueda et a l, 2002). 
Therefore, it seems that a single stimulus can initiate different cell signalling pathways 
and the availability of certain proteins, caspase activation and the events in the 
mitochondria such as production of ROS and/or release of cytochrome c can determine 
whether the cell will die by necrosis or by apoptosis (Kalai et a l, 2002) (Fig. 5.19).
In the present investigation the inhibition of caspases by the pan-caspase inhibitor Z- 
VAD-fink and also DEVD-cho failed to protect cells from cell death by duroquinone. 
Consequently, these data strongly suggest that duroquinone-induced cell death occurred 
by a caspase-independent mechanism of apoptosis and necrosis. It has been reported that 
the caspase inhibitor Z-VAD-fink only partially inhibited apoptotic cell death caused by 
oxidative stress-mediated by the exposure to hydrogen peroxide in liver cells. 
Furthermore, Z-VAD-fink failed to inhibit Bax cleavage and translocation to the 
mitochondria and the subsequent initiation of the apoptotic process (Tamura et a l, 2003).
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Figure 5.19. Redox control of the cell death process.
The mitochondria represent a convergence point fo r the action o f ROS. The damage 
inflicted on mitochondria will decide whether cell death occurs by necrosis or apoptosis. 
M ild oxidative stress will lead to apoptosis with the release o f cytochrome c and caspase 
activation. However, severe oxidative stress will lead to necrosis with the release o f 
cytochrme c but causes the inhibition o f caspase activity and the apoptotic pathway 
(Kaplowitz, 2000; Kass et a l, 2000; Ueda et a l, 2002).
The inhibition of calpains failed to protect HuH7 cells from cell death by duroquinone-
triggered oxidative stress. This is in agreement with Tamura et al. (2003) who
demonstrated that calpain inhibitors failed to influence Bax cleavage and translocation to
the mitochondria and this inhibition did not prevent the apoptotic cell death process
induced by oxidative stress in liver cells. Furthermore, previous work showed that
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inhibition of calcium-activated proteases such as calpains did not block oxidative-stress 
induced apoptosis (Nicotera et a l, 1986), In contrast, the pharmacological inhibition of 
serine proteases with TPCK protected the HuH7 cells jfrom cell death by duroquinone at 
the 30 hour time point although this protection was incomplete and the importance of this 
biological effect would need further investigation. Even though, serine proteases have 
shown to play an important role in apoptosis (Duan et a l, 1996; Wolf and Green, 1999; 
Lieberman, 2003; Stenson-Cox et a l, 2003), previous work has demonstrated that the 
inhibition of these proteases by TPCK prevented TNF-induced necrosis while anti-CD95- 
induced apoptosis was not affected in a human fibrosarcoma cell line (Denecker et a l, 
2001). On the other hand, TPCK has previously shown to partially inhibit anti-CD95- 
induced apoptosis in hepatocytes (Jones et a l, 1998) and also TPCK has shown to 
prevent anti-CD95-induced apoptosis in Jurkat cells (Weis et a l, 1995) and other 
apoptotic systems (Weaver et a l, 1993).
The stress protein kinase signalling, JNK is a target of ROS which causes its pro- 
apoptotic activation (Ichijo et a l, 1997; Seanor et a l, 2003). However, the 
pharmacological inhibition of JNK confirmed that the signalling of this stress-activated 
kinase is not involved in duroquinone-induced cell death in the HuH7 cells despite of its 
activation. Similarly, pro-apoptotic GSK-3 which has shown to be involved in ER-stress- 
induced apoptosis (Song et a l, 2002) played no role in oxidative stress-mediated 
apoptosis in the HuH7 cells. Therefore the link between oxidative stress and the 
activation of the cell death process (apoptosis and necrosis) needs further investigation.
Taken together, this study has shown that duroquinone-induced toxicity by oxidative
stress caused cell death by apoptosis and necrosis in both primary hepatocytes and HuH7
cells. Duroquinone was shown to induce apoptosis via the activation of the
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mitochondrial pathway with the release of cytochrome c and Smac/DIABLO from the 
mitochondria to the cytosol to cause cell death. Bax was found to translocate from the 
cytosol to the mitochondria to allow the release of cytochrome c. Although the 
executioner caspases-3 and -7 were activated by duroquinone-induced toxicity, their 
inhibition did not prevent cell death by apoptosis induced by oxidative stress which 
occurred by a caspase-independent mechanism. The inhibition of serine protease 
protected from cell death by oxidative stress however, this inhibition was not complete. 
Most likely, the majority of HuH7 cells were driven to necrosis by the oxidative stress 
damage caused by duroquinone. In addition, both pro-apoptotic enzymes, JNK and 
GSK-3 did not play a role in the initiation of oxidative stress-mediated cell death by 
duroquinone. Thus, the link between oxidative stress and the initiation of the cell death 
process (apoptosis and necrosis) needs to be further investigated.
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CHAPTER 6
GENERAL DISCUSSION
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Liver cell injury or cell death is a common occurrence in clinical conditions. Therefore, 
the research into the molecular mechanisms leading to cell death is of great importance to 
understand human liver damage and disease (Kaplowitz, 2000; Kaplowitz, 2002). The 
liver plays a central role in the metabolism of xenobiotics and thus, it is a major target of 
drug-induced toxicity. Liver toxicity is the major cause of drug withdrawal for safety 
reasons during drug development which at the moment can only be detected at the later 
stages of animal toxicity studies or clinical trials due to the lack of an universal in vitro 
screening approach for early identification of hepatotoxins (Ballet, 1997). Even though, 
evidence has demonstrated that apoptosis is the major cell death mechanism in liver 
disease (Patel et a l, 1999), the role and mechanisms of apoptosis is still unclear in 
xenobiotic-induced liver toxicity.
In this study, the ability of drugs to trigger apoptosis in liver cells was investigated using 
two cellular models, including primary mouse hepatocytes and the hepatoma cell line, 
HuH7. This investigation was carried out using three model compounds, a hepatotoxin 
paracetamol, thapsigargin and duroquinone. Whereas paracetamol is a well established 
hepatotoxin, the other two compounds were chosen to represent two major mechanisms 
of drug-induced cellular injury, namely ER stress and oxidative stress, respectively.
Extensive research into the apoptotic cell death process has demonstrated that caspases 
play an essential role into the regulation of this so important cell death process (Fesik and 
Shi, 2001). The treatment of HuH7 cells with paracetamol, thapsigargin or duroquinone 
caused the activation of caspases-3 and -7. These two effector downstream cysteine 
proteases are known to be the main executioner caspases involved in the cleavage of 
strategic cellular substrates to cause the dismantling of the cellular structure and
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subsequent cell death. Also, these caspases have shown to link both the mitochondrial 
pathway and the receptor-mediated pathway so that there is an extensive crosstalk of the 
apoptotic process (Engels et a l, 2000). Caspases played a crucial role both in 
paracetamol and thapsigargin-induced apoptosis in the HuH7 cells. This important role 
of caspases is illustrated by the findings that the pan-caspase inhibitor, Z-VAD-fmk 
caused almost complete prevention of cell death by apoptosis. Similarly, the 
development of paracetamol-induced liver damage by apoptosis in vivo was significantly 
prevented by the inhibition of caspase activation with Z-VAD-fmk. The latter was 
administered to the mice before normal treatment with paracetamol (El-Hassan et a l,
2003). However, most in vivo and in vitro studies which have investigated paracetamol- 
induced apoptosis in the liver have failed to detect caspase activation (Lawson et a l, 
1999; Gujral et a l, 2002; Pierce et a l, 2002; El-Hassan et a l, 2003). Thus, it is 
generally thought that the apoptotic response-induced by paracetamol is not properly 
executed, and most likely degenerates to premature secondary necrosis (Adams et a l, 
2001; Pierce et a l, 2002; El-Hassan et a l, 2003).
It has been suggested that the lack of caspase activation can be due to various reasons
including, the oxidation or covalent adduct formation with the caspases, which can cause
their inactivation and also interfere with their activation process (Nobel et a l, 1997;
Hentze et a l, 1999; Lawson et a l, 1999). Paracetamol is known to produce protein
covalent adducts. However, no paracetamol-caspase adducts have been reported as yet.
Also glutathione depletion occurs after paracetamol administration, this by itself has been
shown to block apoptosis and specifically the enzymatic activity of caspases-8, -9 and the
executioner caspase-3 (Hentze et a l, 2002; Hentze et a l, 2003). Another reason for the
failure of caspase activation could be the rapid depletion of cellular ATP which also is a
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characteristic of paracetamol intoxication (Jaeschke et a l, 2003). ATP together with 
cytochrome c is essential for the formation of the apoptosome and therefore the 
subsequent activation of the caspase cascade (Bemardi et a l, 1999; Hengartner, 2000). 
Paracetamol is also known to produce ROS and therefore, can induce severe oxidative 
stress like the prooxidant duroquinone (Wendel et a l, 1979; Wendel and Jaeschke, 1982; 
Wendel et a l, 1982; Wendel, 1983; Wendel and Hallbach, 1986; Jaeschke et a l, 2003). 
Thus, another reason for the inability to activate caspases may relate to the production of 
ROS which can block caspase activity and shift the apoptotic cell death process from 
apoptosis to necrosis (Hirsch et a l, 1997; Kaplowitz, 2000; Ueda et a l, 2002; James et 
a l, 2003).
Still the ultimate reason why caspase-3 activation is not detected or occurs to only a small 
extent in vivo but is readily detected in vitro such as in the HuH7 (this thesis) or SK-Hepl 
cells (Boulares et a l, 2002) is not entirely clear. The difference may be related to the 
rapid transition in vivo from apoptosis to necrosis following limited activation of 
initiation caspases. This issue remains to be further investigated. Nevertheless, caspases 
have shown to play an important causal role in the mechanism of paracetamol-induced 
hepatic damage both in vivo and in vitro (Boulares et a l, 2002; El-Hassan et a l, 2003; 
Macanas-Pirard et a l, 2005).
The mitochondrial PTP is thought to allow the release of pro-apoptotic proteins such as 
cytochrome c and Smac to activate the apoptotic caspase cascade and induce cell death 
(Bemardi et a l, 2001). However, this mitochondrial megachannel did not play an 
essential role in the initiation of apoptosis by paracetamol, thapsigargin or duroquinone 
as its pharmacological inhibition showed no protection from cell death by apoptosis in
-207-
the HuH7 cells. Notwithstanding, the Bcl-2 family member protein, Bax has been widely 
investigated and was found to form mitochondrial pores in synthetic membranes to 
potentially allow the release of cytochrome c and Smac in the absence of mitochondrial 
PTP formation (Epand et a l, 2002; Kuwana et a l, 2002). Therefore, Bax is thought to 
provide an alternative mechanism for the release of pro-apoptotic proteins to cause 
apoptosis (Eskes et a l, 1998; Smaili et a l, 2001; Nutt et a l, 2002; Roucou et a l, 2002; 
Scorrano and Korsmeyer, 2003). This pro-apoptotic protein, Bax was found to play a 
role in apoptosis-induced by all three compounds (paracetamol, thapsigargin and 
duroquinone) and therefore seems to play an important role in the induction of the 
mitochondrial pathway of apoptosis by allowing the release of cytochrome c in these 
hepatoma cells. Bax translocation to mitochondria seems an important marker for drug- 
induced apoptosis via the mitochondrial pathway in the HuH7 cells.
Paracetamol is bioactivated in the endoplasmic reticulum to the reactive metabolite
NAPQI and paracetamol-induced cell injury also leads to cellular oxidative stress
(Bessems and Vermeulen, 2001). Having ruled out a direct effect of ROS or NAPQI in
mitochondria in the initiation of apoptosis, I decided to investigate the potential role of
stress-activated kinases in paracetamol-induced apoptosis. Members of this family of
MAPKinases are known to be activated when cells are subjected to conditions of stress
(Kyriakis and Avruch, 2001; Coffey et a l, 2002). Therefore, the role of stress-activated
INK was investigated as a potential mediator of the apoptotic cell death process after
drug-induced toxicity in the HuH7 cells by paracetamol and also by thapsigargin and
duroquinone. INK has recently been shown to be pro-apoptotic (Elyaman et a l, 2002b;
Lin and Dibling, 2002; Bae and Son, 2003; Kang et a l, 2003; Marderstein et a l, 2003).
The treatment of cells with the compounds, paracetamol, thapsigargin or duroquinone
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caused the phosphorylation and activation of JNK prior to apoptosis, as evidenced by the 
detection of the corresponding phospho-JNK bands. Interestingly, the pattern of JNK 
activation was distinct from that elicited by paracetamol and the ER stress inducer 
thapsigargin (both compounds showed mainly phosphorylation of the upper JNK band) 
(Fig. 3.22 and 4.21) with that elicited by the prooxidant duroquinone (preferential 
phosphorylation of the lower band of JNK) (Fig. 5.17). Consequently, this pattern of 
JNK activation by paracetamol was not primarily due to the oxidative stress damage to 
cells. As paracetamol has shown recently to also cause ER stress in cells (Lorz et a l,
2004), the specific pattern of JNK activation like by thapsigargin could have been caused 
by the induction of cellular ER stress. However, the pharmacological inhibition of JNK 
demonstrated that this pro-apoptotic stress kinase signalling pathway was not primarily 
involved in paracetamol, thapsigargin and duroquinone-induced liver cell death. 
Likewise, the inhibition of p38 MAP kinase or MEK failed to modulate the ability of 
paracetamol to trigger apoptosis in the HuH7 cells.
Recently, GSK-3 has also shown to have a key pro-apoptotic modulatory effect in 
apoptosis linked to the induction of cellular ER-stress (Song et a l, 2002). Here, GSK-3 
was shown to play a crucial role as a major regulator of the apoptotic response-mediated 
by paracetamol and thapsigargin however GSK-3 did not alter duroquinone-induced cell 
death. Paracetamol has recently been shown to induce ER stress in kidney cells (Lorz et 
a l, 2004). These data suggest that GSK-3 activation could be a potential marker for 
apoptosis in drug-induced toxicity by ER-stress in HuH7 cells.
In conclusion, the hepatotoxin paracetamol induces apoptosis in HuH7 liver cells by the 
activation of the mitochondrial pathway of apoptosis through the release of pro-apoptotic
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factors such as cytochrome c and Smac/DIABLO. The release of pro-apoptotic 
cytochrome c, enabled by Bax, leads to downstream caspase activation and the cleavage 
of key cellular substrates to cause cell death by apoptosis (Fig. 6.1). A major regulator of 
the apoptotic response was identified to be GSK-3 which can represent a potential link 
between paracetamol-induced ER stress and the mitochondrial pathway of apoptosis.
Similarly, thapsigargin-induced ER stress triggers apoptosis in HuH7 cells by the 
activation of the mitochondrial pathway of apoptosis through the release of pro-apoptotic 
factors such as cytochrome c and Smac/DIABLO. The release of pro-apoptotic 
cytochrome c mediated by Bax, leads to caspase activation and cell death (Fig. 6.2). A 
major regulator of the apoptotic response was identified to be GSK-3 which can represent 
a potential link between thapsigargin-induced ER stress and the mitochondrial pathway 
of apoptosis.
The molecular mechanism of GSK-3 activation by paracetamol and thapsigargin needs to 
be further investigated and also the link between GSK-3 activation and the activation of 
the mitochondrial pathway of apoptosis is unclear and needs further investigation. 
Similarly, it would be important to study the effect of GSK-3 modulation in paracetamol 
hepatotoxicity in vivo.
Previous work has shown that caspase-12 plays an important role in ER stress-induced 
apoptosis (Nakagawa and Yuan, 2000; Nakagawa et a l, 2000; Rao et a l, 2001; Xie et 
a l, 2002; Kitamura et a l, 2003; Sohn et a l, 2003). Although the role of caspase-12 is 
still controversial in human cells due to the acquisition of inactivating gene mutations 
which may prelude the expression of a frill length active caspase-12 protein (Fischer et
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a l, 2002), it would be important to investigate the role of this protease in paracetamol 
and thapsigargin-induced ER stress in the HuH7 cells.
The prooxidant, duroquinone caused cell death in the HuH7 cells by both apoptosis and 
necrosis (Fig. 6.3). Induction of apoptosis occurred via the mitochondrial pathway with 
the release of cytochrome c and Smac/DIABLO and followed by the activation of the 
caspase cascade. However, the pharmacological inhibition of caspases with the general 
caspase inhibitor, Z-VAD-fmk demonstrated that caspases do not play a role in oxidative 
stress-induced apoptosis by duroquinone in the HuH7 cells. These data suggest that 
duroquinone-induced apoptosis occurred by a caspase-independent mechanism even 
though caspases were activated. Nevertheless, due to the cellular damage inflicted by 
duroquinone-mediated oxidative stress, most HuH7 cells were driven to necrosis rather 
than apoptosis.
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Figure 6.1. Schematic representation of paracetamol-induced apoptosis in the 
HuH7 cells.
This pathway represents the working relationship between paracetamoVs reactive 
metabolite NAPQI, GSK-3, Bax and their action on the mitochondria to induce the 
release o f cytochrome c to the cytosol and the subsequent caspase activation to cause cell 
death by apoptosis. It is also shown the role played by the pan-caspase inhibitor, Z- 
VAD-fmk in modulating this apoptotic cell death pathway.
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Figure 6.2. Schematic representation of thapsigargin-induced apoptosis in the 
HuHT cells.
This cell death pathway represents the working relationship between thapsigargin- 
induced ER stress, GSK-3, Bax and their action on the mitochondria to induce the release 
o f cytochrome c to the cytosol and the subsequent caspase activation to cause cell death 
by apoptosis. It is also shown the role played by the pan-caspase inhibitor, Z-VAD-fmk 
in modulating this apoptotic cell death pathway.
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Figure 6.3. 
HuH7 cells.
Schematic representation of duroquinone-induced apoptosis in the
This diagram represents the cell death process induced by duroquinone. This pathway 
represents the working relationship between ROS and Bax and their action on the 
mitochondria to induce the release o f cytochrome c and cause cell death by apoptosis or 
necrosis.
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